Le rôle de H19, un long ARN non codant dans le système immunitaire by Yang, Junjie
HAL Id: tel-02459135
https://tel.archives-ouvertes.fr/tel-02459135
Submitted on 29 Jan 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
The role of H19, a long non-coding RNA in the immune
system
Junjie Yang
To cite this version:
Junjie Yang. The role of H19, a long non-coding RNA in the immune system. Immunology. Université
Sorbonne Paris Cité, 2018. English. ￿NNT : 2018USPCC206￿. ￿tel-02459135￿
																																																																																																																						
	
Thèse	de	doctoratde		
l’Université	Sorbonne	Paris	Cité	
Préparée	à	l’Université	Paris	Diderot	
Ecole	Doctorale	BioSPC,	ED	562	
The	role	of	H19,	a	long	non-coding	RNA	in	
the	immune	system	
Par	Junjie	Yang	
Thèse	de	doctorat	d’Immunologie	
Dirigée	par	Ana	Cumano	
Présentée	et	soutenue	publiquement	à	Paris	le	17/10/2018	
 
 
 
Jury 
Président du jury : Antonino	Nicoletti/ Professor / INSERM/ Denis	Diderot	University	(P7)	
Rapporteurs	:	Dinis	Calado	/	Professor	/	Francis Crick Institute	
Rapporteurs	:	Joan	Yuan / Associate Professor / Lund	University		
Examinateurs	:	Thierry	Defrance	/	Professor	/	École	normale	supérieure	de	Lyon	
Examinateurs : Bruno	Canque/	Professor	/	École	Pratique	des	Hautes	Etudes 
Directeur	de	thèse	:	Ana	Cumano	/	Professor	/	Institut	Pasteur	
Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																							
	
	
Le rôle de H19, un long ARN non codant dans le système immunitaire 
	
Résumé :  
L'empreinte génomique, une régulation épigénétique unique entraînant une expression 
génique spécifique aux parents d'origine, est essentielle au développement et à la croissance 
des mammifères. H19 est un ARN long non codant exprimé en milieu maternel qui est un 
régulateur central du réseau de gènes à empreinte contrôlant le développement. H19 est 
exprimé pendant le développement embryonnaire dans de nombreux tissus, y compris toutes 
les cellules hématopoïétiques. Le rôle de H19 au cours du développement embryonnaire n'a 
été documenté que pour le placenta où il contrôle la croissance. Le rôle de H19 dans la 
lymphopoïèse n'a pas été étudié. Notre laboratoire a précédemment trouvé H19 comme 
principal transcrit exprimé sélectivement par les proB du foie fœtal (FF), et exprimé de façon 
différentielle par des immigrants thymiques précoces et tardives. Cependant, le rôle du gène 
H19 dans celui du développement des cellules B, ou même dans le système immunitaire, reste 
méconnu. Ici, nous avons réalisé une caractérisation complète des perturbations du 
développement et de la fonction du système immunitaire des souris pour lesquelles un grand 
segment du locus H19 a été supprimé. 
Dans cette étude, nous avons constaté que le mutant H19 avait un impact spécifique sur le 
développement des cellules du FF induisant une augmentation sélective du nombre des 
cellules proB BP1+ présentant des perturbations importantes du réarrangement du locus IgH. 
On observe également chez les animaux H19-/- adultes une expansion anormale du 
compartiment B mature.	 Bien que H19 ne soit plus exprimé après la naissance, les 
lymphocytes B des souris adultes mutantes présentent un phénotype altéré. On observe en 
effet des perturbations importantes du profil d'expression du marqueur B220. Les souris H19-/- 
présentent un défaut d'expansion des lymphocytes B du centre germinatif, ainsi qu'une chute 
de la production des IgM spécifiques dans le sérum	 après immunisation. Indiquant une 
réponse défectueuse des cellules B. De manière cohérente, nous avons trouvé une réactivité 
réduite au BCR des cellules B naïves H19-/-, associée les expériences de reconstitution 
compétitive ont mis en évidence un altération cellule-intrinsèque de la réponse humorale chez 
les animaux mutants. Un défaut d'induction de l'expression des molécules du CMHII, CD40, 
et CD86, qui pourrait être à l'origine des perturbations de la réponse humorale observée chez 
les souris H19-/-. Les analyse de transcriptome réalisées sur les lymphocytes B du centre 
germinal des animaux mutants ont mis en évidence une expression différentielle des gènes 
impliqués dans la régulation de l'intensité du signal émanant du récepteur B à l'antigène.  
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Au total ce travail nous a permis de démontrer l'activité régulatrice exercée par l'ARN non 
codant H19 sur le développement et la fonction du système immunitaire. 
 
 
Mots clefs : LncRNA H19, développement des lymphocytes B, réponse des lymphocytes 
B,	réactivité BCR, réaction du centre germinal. 
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The role of H19, a long non-coding RNA in the immune system 
 
Abstract:  
Genomic imprinting, a unique epigenetic regulation resulting in a parent-of-origin specific 
gene expression, is essential for normal mammalian development and growth. H19 is a 
maternally expressed long non-coding RNA that is a central regulator of the imprinting gene 
network controlling development and growth. H19 is expressed throughout embryonic 
development in multiple tissues including all hematopoietic cells. The role of H19 during 
embryonic development has only been documented for the placenta where it controls growth 
and the role of H19 in lymphopoiesis has not been investigated. The laboratory has previously 
found H19 as the major differentially expressed transcript in two microarrays comparing fetal 
liver (FL) and bone marrow (BM) derived pro-B cells, as well as between early and late 
thymic settling progenitors. However, a role for imprinting gene H19 in B cell development, 
or even in immune system remains elusive. Here we sought to analyze mice where a large 
segment of the H19 locus has been deleted.  
In our work, we found that loss of H19 have specific impact on the FL B cell development by 
producing increased numbers of BP1+ proB cell. Although BP1+ proB cells from H19-/- FL 
showed impaired Ig heavy chain V-D-J rearrangement, that increase resulted in a net enlarged 
B cell compartment in the adult periphery of H19 mutant. In adult mice, although H19 is not 
expressed in B lymphocytes after birth, B cells from H19-/- mice exhibited altered B cell 
surface phenotype, represented by an upregulated B220 expression on all B cell subsets. After 
immunization with different T cell dependent antigens, H19-/- exhibits reduced GC B cells, 
and impaired specific IgM titer in the serum, indicating a defected B cell response in H19-/- 
mice. Competitive reconstitution analysis showed a B cell autonomous impairment in the B 
cell response. Consistently we found a reduced BCR responsiveness of H19-/- naïve B cells 
that together with less efficient upregulation of MHCII and CD40 expression after 
immunization might be responsible for the impaired immune response in H19-/- mice. 
Genome-wide transcription analysis revealed differential expression of genes involved in 
regulating the intensity of B cell receptor signaling.  
This work brings new insights on the regulation role of long non-coding RNA H19 in the 
early B cell development and immune system 
Keywords: LncRNA H19, B cell development, B cell response, BCR responsiveness, GC 
reaction. 
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Le rôle de H19, un long ARN non codant dans le système immunitaire 
	
Résumé :  
L'empreinte génomique, une régulation épigénétique unique entraînant une expression 
génique spécifique aux parents d'origine, est essentielle au développement et à la croissance 
des mammifères. H19 est un ARN long non codant exprimé en milieu maternel qui est un 
régulateur central du réseau de gènes à empreinte contrôlant le développement. H19 est 
exprimé pendant le développement embryonnaire dans de nombreux tissus, y compris toutes 
les cellules hématopoïétiques. Le rôle de H19 au cours du développement embryonnaire n'a 
été documenté que pour le placenta où il contrôle la croissance. Le rôle de H19 dans la 
lymphopoïèse n'a pas été étudié. Notre laboratoire a précédemment trouvé H19 comme 
principal transcrit exprimé sélectivement par les proB du foie fœtal (FF), et exprimé de façon 
différentielle par des immigrants thymiques précoces et tardives. Cependant, le rôle du gène 
H19 dans celui du développement des cellules B, ou même dans le système immunitaire, reste 
méconnu. Ici, nous avons réalisé une caractérisation complète des perturbations du 
développement et de la fonction du système immunitaire des souris pour lesquelles un grand 
segment du locus H19 a été supprimé. 
Dans cette étude, nous avons constaté que le mutant H19 avait un impact spécifique sur le 
développement des cellules du FF induisant une augmentation sélective du nombre des 
cellules proB BP1+ présentant des perturbations importantes du réarrangement du locus IgH. 
On observe également chez les animaux H19-/- adultes une expansion anormale du 
compartiment B mature.	 Bien que H19 ne soit plus exprimé après la naissance, les 
lymphocytes B des souris adultes mutantes présentent un phénotype altéré. On observe en 
effet des perturbations importantes du profil d'expression du marqueur B220. Les souris H19-/- 
présentent un défaut d'expansion des lymphocytes B du centre germinatif, ainsi qu'une chute 
de la production des IgM spécifiques dans le sérum	 après immunisation. Indiquant une 
réponse défectueuse des cellules B. De manière cohérente, nous avons trouvé une réactivité 
réduite au BCR des cellules B naïves H19-/-, associée les expériences de reconstitution 
compétitive ont mis en évidence un altération cellule-intrinsèque de la réponse humorale chez 
les animaux mutants. Un défaut d'induction de l'expression des molécules du CMHII, CD40, 
et CD86, qui pourrait être à l'origine des perturbations de la réponse humorale observée chez 
les souris H19-/-. Les analyse de transcriptome réalisées sur les lymphocytes B du centre 
germinal des animaux mutants ont mis en évidence une expression différentielle des gènes 
impliqués dans la régulation de l'intensité du signal émanant du récepteur B à l'antigène.  
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Au total ce travail nous a permis de démontrer l'activité régulatrice exercée par l'ARN non 
codant H19 sur le développement et la fonction du système immunitaire. 
 
 
Mots clefs : LncRNA H19, développement des lymphocytes B, réponse des lymphocytes 
B,	réactivité BCR, réaction du centre germinal. 
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The role of H19, a long non-coding RNA in the immune system 
 
Abstract:  
Genomic imprinting, a unique epigenetic regulation resulting in a parent-of-origin specific 
gene expression, is essential for normal mammalian development and growth. H19 is a 
maternally expressed long non-coding RNA that is a central regulator of the imprinting gene 
network controlling development and growth. H19 is expressed throughout embryonic 
development in multiple tissues including all hematopoietic cells. The role of H19 during 
embryonic development has only been documented for the placenta where it controls growth 
and the role of H19 in lymphopoiesis has not been investigated. The laboratory has previously 
found H19 as the major differentially expressed transcript in two microarrays comparing fetal 
liver (FL) and bone marrow (BM) derived pro-B cells, as well as between early and late 
thymic settling progenitors. However, a role for imprinting gene H19 in B cell development, 
or even in immune system remains elusive. Here we sought to analyze mice where a large 
segment of the H19 locus has been deleted.  
In our work, we found that loss of H19 have specific impact on the FL B cell development by 
producing increased numbers of BP1+ proB cell. Although BP1+ proB cells from H19-/- FL 
showed impaired Ig heavy chain V-D-J rearrangement, that increase resulted in a net enlarged 
B cell compartment in the adult periphery of H19 mutant. In adult mice, although H19 is not 
expressed in B lymphocytes after birth, B cells from H19-/- mice exhibited altered B cell 
surface phenotype, represented by an upregulated B220 expression on all B cell subsets. After 
immunization with different T cell dependent antigens, H19-/- exhibits reduced GC B cells, 
and impaired specific IgM titer in the serum, indicating a defected B cell response in H19-/- 
mice. Competitive reconstitution analysis showed a B cell autonomous impairment in the B 
cell response. Consistently we found a reduced BCR responsiveness of H19-/- naïve B cells 
that together with less efficient upregulation of MHCII and CD40 expression after 
immunization might be responsible for the impaired immune response in H19-/- mice. 
Genome-wide transcription analysis revealed differential expression of genes involved in 
regulating the intensity of B cell receptor signaling.  
This work brings new insights on the regulation role of long non-coding RNA H19 in the 
early B cell development and immune system 
Keywords: LncRNA H19, B cell development, B cell response, BCR responsiveness, GC 
reaction. 
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1 The immune system 
The immune system protects the organism against invasive pathogens or foreign 
environmental antigens. It is a highly organized and effective system to prevent morbidity 
through the coordination of various components of this system, such as immune cells and 
effector molecules. To combat a great variety of pathogens and non-self-antigens, the immune 
system comprises different layers of defense the most distinguishable of which are innate and 
adaptive immune systems. The former serves as a first line of defense which plays a crucial 
role in protecting the organism from pathogens, this process is taking place at the very 
beginning of the infection through the recognition of some common features of the pathogens, 
such as the relatively conserved structural moieties in microorganisms, called pathogen 
associated molecular patterns (PAMPs). However, the function of the innate immune system 
is limited because the recognition of pathogens is a rather unspecific process through 
invariant receptors, being therefore inefficient in eliminating infectious organisms. If the 
innate immune reaction does not eliminate a pathogen, another more effective mechanism 
called adaptive immune reaction is adopted to better protect the organism. The immune cells 
and molecules in this system are more specific against pathogens in comparison to the innate 
immune system. The adaptive immune system, consisting of B and T lymphocytes and a 
variety of effector molecules, is responsible for the specific humoral and cellular protection 
against foreign antigens or microorganisms. Furthermore, the immunological specificity of B 
and T lymphocytes is due to the diversity of antigen receptors on their surface (Tonegawa, 
1983). For example, the B cell receptor (BCR) is a membrane bound immunoglobulin (Ig), 
which can also be secreted after B cell activation to exert their immunological function 
through binding to foreign antigens or microorganisms. By contrast the T cell receptor (TCR), 
which is not secreted, can bind to the peptide fragments from foreign antigens presented by 
major histocompatibility complex molecules (MHC). Moreover, B lymphocytes can adjust 
their effector functions and adjust the affinity of its immunoglobulin by undergoing somatic 
hyper-mutation (higher mutation rate in the variable regions of the immunoglobulin genes) to 
enhance the antibody affinity. During B cell activation immunoglobulins can switch their 
initial immunoglobulin constant region from M (IgM) and/or IgD to IgA, IgG or IgE 
antibodies through a process called Ig class switch recombination. Both processes are 
mediated by AID (B cell–specific activation-induced cytidine deaminase). In addition, the 
adaptive immune system can also induce a memory response, which mediates a faster and 
stronger response against re-infection of the same pathogen (Bevan, 2011), and this memory 
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response provides a long term or even lifelong protection. The synergistic action of both the 
innate and the adaptive immune system is the basis for a rapid, highly specific and protective 
immune response against potentially pathogenic microorganisms. This allows survival in a 
principally hostile microbial environment.  
 
  
1.1 B cells in the immune system 
1.1.1 B1 cells  
B lymphocytes, the core cellular mediators of adaptive immunity, are divided into B1 and B2 
cells. In contrast to B1 cells, Extensive studies showed that B1 cells mainly localized in 
peritoneal cavity and pleural cavity, as well as spleen, exhibiting an innate-like immune 
function for a rapid response characterized by secreting essentially poly-reactive, IgM 
dominated, low-affinity antibodies. Thus, they are grouped into innate rather than in the 
adaptive immune branch.  
B1 cells are mainly derived from the FL B lymphocyte development (Hayakawa et al., 1985a). 
One hypothesis to explain the origin of B1 cells is that B1 cells derive from distinct 
precursors from that of B2 cells (Herzenberg, 2000). However, later studies indicated that B1 
cells originate also from adult HSC (Lam and Rajewsky, 1999; Düber et al., 2009), and they 
share the same progenitors as B2 cells. Recent evidence shows that Lin28b expression in FL 
HSC correlates with the B1 cells production versus that of B2 cells (Kristiansen et al., 2016). 
Phenotypically, B1 cells are characterized as CD19hiB220loCD43+CD23-IgMhiIgDlo, they 
have self-renewal capacity and can be further divided into B1a and B1b cells by the 
expression of CD5 on the cell surface of the B1a cells (Baumgarth, 2011). Other major 
features of B1 cells include less diverse BCR repertoire compared to B2 cells caused by 
limited usage of Ig heavy chain V segments and lower N sequences insertion in the V-D-J 
joining mediated by TdT (terminal deoxynucleotidyl transferase) during its development 
(Schatz and Swanson, 2011). 
Because of their anatomical location (various cavities), these cells are more prone to access 
and respond to pathogens. In this process, Toll-like receptors (TLRs) appear to play an 
important role in early host defence recognizing conserved structural moieties in 
microorganisms, called pathogen associated molecular patterns (PAMPs), including LPS, 
peptidoglycan, sugar mannose, unmethylated CpG DNA, bacterial flagellin, glucans from 
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fungal cell walls. In addition, activation of innate-like B1 cells can also produce a wide 
variety of effectors, such as chemokines, cytokines, anti-microbial factors, etc.(Janeway, 
2002). However, B1 cells show a limited diversity of BCR and initially produce membrane or 
secreted form of IgM, and B1 cell response is not antigen specific and lack of memory 
response which provide a recall response and long-term immunity against pathogens, a 
feature of the adaptive immune branch. 
 
1.1.2 B2 cells 
Another B cell subset called B2 cell, also known as conventional B cell, which comprise two 
major subsets: marginal zone B cell (MZB) and follicular B cell (FOB). MZB cells, defined 
as CD19+B220+IgMhiCD23-CD21+, are characterized by their ability to effect early and rapid 
responses against pathogens. MZB cells mainly reside in the unique location called marginal 
zone in the white pulp of the spleen. They are non-recirculating B cells. Similar to B1 cells, 
MZB cells produce low-affinity pathogen-specific IgM or IgG3 antibodies after being 
activated by T cell independent antigens. FOB cells, characterized as 
CD19+B220+IgM+CD23+CD21lo, represent the majority of B lymphocytes in peripheral 
lymphoid organs such as the spleen and lymph nodes, comprising up to 80–90% of B cells in 
these organs. FOB cells play a crucial role in the adaptive immunity because of their 
capability in producing high-affinity, class-switched, and less cross-reactive antibodies 
against pathogens. Because they are located close to the T cell zone they are well suited to 
respond to T cell dependent (TD) antigens and eventually effect the GC reactions (Victora 
and Nussenzweig, 2012b). Under stimulation with pathogens or foreign antigens, FOB cells 
can be programed with the aid of T helper cells to produce high affinity antigen specific 
antibodies. This B cell population has the capability to undergo extensive proliferation, 
somatic hyper-mutation, and Ig class-switching, to give rise high affinity IgG, IgA, and IgE 
antibodies. In addition, activated B2 cells may undergo further differentiation into antibody 
secreting plasma B cells, as well as memory B cells. However, in contrast to the rapid 
response of B1 cells, FO B2 cells requires days to weeks of activation and undergo Ig class-
switch.  
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1.2 The ontogeny of B cell subsets 
B lymphocytes derive from multipotent HSC first appear in the FL at about embryonic day (E) 
12.5 in mice. These B cell progenitors reside, expand and undergo differentiation in the FL. 
Shortly before birth they gradually migrate to the BM, and sustain B cell production in BM 
throughout the life, although the rate of production declines with age (Min et al., 2006). The 
mechanisms underlying the generation of B1 versus B2 cells as well as those regulating the 
formation of the different B cell subsets are still incompletely understood.  
Two models have been proposed to explain the co-existence of the B1 and B2 (FO and MZ) 
subsets. The first one is the lineage model that postulates that B1 and B2 cells are derived 
from distinct progenitors (Hayakawa et al., 1985a). The other theory is called selection model 
which holds the opinion that the polarization and fate of B1 and B2 cells are driven by the 
strength of BCR signaling (Berland and Wortis, 2002; Dorshkind and Montecino-Rodriguez, 
2007). The evidence of a FL B1 specific progenitor, characterized as lin-
AA4.1+CD19+B220lo/-, added weight to the lineage hypothesis (Montecino-Rodriguez and 
Dorshkind, 2006). These B1 progenitors are abundant in the FL and rare in adult BM, which 
is consistent with the observation of in vivo reconstitution, which demonstrates that FL cell 
transfer can reconstitute B1 cell compartment but BM transfer is less efficient in that 
reconstitution (Hayakawa et al., 1985b). Thus, in the lineage model, B1 cells are viewed as 
mainly produced from fetal B1 specific progenitors, whereas B-2 cells are derived from the 
B2 progenitors that predominate in the adult BM.  
However, This model has been challenged in several experimental systems by other studies, 
which indicated that B1 cells can also originate from adult HSC (Düber et al., 2009; Lam and 
Rajewsky, 1999), and share the same progenitors as B2 cells. These observations provide 
direct support for the selection model, where BCR signaling plays a role in the fate decision 
of different B cell subsets. 
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HSC express the IL7Ra which is a hallmark of lymphoid commitment, are restricted to 
lymphoid lineage by losing other lineage potential in the BM (Kondo et al., 1997), although 
CLPs still retained the dendritic cell differentiation potential (Liu and Nussenzweig, 2010) 
(Douagi et al., 2002). This fate decision process is mainly achieved by differentially 
expression of lineage specific transcription factors that are the key regulators of the lineage 
priming and commitment. In this process, transcription factors, such as Ikaros, E2A, PU.1, 
Ebf1 and Pax5.  Hereafter, we will review the role of these key transcription factors in the B 
cells priming and their identity maintenance. 
 
2.1.1 PU.1 
PU.1 is an Ets-domain transcription factor encoded by the Spi-1 gene and is expressed 
exclusively in cells of the hematopoietic lineage, the expression of PU.1 is upregulated during 
myeloid and B-lymphoid cell development (Reya and Grosschedl, 1998)(McKercher et al., 
1996). PU.1 can regulate its target genes by binding to a PU-box, which is a purine-rich 
sequence near the promoter region of target genes.  
 
PU.1 deficient mice die around embryonic day 18 and lack of both B cells and 
myelomonocytic cells in the FL (McKercher et al., 1996; Scott et al., 1994). The progenitors 
in the FL are also affected in PU.1 deficient mice and multiple studies showed that HSC (Kim 
et al., 2004), lympho-myeloid progenitors (AA4.1+, Lin-)(Scott et al., 1997), as well as CLPs 
and early B cell precursors (IL7R+Kit+) are dramatically impaired in PU.1 deficient embryos 
and in vitro culture showed these progenitors fail to differentiate into B lymphoid or myeloid 
cells. However, the B cell development deficiency can be partially rescued by enforced 
expression of the downstream target genes of PU.1, such as transcriptional factor Ebf1, over 
expression of which can give rise to B cells, while over expression of IL7R can also lead to B 
cell growth but at lower frequencies. These observations indicate that PU.1 affecting B cell 
commitment or development partially through regulating the IL-7R (DeKoter et al., 2002) and 
Ebf1 genes (Betancur et al., 2010).  
Min Y et al described that mice with conditional deletion of Pu.1 in CD19-expressing B cells 
produced an increased compartment of cells resembling B1 cells, while B2 cells were 
compromised. This imbalanced of B1/B2 cell development became more pronounced with 
Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																							
	
	
22	
age, indicating that Pu.1 deletion in B cells resulted in a shift from B2 cells to B1-like cells 
which might associated with B1/B2 cell reprograming (Ye et al., 2005).  
 
2.1.2 Ikaros 
Ikaros genes belong to a zinc finger transcription factor family, widely expressed in 
hematopoietic cells that are key regulators of hematopoiesis. Ikaros was first identified to 
regulate Dntt (encoding TdT) (Lo et al., 1991) and CD3d (Georgopoulos et al., 1992) 
expression, two lymphoid specific genes by binding its regulatory region. In lymphoid lineage 
development, Ikaros deficient mice showed impaired B cell, T cell and NK cell production, 
while the myeloid lineage and erythroid lineage showed no major differences (Georgopoulos 
et al., 1994). Similar deficiency phenotype of B, T, and NK cells was also observed in another 
Ikaros null mouse model in which DNA binding site of Ikaros transcriptional factor was 
deleted (Allman et al., 2003). In addition, in the latter mouse model, the hematopoietic 
progenitors are impaired, with decreased HSC compartment as well as reduced self-renewal 
capacity and severely decreased CLP numbers (Wang et al., 1996; Nichogiannopoulou et al., 
1999).  
 
Ikaros regulates B cell specification, B cell development, maturation and B cell responses in 
different aspects. Ikaros null LMPPs (lymphoid-primed multipotent progenitors) failed to 
express lymphoid genes IL7R and Flt3, signals that are critical for early B lineage 
specification form lymphoid progenitors (Sitnicka et al., 2003). However, B cell development 
was not rescue by overexpression of IL7R and Flt3 in Ikaros-/- LSK cells.  Further studies 
showed that Ikaros also induced Ebf1 expression, which in turn promoted B cell 
differentiation by activating the B cell transcriptional program, and over expression of Ebf1 in 
Ikaros-/- LSK cells rescued B cell potential (Sitnicka et al., 2003; Reynaud et al., 2008). In 
addition, Ikaros contributes to B cell development by regulating signaling from preBCR (pre-
B cell signaling complex). Conditional deletion of Ikaros in proB cells arrested B cell 
development in proB cell stage by downregulating preBCR signaling associated genes and 
upregulating integrin signaling related genes (Thompson et al., 2007; Schwickert et al., 2014). 
Ikaros also plays regulatory roles in Igh locus recombination via activating Rag gene 
expression as well as by controlling VH gene accessibility and constricting the Igh locus to 
allow for antigen receptor recombination (Reynaud et al., 2008). Thus, Ikaros promotes and 
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maintains B cell identity by repressing alternate lineage genes and by concomitantly inducing 
B lineage specific VH segment rearrangement at the Igh locus. 
During B cell response in the periphery, Ikaros regulate B cell activation thresholds 
(Kirstetter et al., 2002), as well as antibody isotype selection via Ig class switch 
recombination (CSR). Ikaros deficient B cells showed higher sensitivity to anti-IgM 
stimulation and Ikaros regulates CSR by activating epigenetic marks and transcription at 
constant region gene promoters.  
Kirstetter et al demonstrated that Ikaros mutant mice exhibit an abnormal serum antibody 
profile, characterized by reduction in IgG3 and IgG1, and increased in IgG2b and IgG2a 
production (Kirstetter et al., 2002). Mechanistically, Ikaros binds the 3’ enhancer and S 
region promoters of Igh locus to increase AID accessibility to Sγ2b and Sγ2a to induce AID 
dependent CSR to IgG2b and IgG2a. Thus, Ikaros is a crucial regulator of CSR through 
modulating transcriptional competition between S regions. 
 
2.1.3 E2A 
The transcription factor E2A is one of the E proteins belong to the helix-loop-helix (HLH) 
protein family, which regulates genes expression through binding to E box domain of DNA 
(Massari and Murre, 2000). E2A is required for lymphopoiesis in regulating both B and T cell 
development, especially controls the initiation of B lymphopoiesis.  
During hematopoiesis, HSC differentiate in a stepwise manner into CLPs, which have a B, T 
and NK cell potential (Nutt and Kee, 2007b). The further differentiation from CLP to B 
lineage is dependent on several transcription factors, such as E2A, EBF1, and Pax5(Nutt and 
Kee, 2007a).  
B cell development in E2A-deficient mice is arrested at the very early stage, at which the 
initiation of immunoglobulin DJ rearrangements is not yet occurred(Bain et al., 1994; Zhuang 
et al., 1994; Borghesi et al., 2005). In the absence of E2A lymphoid progenitors failed to 
express B lineage associated genes, such as Rag1, Pax5, CD19, CD79a (mb1) and λ5, and 
Ebf1 expression is also suppressed. Induced expression of E2A in E2A-deficient progenitors 
can restore Ebf1 expression by binding and activating the promoter of Ebf1 gene (Ikawa et al., 
2004; Smith et al., 2002; Roessler et al., 2007).  Forced retroviral expression of Ebf1 in E2A-
deficient progenitors gives rise to proB cells in vitro cultures, as well as normal V(D)J 
recombination at the IgH locus and show normal expression of B-lymphoid genes (Seet et al., 
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2004). All the evidence indicates that E2A acts upstream of Ebf1 and Pax5 in the initiation of 
the B lineage differentiation program (Bain et al., 1994; Bain et al., 1997).  
 
2.1.4 Ebf1 
Ebf1 (Early B cell factor 1) belong to EBF transcriptional factor family. Ebf1 is exclusively 
expressed in B lineage cells and has a regulatory role in the earliest B cell specification and 
development (Lin and Grosschedl, 1995). Mice deficient in Ebf1 fail to express B lineage 
specific genes, such as Pax5, mb-1, surrogate light chain λ5 and VpreB, etc.(Busslinger, 2004; 
Sigvardsson et al., 2002; Lin and Grosschedl, 1995). B cell development in Ebf1-/- mice is 
blocked and fail to rearrange heavy chain loci. This arrested B cell development phenotype is 
similar to E2A deficiency mice, suggesting these two factors act in concert to control B cell 
development. However, compared to Pu.1, Ikaros and E2A deficient mice, which arrest multi-
lineage cell development, Ebf1 inactivation specifically affects B lineage development, 
indicating that the transcription factors PU.1, Ikaros, and E2A, are expressed prior Ebf1, and 
the onset of B cell differentiation is initiated by Ebf1, which drives B cell specification and 
commitment.  
Ebf1 has abilities to restart B cell program in progenitors deficient in upstream transcription 
factors, including PU.1 and E2A. Ectopic Ebf1 expression in E2A-/- (Seet et al., 2004), Pu.1-/-
(Medina et al., 2004), IL7-/- (Dias et al., 2005; Kikuchi et al., 2005) mice can to some extend 
restore B cell development by inducing B lineage gene expression. This suggests that Ebf1 
plays a crucial role in B cell programing.  
Ebf1 starts to be expressed in CLPs, and expression correlates with B lineage restriction in 
Ly6d+Il7R+ CLPs (Inlay et al., 2009), at which stage most B cell specific genes are not yet 
expressed. Expression of Ebf1 in Ly6d+Il7R+ CLPs is sufficient to activate a B lineage 
specific transcription network, comprising genes such as Pax5 (Mansson et al., 2010), 
accompanied by the silencing of genes of T and NK cells. The importance of Ebf1 in the 
proliferation of B lineage cells is highlighted in a mouse model of Ebf1 conditional deletion 
(Györy et al., 2012). Nechanitzky et al. showed conditional deletion of Ebf1 in committed 
pro-B cells restored innate lymphoid cells (ILCs) and T cells potential after transfer into 
alymphoid mice. However, the T cells derived from Ebf1-deficient proB cells had VDJ 
rearrangements of loci encoding both B cell and T cell antigen receptors (Nechanitzky et al., 
2013), as well as expression of NK, ILC, and T cell specific transcription factors, including 
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Id2, Gata3 and Tcf7, which are normally suppressed by Ebf1. Thus, Ebf1 is required for B 
lineage commitment by repressing alternative cell fates. 
Interestingly, although Ebf1 is required for starting the B lineage programing by activating the 
B cell transcriptional network, it seems dispensable for the maintenance of their expression as 
development progresses. In addition, Ebf1 regulates different sets of genes at different stages 
of B cell development. Conditional deletion of Ebf1 at later B cell developmental stages did 
not result in major differences in the expression of a number of Ebf1 target genes, such as 
Pax5, mb-1 and CD79b that remained expressed after the deletion of EBF1 (Hagman et al., 
1993; Hagman et al., 1991) 
 
2.1.5 Pax5 
Pax5 also called B cell lineage specific activator protein (BSAP) is a member of a paired box 
family 5. Pax5 is exclusively expressed within the B cell lineage, starting from pro-B stage of 
B cell development (Fuxa and Busslinger, 2007). One of the important roles of Pax5 is the 
regulation of CD19 expression. Deficiency of Pax5 arrests B cell development in a stage 
before proB stage in both fetal and adult (Nutt et al., 1997).  However, the Pax5-/- progenitors 
did express E2A and Ebf1, as well as several other B cell-specific target genes. the B cell 
development of Ebf1-/- deficient progenitors cannot be rescued by Pax5 over-expression 
(Medina et al., 2004), suggesting Pax5 functions downstream of E2A and EBF1 in the 
transcription network of early B cell development (Nutt et al., 1998; Nutt et al., 1997). In 
addition, in vitro culture in the presence of IL7 shows that Pax5-/- progenitors can generate 
proB-like cells, while in the presence of other cytokines, Pax5-/- progenitors can differentiate 
into other lineages, such as macrophages, granulocytes, dendritic cells or natural killer cells. 
Pax5-/- proB cells also retain T cell potential in reconstitution assays of Rag2-/- mice (Rolink 
et al., 1999) and in vitro co-culture with OP9-DL1 stromal cells which express the Notch 
ligand Delta-like 1, suggesting Pax5-/- proB progenitor cells are not fully committed to the B 
cell lineage (Rolink et al., 1999; Nutt et al., 1999). These studies show that Pax5 is a critical B 
lineage-specific factor to restrict the differentiation to B lineage pathway and inhibit 
alternative pathways.  
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2.2 B cell development 
B cell development is a highly organized process, which begins in the FL and later shifts to 
the BM where it is maintained throughout life. Early B lymphocyte differentiation starts in 
common lymphoid progenitor cells (CLPs) in the FL during embryogenesis and later in the 
BM and progresses in a stepwise manner (Inlay et al., 2009). Over the past decades, our 
understanding of B cell development has greatly progressed. The first comprehensive scheme 
of B cell development was proposed by Randy Hardy identified 7 different developmental 
fractions (fraction A to F) of B cell precursors in the BM (Hardy and Hayakawa, 1991). In 
this scheme, different developmental stages of B lymphocytes were characterized by B cell 
surface markers, comprising B220, CD43, IgM, HSA (CD24), and BP1. In addition, this 
study also identified the fractions where the Ig heavy and light chain rearrangements occurred. 
In the FL, similar subsets can also be found, but the majority of B lymphocytes do not 
develop beyond the fraction B stage. Fraction A was identified as the first B lineage stage 
characterized by co-expression of B220, CD43 and low level CD24. Additional studies 
showed that this subset also include a population of CLP (Martin et al., 2003; Allman et al., 
1999).  
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2.2.1 Ig heavy chain VDJ rearrangement 
The B lineage marker CD19 was introduced to define B cell development and was integrated 
in the Hardy’s scheme. The most immature B lineage cells co-express CD19, B220 and CD43 
and can be further subdivided with BP1 and HSA (CD24) cell surface markers into three 
subsets (fraction B, C and C’). Expression of CD19 first appears in the fraction B cells 
(defined as CD19+B220+IgM-CD43+CD24+BP1-) in the proB stage, marks B lineage 
commitment and maintenance of B lineage identity, despite that B cell priming is initiated 
before CD19 expression (Nutt et al., 1999; Rumfelt et al., 2006). In CD19+ fraction B stage, 
B lymphocytes start to rearrange Ig heavy chain (IgH) which are composed of variable (V), 
diversity (D) and joining (J) antigen receptor gene segments. The Ig heavy chain 
recombination begins with DH to JH at both IgH alleles. This assembly process is mediated by 
the recombination activating gene 1 and 2 (Rag1 and Rag2), which can bind to the 
recombination signal sequences (RSSs) that flank the V(D)J gene segments to form the 
recombination centers (Schatz et al., 1989; Schatz and Swanson, 2011). This process is finely 
regulated during lymphocyte development (Ji et al., 2010a). During the V(D)J rearrangement, 
the expression of Rag1/2 is exclusively upregulated in lymphocytes. They form a complex to 
induce cleavage of DNA double strands at the RSSs, and then the Rag protein cooperates with 
DNA repair factors to paste the selected DNA double strand ends. This process is called non-
homologous end joining (NHEJ). Briefly, the NHEJ is mediated by several core factors 
comprising Ku70, Ku80, DNA-PKcs (DNA-dependent protein kinase catalytic subunit), 
Artemis endo/exonuclease, XRCC4, DNA-Ligase IV and Xlf. In the NHEJ of VDJ 
rearrangement process, first Rag1/2 induced broken DNA ends are recognized and protected 
by the Ku70/Ku80/DNA-PKcs complex. Then Artemis participates in processing the DNA 
ends and finally the XRCC4/ DNA-Ligase IV/Xlf complex together with later discovered 
DNA repair factor PAXX (Paralog of XRCC4 and Xlf) (Xing et al., 2015; Ochi et al., 2015; 
Craxton et al., 2015) ultimately ligate the ends and reseals the DNA breaks. NHEJ has a 
critical function preventing genetic instability and controls propensity to develop various 
types of cancers, notably leukemia and lymphomas (Alt et al., 2013). Through this process the 
B and T cell receptors generate a large antibody repertoire. Further repertoire diversity is 
induced by a random insertion of nucleotide without template at the end of DNA double 
strand break (DBS) by TdT (Schatz and Swanson, 2011). 
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2.2.2 Pre-BCR selection 
Once a productive VHDHJH recombination has been successful, intracellular Igµ chain is 
produced in fraction C’, defined as CD19+B220+IgM-CD43+CD24hiBP1+, at which stage B 
lymphocytes start to assembly Pre-BCR and go through the Pre-PCR check point, also termed 
positive selection. Pre-BCR complex, similar to the structure of BCR, contains two Igµ chains, 
two surrogate light chains (SLCs) and signal transduction subunits Igα and Igβ. The 
difference between the SLCs and the conventional light chain IgL is that, in contrast to a 
rearranged IgL, the SLC is composed of two germline-encoded invariant proteins, VpreB and 
λ5. Although Pre-BCR is only transiently expressed, it is an important check point of B cell 
development. Once the Pre-BCR is expressed on the cell surface, signals from the Pre-BCR 
provide a rapid feedback and cells undergo further differentiation and maturation. Lack of the 
components of this Pre-BCR lead to arrested B cell development in proB cell stage. In µmt-/- 
mice, which lack transmembrane region of Igµ, results in a block of B cell development in 
proB cell stage (Kitamura et al., 1991).  In mice deficiency in either SLC component λ5 
(Kitamura et al., 1992) or Igα/Igβ (Gong and Nussenzweig, 1996; Pelanda et al., 2002) B cell 
development is also arrested at the proB cell stage. Similar B cell arrest phenotype has also 
been observed in mice deficient in VpreB1 and VpreB2, which are two major isoforms of 
VpreB SLC (Mundt et al., 2001). However, in contrast to Rag1 or Rag2 deficient mice, B cell 
development in mice lack SLC components (λ5 or VpreB) is not completely blocked, rare 
light chain rearrangement prior to heavy chain in proB cells can coupled with Igµ form a 
functional BCR to bypass preBCR check point (Shimizu et al., 2002). The initiation of Pre-
BCR signaling is still not clear whether or not is a ligand dependent process. Some studies 
showed that Galectin-1 and heparin sulfates, produced by the BM stromal cells, can bind the 
preBCR (Gauthier et al., 2002; Bradl et al., 2003). However, no apparent B-cell phenotype is 
observed in galectin-1 deficient mice, indicating that it remains possible that the pre-BCR 
interacts with other ligands. More evidence added by showing the positive charged protein λ5 
is crucial for interacting with some matrix structures in the FL and BM microenvironment, 
such as insulin, lipopolysaccharide, galectin and heparin sulfates (Köhler et al., 2008). The 
poly-reactive λ5 might mediate the crosstalk between preB cell and the microenvironment and 
facilitate the preBCR signaling initiation.  
PreBCR signaling triggers proliferation (several rounds of division in fraction C’) before IgL 
chain rearrangement in the fraction D stage. This process is thought to be mediated by the 
PrePCR signaling through phosphoinositide 3 kinase (PI3K)-protein kinase B (PKB, also 
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called AKT) pathway (Manning and Toker, 2017; Herzog et al., 2009). Pre-BCR signaling 
also provides a feedback of the productive VDJ rearrangement of IgH locus that feeds back 
thus inhibiting VH to DJH recombination at the second IgH allele to establish allelic exclusion 
via downregulating Rag1/2 expression (Grawunder et al., 1995; Mårtensson et al., 2002).  
Allelic exclusion is of great importance to guarantee a single BCR specificity on the B cell 
surface. Mono-specificity of BCR allows efficient generation of self-tolerant B cells and 
contributes to establishing efficient antigen-specific antibody responses. The decision of 
which allele is going to rearrange is mainly accomplished by pre-established epigenetic marks, 
such as DNA methylation and histone modification (Cedar and Bergman, 2008). Thus, 
antigen receptor genes rearrangement and allelic exclusion ensure the immune system to 
generate millions of different antibodies to respond against millions of different antigens in a 
mono-specificity manner.   
 
2.2.3 Ig light chain VJ rearrangement 
In fraction D, successful Ig light chain rearrangement leads to the expression of a complete 
BCR on the cell surface and cells become immature B lymphocytes defined as fraction E 
(CD19+B220+IgM+IgD-). In this process, B lymphocytes close their IgH chain loci and open 
the light chain loci including κ and λ chain and the rearrangement machinery is reactivated, 
i.e. RAG1 and RAG2. Light chain rearrangement first takes place in κ chain locus by bringing 
together Vκ gene segments and Jκ gene segments (Woof and Burton, 2004). A functional, in 
frame-rearranged κ light chain can associate to the pre-expressed IgH to form a BCR 
expressed on the B cell surface. Failed κ light chain rearrangement from both alleles leads to 
λ light chain gene rearrangement by bringing together a Vλ and Jλ.  Functional λ light chain 
also can pair with the pre-expressed IgH to form a BCR in immature B cell or fraction E, 
which can egress from the BM to the peripheral secondary lymphoid organs to complete their 
maturation (Allman et al., 2001). 
This hierarchical light-chain rearrangement process is supported by the evidence that 
impaired V-J rearrangement was observed by deletion of either Igκ enhancers or deletion of 
genes encoding histone-modifying enzymes or transcription factors (Inlay et al., 2002; 
Ribeiro de Almeida et al., 2015). Thus, Igκ locus accessibility is regulated by the recruitment 
of epigenetic markers as well as transcriptional machinery. 
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2.2.4 BCR receptor editing  
Before the immature B cells leave BM, B lymphocytes undergo another check point resulting 
in BCR self-tolerance and elimination of B cells bearing a BCR with strong affinity against 
self-antigens (Norvell et al., 1995). This is accomplished by apoptosis termed clonal deletion 
or via modifying its receptor to form a low self-reactive BCR through receptor editing 
(Halverson et al., 2004). The model of receptor editing proposed by Sebastian et al. postulates 
that B cells that produced an autoreactive BCR, leading to the cross linking of self-antigens, 
trigger internalization of BCR. This induces a secondary IgL gene rearrangements (receptor 
editing) by downregulating PI3K-AKT signaling and upregulating FOXO transcription factor 
expression. In this process, PI3K signaling plays an important role in regulating RAG1 and 
Rag2 expression. Inhibition of PI3K induces Rag1 and Rag2 expression and promotes IgL 
gene recombination. In agreement with this notion is the observation that immature B cells in 
PI3K subunit p85α deficient mice, in which Rag1 and Rag2 expression is poorly suppressed, 
undergo excessive receptor editing (Verkoczy et al., 2007b). Likewise, mice deficient in 
spleen tyrosine kinase (SYK) or CD19, both of which molecules are required for PI3K 
signaling exhibit excessive receptor editing. Receptor editing even in non-autoreactive B cells 
is promoted by loss of SYK, which suggests that SYK reinforced PI3K signaling suppress 
receptor editing (Meade et al., 2004). Downregulation of PI3K-AKT signaling results in re-
expression of the RAG1-RAG2 recombination machinery (Tze et al., 2005; Verkoczy et al., 
2007a). If the editing process result in a non-autoreactive BCR, this is then stably expressed 
on the cell surface, leading to constant BCR signaling activity, then the PI3K-AKT activity 
can be restored, which in turn terminate IgL gene recombination through downregulation of 
FOXO transcriptional factor. Consequently, non-autoreactive BCR expression on the B cell 
surface allows transit through the check point or negative selection and migration out of the 
BM to the periphery where B cells acquire IgD expression and become mature B cells, which 
are defined as fraction F stage (CD19+B220+IgM+IgD+) according to Hardy’s scheme. These 
mature B cells (fraction F) can also circulate to other peripheral organs. 
 
3 B cell activation 
The activation of B cells can occur with or without T cell help, correspondingly termed as T 
cell-dependent (TD) responses and T cell-independent (TI) responses.  
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TI responses can be further divided into TI type 1 (TI-I) and TI type II (TI-II) responses 
according to the engagement of BCR in the B cell activation. TI-I B cell activation results 
from the cross linking of TLR and BCR but cannot be accomplished by TLR activation alone. 
TI-II response is dependent on BCR engagement, or cross-linking of numerous BCRs, i.e. 
polysaccharides can cross-link the BCR on B cell surface because of their repeated antigenic 
sites. In a TD response, B cells not only need a signal for BCR, the second signal provided by 
the T helper cell is also required, this second signal for B cell activation can also come from 
other cells, such as DCs (Cerutti et al., 2012). The innate-like B cell subsets MZBs and B1 
cells are more prone to respond to TI antigens. Their BCR repertoire is limited but showed 
specificities to TI antigens, such as microbial carbohydrates, glycolipids or the apoptotic cells 
(Kearney, 2005). Upon activation by antigen, innate-like MZBs and B1 cells can differentiate 
into antibody producing cells. However, some studies supported that in TI-II immune 
responses, B cells can generate memory B cells (de Vinuesa et al., 2000; Obukhanych and 
Nussenzweig, 2006). TD antigens are mainly protein antigens, they have complex structure of 
antigen epitopes. FOBs are mainly responsible for the response to the TD antigens. Briefly, 
the naïve B cells in the secondary lymphoid organs, spleen and lymph nodes, get activated 
after encountering TD antigens and undergo proliferation. Proliferating B cells differentiate 
into short-lived plasma cells or form a GC, composed of dark zone (DZ) and light zone (LZ). 
In the DZ, activated B cells undergo clonal expansion. The cells that exit the cell cycle 
migrate to the LZ, where affinity maturation takes place by receiving signals from antigen 
presenting follicular dendritic cells (FDCs) and antigen-specific T follicular helper (TFH) 
cells. The affinity-selected GC B cells can re-enter the GC to regain a cycling phenotype. 
Alternatively, GC B cells further differentiate to memory B cells (MBC) or to long-lived 
plasma cells (LLPC) for the serological memory or antibody secreting. 
 
3.1 The germinal center 
After B cells activated by antigens the GC appear in the follicles of secondary lymphoid 
organs in TD response. The chemokine CC receptor 7 (CCR7), which binds the chemokine 
CC ligand 21 (CCL21), guides the activated B cell towards the T-B zone where GCs are 
formed. B cells expand extensively and form the DZ, upregulate AID expression, which 
mediates somatic hypermutation (SHM) and class switch recombination (CSR). AID transfers 
deoxycytidine into deoxyuridine at the immunoglobulin genes thereby triggering mutagenic 
Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																							
	
	
35	
DNA repair (Muramatsu et al., 1999). SHM is a process that introduces random point 
mutations in the variable-region gene segments of the BCR resulting in altered BCR affinity 
to antigens. Because mutations are random, this process can lead to unchanged, increased or 
decreased BCR affinity and to self-reactive BCR. BCR diversification facilitates B cells to 
form a more efficient BCR to neutralize antigens or pathogens. This process is mainly taking 
place in the DZ of GC.  
In order to select B cells with sufficiently affinity against the antigen encountered, some of 
the B cells exit cell cycle and migrate to the LZ, where they get signals from FDCs and TFH 
cells through TCR-MHC complex, as well as cytokine signaling pathway (e.g. IL 21 and IL 4). 
The FDCs present antigens to B cells by using complement and FcRs rather than antigen-
MHC complex (Aguzzi et al., 2014). This allows for antigen-driven selection of high affinity 
BCR. B cells that do not get selected undergo apoptosis and phagocytosis by macrophages 
(Smith et al., 1998). B cells that enter LZ also get the help from TFH in a TD response, which 
is essential for affinity maturation as well as memory B cell production. The TFH cell is a 
specialized T helper cell subset, which expresses CXCR5, PD-1 (programmed cell death 
protein 1), ICOS and CD40L and secretes the cytokine IL-21. TFH cells interact with LZ B 
cells to facilitate B cells selection and also play a role in B cells differentiation into memory B 
cell or an antibody secreting plasma cell.  B cells in the LZ also have a third option, to re-
enter the DZ and go through more rounds of proliferation, SHM and selection. 
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3.2 Plasma cells 
Secreted neutralizing antibodies are of great importance to humoral response to protect the 
host against the infections caused by pathogens. The antibody secreting function is mainly 
accomplished by plasma cells. Upon activation, B cells can differentiate to centroblasts and 
antibody producing plasma cells. Plasma cells are larger in size than other B cells because 
they exhibit a larger cytoplasm containing extended endoplasmic reticulum to maintain the 
production, storage and secretion of large quantities of antibodies (Pelletier et al., 2006). They 
are characterized by downregulated pan B cell marker B220, upregulated cell surface marker 
CD138 and of transcription factor Blimp-1 (Shaffer et al., 2002). 
Plasma cells can be divided into two different pools, short-lived and long-lived plasma cells, 
according their life-span. The life span of short-lived PCs is 3-5 days (Ho F, 1986). They are 
thought to be generated from extra-follicular foci in the secondary lymphoid organs through a 
GC independent pathway, majority of the short-lived PCs secrete low affinity IgM antibodies. 
In contrast, the long-lived PCs can persist for months or years in mice and perhaps decades in 
human (Manz et al., 1997), they are mainly generated through a GC dependent pathway and 
secrete high affinity, isotype switched antibodies (Manz et al., 1997). Sustained pathogen 
specific antibodies secreted by short- and long-lived PCs are essential for protective immunity 
against infection.  
In a TI response, plasma cells can also be generated through a GC independent pathway in the 
extrofollicular foci in the spleen (Ho et al., 1986), but most are short lived IgM secreting 
plasma B cells. In a TD response the majority of the plasma cells are produced in a GC 
dependent pathway (Kräutler et al., 2017), and differentiation into PCs is induced among a 
discrete subset of high-affinity B cells residing within the LZ of the GC. Majority of long-
lived plasma cells home to the BM and reside there for a long-term secretion of antigen-
specific antibodies. A small population of long-lived plasma cells can also be found in the 
spleen (Sze et al., 2000).  
3.3 Memory B cells 
The success of humoral response also depends on the memory B cell reaction in case of the 
host encounters the same pathogens again. Antibodies secreted by the plasma cells provide 
the first layer of humoral defense against reinfection if the antibody concentration is 
sufficiently high to protect the host. A second line of humoral defense that is pathogen-
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experienced memory B cells are rapidly reactivated to produce antibodies. This memory 
response is typically activated faster, and of greater magnitude and produce antibodies with 
switched isotypes and higher affinity. As the majority of the antibodies generated following 
secondary antigen challenge are of switched isotypes and have higher affinity compared to the 
antibodies generated in the primary response, it is thought that memory B cells derive from 
the B cells bearing a class-switched and high-affinity B cell receptors (BCRs) on their surface. 
However, some groups also provided evidence to show the presence of GC independent 
memory B cells (Taylor et al., 2012; Kaji et al., 2012), as well as unswitched IgM+ memory B 
cells (Pape et al., 2011), in addition to the classic GC dependent B memory cells pathway. It’s 
still not clear whether these distinct memory B cell subsets have different roles in the humoral 
response.  
What governs the fate of activated B cells to differentiate into a memory B cell or to a plasma 
cell through a GC dependent pathway is a question that was addressed in several laboratories 
(De Silva and Klein, 2015; Nutt et al., 2015; Shlomchik and Weisel, 2012; Victora and 
Nussenzweig, 2012a). It was shown that the cell fate in the GC can be regulated by signals 
transduced by CD40, as well as the cytokines IL4 and IL21. In vivo antibody inhibition and 
genetic deletion studies added more pieces to the puzzle. Blocking GC with anti-CD40 or 
ICOSL antibodies, lead to a decreased long lived plasma cell (LLPC) response (Takahashi et 
al., 1998; Taylor et al., 2012). Deletion of CR1 and CR2 (Gatto et al., 2005), interleukin 21 
receptor (IL-21R) (Linterman et al., 2010; Zotos et al., 2010), PD-1, PD-L1 and PD-L2 
(Good-Jacobson et al., 2010), CD80 (Good-Jacobson et al., 2012) affect proper GC 
maturation or progression but not GC initiation. All the studies above showed a decreased 
LLPC numbers, which correlated with improper GC progression while early memory B cell 
(MBC) populations are mainly unaffected (Good-Jacobson and Shlomchik, 2010). Recently, a 
study showed that MBC and LLPC could be generated at different time points during the 
course of the GC maturation or progression (Weisel et al., 2016).  
In summary, the quality and quantity of a memory response will be different depending on the 
GC reaction, T-B contact, the type of B cell activation and the type of antigen, as well as the 
strength of various signaling involved in this process (Alugupalli et al., 2004).  
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4 B cell signaling 
B cell activation can be achieved thought a complex network of signaling pathways 
depending on different receptors on the B cell surface. The BCR signaling is one of the most 
important activators of B cells. Numerous studies have showed the importance of BCR 
signaling for B cell development, fate and activation. In the B cell development in both FL 
and BM, signaling through preBCR and BCR are responsible for the preBCR selection, as 
well as negative selection for eliminating self-reactive B cell or triggering BCR editing, 
respectively. BCR also plays crucial role during the transition from immature to mature B cell, 
GC formation and progression, SHM and B cell differentiation into MBCs and LLPCs (Niiro 
and Clark, 2002). The binding of antigen to the BCR triggers a series of catalytic cascade by 
activating the protein tyrosine kinase Lyn of the Src family kinases. This process is 
accomplished by two components of BCR complex, Igα and Igβ, which contain immune-
receptor tyrosine activation motifs (ITAMs) in their cytoplasmic tails that can get 
phosphorylated by Lyn. This can in turn phosphorylate another tyrosine kinase, Syk, that 
triggers the formation and activation of a multi-component complex, comprising Bruton 
tyrosine kinase (BTK), AKT, phosphoinositide 3-kinase (PI3K), and B cell-linker protein 
(BLNK). Signals transduced by BCR co-receptor CD19 is also important for PI3K, BTK and 
AKT activation, which triggers the downstream signaling cascade, leading to different effects, 
such as the calcium influx and activation of nuclear factor-κB (NF-κB). This process 
eventually regulates B cell survival, proliferation, cell fate and response (Srinivasan et al., 
2009). 
Inhibitory signaling events play an important role in attenuating immune responses through 
different inhibitory receptors on the B cell surface. Such as CD22, PD-1, CD72 and paired 
immunoglobulin-like receptor B (PirB), as well as FcR. Signaling downstream of these 
inhibitory receptors can activate Lyn which in turn phosphorylates their cytoplasmic ITIM. 
Then activates the SH2-domain-containing inositol polyphosphate 5' phosphatase (SHIP), 
which dephosphorylates PIP3, leading to Btk and PLCγ2 to dissociate from the cell 
membrane. The outcome of this process is inhibition of calcium flux and suppression of 
proliferation by decreasing the proliferative signals transduced by survival factor Akt and/or 
the mitogen-activated protein (MAP) kinase (Pritchard and Smith, 2003). Thus, the Akt 
pathway could play a dual role in both inhibitory and activating consequences in B cell 
response (Limon and Fruman, 2012).  
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is composed of one extracellular domain, one transmembrane domain and two tandem 
intracytoplasmic catalytic segments. It has been shown to have an essential role in T- and B-
cell antigen receptor signaling (Kishihara et al., 1993; Byth et al., 1996). CD45 family 
consists of multiple isoforms, which have different distribution in hematopoietic cells. One of 
the isoforms dominantly expressed on B cells is CD45R with large amount of glycosylation, 
which increases the molecular weight to 220kDa, hence named B220. B220 expressed on B 
cells is of great importance for BCR signaling. Extensive studies demonstrated that CD45 
could play a dual role in regulating BCR signaling by either direct interaction with 
components of BCR complexes or through regulating various Src family kinases (Trowbridge 
and Thomas, 1994), which could also play dual role in BCR signaling.  
In Cd45 deficient mice, B cell development is arrested, in particular Src family kinase (SFK) 
activity in Cd45-/- B cells is dysregulated (Thomas, 1994; Huntington and Tarlinton, 2004a), 
and phosphorylation of CD19, a co-stimulator of BCR is also impaired. In addition, Cd45-/- B 
cells show a severely impaired BCR-mediated proliferation, as well as blocked B cell 
maturation at a transitional stage in the spleen. Furthermore, deletion of autoreactive Cd45-/- B 
cells are also impaired (Zikherman et al., 2012); both phenomena are considered to reflect an 
increased threshold of BCR signaling.  
The molecular and cellular mechanism underlying the defected response of Cd45-/- B cells to 
BCR ligation are a reduced activation of extracellular signal–regulated kinases (Erk1/Erk2)  
and MAP kinases, phosphatidylinositol-3-OH kinase (PI(3)K) and the transcription factor NF-
κB. CD45 expression in B cells is not required for GC initiation but was essential for GC 
persistence due to failed upregulation of anti-apoptotic Bcl-2 family members and to impaired 
CD40 signaling-induced proliferation thus triggering B cell apoptosis. The defected GC 
persistence could be partially rescued by enforced expression of anti-apoptotic factor Bcl-xL 
(Huntington et al., 2006; Huntington and Tarlinton, 2004b).  
CD45 deficient BCR transgenic B cells failed to be negatively selected in the presence of the 
cognate antigen (Cyster et al., 1996). This study reinforced the notion that in the absence of 
CD45, BCR signaling is dramatically weakened, leading to the conclusion that CD45 is a 
crucial positive regulator of the BCR.  
CD45 associated BCR signaling transduction through SFKs, such as Lyn and Fyn, can also 
have negative effects. After BCR stimulation, Lyn rapidly initiates a negative regulatory 
feedback loop by phosphorylating ITIMs in the cytoplasmic domains of inhibitory receptors 
such as CD22 and Fcγ RIIB. This allows recruitment of SHP1 and SHIP, facilitating 
downregulation of the B cell response (DeFranco et al., 1998). CD45 also exerts its negative 
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regulatory role incorporated with BCR complex following antigen binding. BCR engagement 
results in the aggregation of multi-signaling-component to form a lipid raft structure, but the 
CD45 molecule is excluded from the central raft (Weintraub et al., 2000; Shrivastava et al., 
2004; Cheng et al., 1999). Because CD45 constitutively inhibits SKFs by dephosphorylating 
their regulatory sites, the movement of CD45 away from the BCR complex facilitates the 
phosphorylation and activation of SFKs. The activated SFKs within the lipid raft will then 
phosphorylate the ITAMs within the BCR complex raft and initiate signal transduction. After 
a period of activation, CD45 move back to the rafts and re-associate to the BCR complex, 
leading to reduced Lyn activity through dephosphorylation, which in turn attenuates BCR 
signaling (Gupta and DeFranco, 2003; Shrivastava et al., 2004). In this process, the dynamic 
behavior of CD45 serves as a regulator to fine-tune BCR signaling through the regulation of 
SFKs activity.  
4.2 Calcium Signaling in B Cell Activation and Biology 
Calcium signals in immune cells may regulate a variety of cellular processes, such as 
differentiation and activation.  For B cells, an increased calcium influx can be induced by the 
engagement of BCR, as well as chemokine and co-stimulatory signaling. When encountering 
their specific antigen, intracellular signaling is activated through BCR, which is a 
fundamentally important event for the development of adaptive immunity. One of the key 
signals for B cell physiological outputs is the increase of intracellular free calcium ion (Ca2+). 
The first observation that BCR stimulation induces Ca2+ mobilization inside B cells came 
from a study using labeled 45Ca2+ ions (Braun et al., 1979). Intensive studies established the 
important role of Ca2+ signaling in B cell responses, and the molecules regulation of Ca2+ flux. 
The binding of an antigen to the BCR triggers the recruitment of multiple signaling 
components including PTK and their substrates, eventually leading to the activation of 
phospholipase C-γ2 (PLC-γ2) signaling pathway (Kurosaki and Baba, 2010; Scharenberg et 
al., 2007). Activated PLC-γ2 hydrolyzes the membrane lipid phosphatidylinositol-4,5-
bisphosphate to generate two second messenger products: the membrane lipid diacylglycerol 
(DAG) and the diffusible soluble inositol-1,4,5,-triphosphate (IP3). IP3 spreads into the 
cytosol and binds to the IP3 receptors (IP3R) on the membrane of endoplasmic reticulum 
(ER), leading to the rapid release of Ca2+ from the ER store into the cytosol and the 
extracellular Ca2+ influx into the cytosol (Baba and Kurosaki, 2009; Parekh and Putney, 
2005). Ca2+ influx therefore is linked to the strength of BCR signaling.  
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transcription factors Ikaros, E47, Ebf1 and Pax5 coupled with epigenetic regulation of 
lymphoid and B cell-associated genes is responsible for promoting B cell specification and 
commitment (Santos and Borghesi, 2011). The major epigenetic marker responsible for B 
lymphocyte commitment is methylation of H3K4 (H3K4me) at the enhancer regions of B cell 
lineage specific genes (Mercer et al., 2011). Methylation at H3K4 of transcription factors E2A 
associated genes orchestrates B cell commitment during the CLP to proB transition, and 
subsequently, B cell specific genes. This process is regulated by the transcription factors EBF 
and FOXO1 (Lin et al., 2010). In both proB and preB cells, E2A regulates different B cell 
associated genes expression by introducing H3 acetylation activating marks or repressive 
methylation markers H3K27me3 to their regulatory regions (Treiber et al., 2010).  
Other epigenetic marks, such as ubiquitination, have also proved to play a role in regulating 
early B cell development. Histone H2A deubiquitinase coding gene Mysm1 deficient mice 
show a drastic decrease of B cells in the bone marrow, peripheral blood, and lymph nodes. 
The mechanisms underlying this phenotype comprise the antagonistic function of MYSM1 
PRC1 in the Ebf1 promoter, increasing the chances to recruit some of B cell lineage specific 
transcription factors, such as E2A to upregulate Ebf1 transcription (Jiang et al., 2011).  
In proB cells, the most important event taking place is Ig heavy chain locus V(D)J 
recombination. At the start of the V(D)J recombination, histone H3 acetylation is abundant 
within a 120 Kb region that contains the DH gene segments, and after DJ rearrangement, the 
hyperacetylated domain extends to the distal VH segments. The histone modification 
(acetylation) pattern synchronizes with the V(D)J rearrangement (Su and Tarakhovsky, 2005). 
Methylation of histone H3 on lysine residues like H3K9 is sufficient to repress RAG protein 
complex accessibility which in turn decreases the efficiency of V(D)J recombination (Su and 
Tarakhovsky, 2005). Pax5 (Johnson et al., 2004) removes this repressive methylation thus 
enhancing the accessibility of RAG complex. Trimethylation of lysine 4 in histone H3 
(H3K4me3) is also shown to correlate well with V(D)J recombination (Ji et al., 2010b). The 
plant homeodomain (PHD) finger of RAG2 protein can specifically bind to H3K4me3 
(Matthews et al., 2007), guiding RAG2 to regions of active chromatin and enhancing the 
catalytic activity of the RAG complex (Schatz and Ji, 2011).  
Epigenetic modifications tightly regulate microRNAs expression thus controlling of B cell 
development. In particular, S. Kuchen et al showed that the repressive mark H3K27me3 is 
associated with gene silencing of lineage-inappropriate miRNA during lymphopoiesis 
(Kuchen et al., 2010). Mice deficient in Ago2, which encodes a protein essential for 
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microRNA biogenesis and function, showed a block in B cell development at the pro-B cell 
stage (O'Carroll et al., 2007). Likewise, totally abolishing miRNA by deletion of Dicer in 
proB cells, results in a complete block in B cell development at the proB cell stage (Koralov 
et al., 2008). In addition, miR-181, miR-150, miR-17-92, have a regulatory role in proB cells, 
while miR-34a acts in preB cells, and miR-185 in immature B cells (Kuchen et al., 2010). 
6 Epigenetic regulation of B cell response 
Following productive Ig recombination and expression of the BCR on the cell surface, B cells 
undergo terminal differentiation dependent on signals from the BCR (Rajewsky, 1996). The 
majority of naïve B cells in the periphery are in a resting state. Once activated, they either 
initiate GC reaction or differentiate into antibody secreting plasma cells or memory B cells. In 
this process, proliferation and differentiation, including somatic hypermutation and Ig class 
switch, are associated with genome wide DNA methylation and an overall increase of histone 
acetylation (Shaknovich et al., 2011). Initiation of GC reaction is regulated by Bcl6. The 
induction of Bcl6 expression is concomitant with enrichment of activating histone marks 
H3K9ac and H3K4me3 in the Bcl6 promoter (Ramachandrareddy et al., 2010). Bcl6 inhibits 
B cell differentiation into plasma cells through transcription repressor functions that likely 
modify chromatin accessibility to Blimp-1 (Shapiro-Shelef and Calame, 2005). The 
generation of plasma cells is regulated by Blimp-1. Bcl6 and Blimp-1 act as a pair of 
transcriptional repressors and work in a mutually exclusive manner (Calame et al., 2003).One 
of the possible mechanisms is Bcl6 interaction with the chromatin remodeling complex Mi-
2/NuRD in GC B cells, leading to the repression of specific genes that are characteristic of 
plasma cells. This Mi-2/NURD-mediated repression can be achieved through recruitment of 
histone deacetylases HDAC1 and HDAC2 (Fujita et al., 2003; Fujita et al., 2004). While 
Blimp-1 has also been shown to interact with the histone lysine demethylase LSD1 leading to 
a more accessible chromatin structure to its target genes (Su et al., 2009). 
A number of histone modifiers could exert their regulatory role in the B cell response, such as 
Enhancer of zeste homolog 2 (EZH2) and the histone acetyltransferase monocytic leukemia 
zinc finger protein (MOZ), the former could modulate Ig heavy chain rearrangement and also 
essential for GC reaction. The conditional deletion of EZH2, with either Cγ1-Cre or CR2-Cre, 
dramatically reduced GC frequency (Béguelin et al., 2013; Caganova et al., 2013a). Both 
studies demonstrated the regulation of cell cycle genes by EZH2 and inhibition of apoptosis. 
MOZ deficient mice in all B-cells or in specifically in GC B-cells also resulted in decreased in 
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GC B-cells (Good-Jacobson et al., 2014) due to defective proliferation correlating to a 
decrease specifically in DZ B cells.  
In the absence of EZH2, there was a reduced IgG1+ memory B cells as well as reduced 
secondary recall response (Caganova et al., 2013b)(Béguelin et al., 2013; Caganova et al., 
2013a). High affinity IgG1+ memory B-cells were also reduced in the absence of MOZ 
(Good-Jacobson et al., 2014) but IgM+ memory B cell numbers were increased. Thus, MOZ 
regulated the composition and functional outcome of the memory compartment. More work is 
now needed to investigate in detail the role of epigenetic regulation in memory B cell 
formation and function.  
Epigenetic regulation of microRNAs also play very important roles in B cell responses. 
Distinct miRNA expression profiles regulate naïve B cell activation, GC formation, and 
terminal differentiation into plasma cell and memory cell (Malumbres et al., 2009a; Zhang et 
al., 2009). Multiple miRNAs, including miR-155 and miR-125b, have been shown to have a 
regulatory role in the expression of genes that fine tune B cell GC differentiation (Thai et al., 
2007a; Gururajan et al., 2011). MiR-155 can target multiple genes, including Aicda, which 
encodes AID, and Pu.1, thereby regulating sequential B cell differentiation stages (Thai et al., 
2007b). By contrast, multiple miRNA molecules, such as miR-15a and miR-16, can 
cooperatively target one gene, such as Bcl2 in GC B cells (Malumbres et al., 2009b) .  
Taken together, multiple B cell-intrinsic epigenetic regulations may guarantee B cell 
development and immune response, such as GC formation, SHM, and Ab affinity maturation 
in the GC reaction, as well as differentiation to memory B cells and long-lived plasma cells. 
7 Role of long non-coding RNA in the immune system 
Recently, the discovery of long noncoding (Lnc) RNAs as essential mediators of cellular 
biology and potentially important regulators of cell differentiation, development and 
malignant transformation has shown that they are more than just a “black matter of the 
genome”. Moreover, LncRNAs have a broad range of possible functions at the transcriptional, 
posttranscriptional and protein level and their aberrant expression significantly contributes to 
the hallmarks of cancer cell biology. Furthermore, their high tissue- and cell-type specificity 
makes LncRNAs especially interesting as biomarkers, prognostic factors or specific 
therapeutic targets. 
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The emergence of LncRNAs controlling innate and adaptive immunity raised the possibility 
that they may be important regulators of immune cells. For example, Lnc-DC is required for 
normal dendritic cell differentiation and function (Wang et al., 2014), IL1b-eRNA and IL1b-
RBT46 are required for lipopolysaccharide-induced pro-inflammatory responses in monocyte 
(IIott et al., 2014) and NRAV modulates cellular responses to viral infections (Ouyang et al., 
2014). In T cells, an intronic LncRNA NRON abrogates the nuclear transport of nuclear factor 
of activated T cells (NFAT) and hence modulates expression of interleukin-2 (Willingham et 
al., 2005) and in B-cell lymphomas, the LncRNA Fas-AS1 modulates expression of soluble 
Fas receptor messenger RNA that functions as an important regulator of apoptosis (Sehgal et 
al., 2014). Altogether, LncRNAs have proven to influence both normal and pathological 
immune cell development and function. 
7.1 LncRNA H19 in hematopoiesis  
7.1.1 H19, a Prototype of a Multitask LncRNA 
Long non-coding RNAs (LncRNAs) are transcripts that do not encoding proteins but have a 
crucial role in various biological functions. LncRNAs can exert its regulatory functions 
through different mechanisms, such act as regulators of its target genes expression.  This can 
be accomplished at different level of regulation, including chromatin organization, 
transcriptional regulation, and post-transcriptional control. Abnormal or misregulated 
LncRNAs expression has been shown to be associated with cancer and other disorders 
(Wapinski and Chang, 2011; Tano and Akimitsu, 2012).  
H19 is one of the first discovered LncRNAs originally isolated in four different laboratories 
(Davis et al., 1987; Pachnis et al., 1988; Wiles, 1988; Poirier et al., 1991). The 2.3-kb gene is 
composed of five exons and four small introns and the H19 RNA is fully capped, spliced and 
poly-adenylated. The H19 gene was found to be monoallelically expressed from the 
chromosome of maternal origin in mouse and in human and, with (Bartolomei et al., 1991; 
Zhang and Tycko, 1992).  
H19 is mainly expressed throughout embryonic development in multiple tissues including 
hematopoietic cells (Poirier et al., 1991; Pachnis et al., 1988). After birth H19 has only been 
detected in muscle satellite cells (Xu et al., 2017; Martinet et al., 2016; Dey et al., 2014a), in 
cardiomyocytes (Zhang et al., 2017; Liu et al., 2016) and in DN3a thymocytes (unpublished 
data, IMMGEN database). It is maternally expressed from mouse chromosome 7 and human 
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H19 regulates Igf2 expression through a cis regulatory process that influences growth and 
development. H19-/- mice are viable, but showed an overgrowth phenotype in both 
embryogenesis and adult life. It has been described that the H19 locus is linked to the 
Beckwith-Wiedemann syndrome (BWS) and Wilms’ tumors, both are imprinting disorder 
characterized by postnatal overgrowth, macroglossia, anterior abdominal wall defects and an 
increased risk of embryonic or childhood tumors (Zhang et al., 1993; Cohen, 1994; Reik et al., 
1994). The higher incidence of tumors rises the possibility that H19 may function as a tumor 
suppressor (Maher and Reik, 2000). Meanwhile several other extensive studies consider H19 
as being the tumor suppressor gene (Hao et al., 1993; Juan et al., 2000). It has been proposed 
that a biallelic expression of Igf2 in Wilms’ tumor where H19 is fully repressed through 
hypermethylation in H19 DMR region on both alleles is the cause of the tumor (Dao et al., 
1999)(Frevel et al., 1999). In BWS cases, patients also showed deficiency in H19 DMR 
region, which lead to Igf2 expression from both allele, while silencing H19 expression 
(Sparago et al., 2004; Prawitt et al., 2005a; Prawitt et al., 2005b).  While Loss of IGF2 
expression with a biallelic H19 expression is responsible for 20 to 60% of cases of Silver–
Russel syndrome (SRS) (Peñaherrera et al., 2010). SRS is characterized by embryonic and 
postnatal overgrowth with facial dysmorphia and corporal asymmetry. All these studies above 
showed altered gene expression at the H19/IGF2 locus are associated to malignancies and 
developmental disorders.  
On the other hand, various cancers in different tissues, such as breast (Adriaenssens et al., 
1998; Lottin et al., 2002), bladder (Cooper et al., 1996), lung (Kondo et al., 1995). showed 
H19 overexpression that could contribute to tumor progression and aggressiveness. 
7.1.2 The LncRNA H19 controls genome expression at multiple levels  
As described above, LncRNAs can exert its roles through different molecular mechanisms by 
regulating genome expression. The complexity of mechanisms adopted by LncRNA H19 on 
gene expression have been illustrated to be extremely diverse at various levels. One 
mechanism elucidated by Luo and colleagues showed that H19 can exert its function through 
chromatin modification, by guiding chromatin modifying enzymes to distinct loci (Luo et al., 
2013). In some cases of bladder cancer, H19 binds to and recruit the histone methyltransferase 
EZH2 at the E-cadherin promoter, leading to an increase in H3K27me3 repressive marks and 
to silence the expression of E-cadherin gene (Luo et al., 2013). H19 has been shown to 
interact with and physically bind to the methyl-CpG-binding domain protein 1 (MBD1) 
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7.1.3 Regulatory role of LncRNA H19 in hematopoiesis 
The role of H19 in hematopoiesis showed by Venkatraman et al. (Venkatraman et al., 2013), 
is to maintain hematopoietic stem cell quiescence. By deleting the DMR region of H19/Igf2 
locus from the maternal allele, hematopoietic stem cells lose quiescence and showed an 
increased differentiation ability through an increased-Igf1r/Igf2 signaling circuit. This 
increase leads to loss of downstream FOXO-mediated inhibition of HSC cell cycle activity.  
This work also supports the idea that imprinted gene networks play an important role in stem 
cells. Previous work by other groups showed that most imprinted genes were preferentially 
expressed in the HSC compared to their differentiated progeny (Berg et al., 2011; Varrault et 
al., 2006; Rossi et al., 2012). This work highlighted the importance of the imprinted genes in 
development. 
 
Previous studies from our laboratory found that H19 is the major differentially expressed 
transcript in microarray data (P. Vieira, personal communication) comparing FL and adult 
BM derived pro-B cells and between the early (embryonic date 13-16) and late (embryonic 
date 16-19) thymic settling progenitors (TSPs) (Ramond et al., 2014). Intriguingly, H19 is 
also expressed in the adult double-negative 3a (DN3a), a stage at which T lymphocytes 
undergo TCR beta chains recombination. These observations raised the possibility that H19 
might play a role in developing lymphocytes.  
 
This thesis focuses on the impacts of this LncRNA H19 on the B cell development in the FL 
and BM, and B cell response in the adult periphery. 
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The global aim of this work is to understand what the is impact of the expression of the 
LncRNA H19 in the immune system more specifically in B lymphopoiesis and B cell response.  
Venkatraman et al. have shown that H19 had a role in hematopoiesis in maintaining 
hematopoietic stem cell quiescence (Venkatraman et al., 2013). Other studies showed that 
imprinting gene network regulated developmental events at the embryonic stage and in adult 
stem cells through epigenetic modifications (Berg et al., 2011; Varrault et al., 2006; Rossi et 
al., 2012). H19 is the major differentially expressed transcript in microarray data (P. Vieira, 
personal communication) comparing FL and adult BM derived pro-B cells and comparing 
ETP different developmental stages. These data suggested that H19 had a role in the 
development of the immune system. 
This thesis focuses on the impacts of LncRNA H19 on B cell development in the FL and BM, 
and on molecular mechanisms affecting the B cell response in the adult periphery. 
Our strategy in this work is as the following: 
 
B cell development: 
l Characterize the distinct B cell developmental stages in the FL from the embryonic date 
13 to 19 and in the BM of the new born and adult mice of wt, H19-/-, H19mat-/+ and 
H19+/pat-. 
l Dissect the differentially affected developmental stage and understand the molecular 
events affected by the deletion of H19 
 
B cell function 
l Characterize the B cell phenotype in the peripheral organs 
l Investigate B cell response to different T cell dependent and independent antigens at 
both cellular and antibody response level. 
l Explore the molecular mechanisms underlying the differentially response profile of H19-
/- mice. 
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Results 
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Early B cell development is altered in H19-/- FL 
Previous data from our laboratory found that H19 is the major differentially expressed 
transcript in microarray data (P. Vieira, personal communication) comparing FL and adult 
BM derived pro-B cells and between early thymic progenitors from the first and second 
waves (Ramond et al., 2014). Thus, we wondered what was the role H19 plays in the 
lymphopoiesis in the FL. Based on the B cell development scheme in the BM described by 
Hardy (Hardy et al., 1991), B cell surface markers B220, CD43, BP1 and CD24 (HSA) are 
used to define different stages of B cell development. Briefly, B220+CD43+ B lymphocytes 
are subdivided into four subsets, fractions A (BP1-CD24-), B (BP1-CD24+), C 
(BP1+CD24+/lo), and C’ (BP1+CD24hi). A correlation between these surface marker 
expression and Ig gene rearrangement status was established. The Ig heavy chain genes in 
cells from fraction A are in germline configuration, whereas the majority of fraction B cells 
show D-J rearrangement, but rarely V-DJ recombination. Furthermore, complete heavy chain 
rearrangement mainly takes place in fraction C stage where Igµ is expressed and paired with 
surrogate light chain VpreB and λ5 to form a preBCR on the surface of majority fraction C’ 
cells, in order to trigger a rapid proliferation and further differentiation. The B cell specific 
marker CD19 used to characterize committed B cell progenitors (Nutt et al., 1997) is not 
expressed in cells from fraction A and therefore they are not committed to B cell lineage and 
also comprise CLP (CLP-2) (Martin et al., 2003) and NK cell progenitors (Rolink et al., 1996). 
On the other hand, B220+CD19+IgM+CD43+proB cells consist of the three fractions, B, C, 
and C’ subpopulations (Hardy and Hayakawa, 2001). Therefore, we focused on the analysis 
of these three fractions in the FL of different embryonic stages from both wild type Sv129 and 
H19 mutant (on Sv129 background) mice.   
We analyzed the expression level of H19 in proB cells from FL of different embryonic dates 
(from E15 to E18) and adult BM, we found H19 is highly expressed in the proB cells from FL, 
decreased with fetal age, and not expressed in the proB cells from adult BM (Fig 11A). We 
also observed an overgrowth phenotype in the embryo and in the FL of H19-/- (Fig 11B), this 
was in line with previously reported data (Gabory et al., 2009; Wojdacz et al., 2008). 
However, unlike H19 deficient human embryo (Moulton et al., 1994), we have not observed 
embryonic tumors in H19-/- embryos.  Further analysis of B cell development in the FL 
showed the first B lineage cells (B220+CD19+) appear around embryonic day (E) 13.5 in the 
FL, and during gestation, the majority of B lineage cells remain in the proB progenitor stage. 
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From E13.5 to around E17.5, pro-B cells are mainly in fraction B, then after E17.5, pro-B 
cells upregulate the expression of BP1, a molecule predominantly found on early B lineage 
cells (Wang et al., 1998). BP1 is expressed in the late proB cells, fraction C, C’, and 
maintained its expression in the preB cell stage. We identified these three fractions in E18 FL 
from both WT and H19-/- embryos. Of note, at this developmental stage proB cells accounted 
for more than 90% of total CD19+ lymphocytes in FL of both wt and H19-/-. However, proB 
cells of H19-/- showed upregulated BP1 on the cell surface (Fig 11C), as well as altered B220 
and CD43 expression (Fig 11D). The mean fluorescence intensity (MFI) of B220 showed a 
higher than 2-fold increase while CD43 MFI exhibited a 2-fold decrease.  
Furthermore, BP1 and HSA expression showed that H19-/- FL proB cells exhibited an 
increased fraction C and C’ in both frequency (Fig 11C) and absolute cell numbers (Fig 11F), 
with a 10 and 5-fold increase in fraction C and C’, respectively. Myeloid lineage cells as well 
as the more immature progenitors, such as LSK, HSC and CLP were not affected (Fig 11E). 
Similar enlarged fraction C and C’ was also observed in the adult BM B cell compartment 
(data not shown), indicating that H19 impacts the B cell development by generating more 
proB cells with enlarged late proB cells defined as fraction C and C’.  
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independent experiments with 3 replicates each experiment. *p<0.05; **p<0.01; ***p< 0.001, ****p< 0.0001 
unpaired t test. 
 
Altered B cell development in vitro culture in absence of H19 
We next investigated the in vitro proliferation and differentiation capacity of the proB cells 
from E15 FL of both wt and H19-/-. CD19+B220+IgM-CD43+ FL cells were sorted and 
cultured with OP9 stromal cells, complemented with saturating amounts of IL7, Flt3L and 
KitL. After 7 days in culture, positive wells with growing colonies were analyzed by flow 
cytometry and the number of B lymphocytes at different developmental stages was calculated, 
including proB, preB and IgM+ cells. The in vitro culture showed that although H19-/- proB 
cells generate comparable number of total CD19+ B lymphocytes compared to wt proB cells, 
they differentiate faster to the preB stage and give rise to more preB cells, as a result, an 
elevation in IgM+ B cells generated by H19-/- proB cells occured (Fig 13A), indicating that 
H19 could affect B cell differentiation.  
Furthermore, LSKs (Lin-c-kit+Scal+) and CLPs from E15 FL of wt and H19-/- were sorted and 
cultured under the same condition as described in the proB culture. Consistent with the 
previous results from proB cell culture, LSKs and CLPs from H19-/- FL generated higher 
frequency and numbers of BP1+proB cells (Fig 13B and 13C), reinforcing the link between 
H19 and B cell proliferation and differentiation. 
 
Altogether, the results above indicate that in absence of H19, B cell development is altered 
resulting in an increased production of B lymphocytes in fraction C and C’ in the FL.  
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rearrangement in absence of H19 
Genomic DNA was extracted from sorted fraction B, C and C’ (labeled as FB, FC, Fc’, respectively) (A), and Ig 
heavy chain D-J and V-DJ rearrangement was analyzed by PCR using primers which recognize the 5’ sequence 
of VH-J558, DH-Q52 segments and 3’ sequence of JH4e segment. (B) D-J rearrangement PCR product was 
analyzed by agarose electrophoresis; the intensity of the bands was scanned and the germline band was 
calculated through normalizing to the loading control. (C) the Rag1/2 expression in the proB cells was measured 
by western-blot analysis; (D) V-DJ PCR product was analyzed by agarose electrophoresis, and VDJH4 fragment 
have been purified and cloned into TOPO vector for sequencing, and the rate of productive V-DJ rearrangement 
was calculated and plotted in the histogram.  *p<0.05; **p<0.01; ***p< 0.001, ****p< 0.0001 unpaired t test. 
 
To confirm this observation, DNA double strands breaks (DSB) in these subpopulations were 
analyzed by intracellular staining with anti- γH2AX fluorescence labeled antibody.  γH2AX 
accumulates in the DSBs created by the V(D)J recombination and can be detected by flow 
cytometry (Sharma et al., 2012; Hopp et al., 2017). Cells in fraction B from both WT and 
H19-/- showed similar γH2AX staining profile. However, in fraction C and C’, cells from H19-
/- FL showed lower frequency of γH2AX positive cells compared to that of wt. In fraction C 
the frequency of γH2AX+ cells accounts for 30±0,8% in wt and 12.6±2.2% in H19-/-, while in 
fraction C’, 57.2±4.9% in wt and 38.9±1.8% in H19-/-, respectively. In proB cells, γH2AX not 
only recognizes cells undergoing DSBs caused by the VDJ recombination but also stains cells 
undergoing mitosis (Tu et al., 2013). A majority of cells in fraction C’ accomplished a 
productive VDJ rearrangement in Ig heavy chain locus and express preBCR on the cell 
surface. For that reason, they become highly proliferative and stain positive for γH2AX (Fig 
15A).  The decreased frequency of γH2AX+ cells in fraction C of H19-/- FL indicates a lower 
frequency cells undergoing VDJ recombination.  
We performed intracellular IgM staining to analyze the frequency of productive VDJ 
rearrangements in dividing fraction C’ cells. Cells in fraction B and C’ from both WT and 
H19-/- showed similar intracellular IgM staining profile. However, in fraction C, cells from 
H19-/- FL showed lower frequency of intra-IgM positive cells compared to that of wt, that is 
around 22.8±1.9% in H19-/- versus 41.8±8,4% in wt (Fig 15B). Although reduced productive 
Ig heavy chain VDJ rearrangements observed in fraction C of H19-/-, fraction C and C’ in H19 
mutant FL still showed an increased absolute numbers of intracellular IgM positive cells 
compared to the wt resulting in a net increase of B cell production (Fig 15B).  
The decreased frequency of γH2AX and intracellular IgM positive cells in the fraction C of 
H19-/- FL also indicates an aberrant VDJ rearrangement profile. Extensive studies showed that 
B cell progenitors require cell cycle arrest to fulfil the VDJ rearrangement (Lin and Desiderio, 
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1994). We wondered whether the aberrant VDJ recombination in fraction C in absence of 
H19 was caused by the failed cell cycle arrest. To this end cell cycle analysis was performed 
and the results showed a majority of cells in the fraction C from both genotyped FL are in G1 
phase, whereas cells in fraction C’ that bear a productive Igµ chain are highly proliferative.  
Fraction C cells from H19-/- FL showed an even lower frequency cells in S/G2/M phase 
compare to that of wt (Fig 15C), indicating that loss of H19 did interfere with cell cycle arrest 
in this population. Both fraction C and C’ from H19-/- FL showed increased absolute cell 
numbers in S/G2/M phase, also consistent with the increased B lineage production in the H19 
mutant FL.  
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To assess the efficiency of the productive V-DJ rearrangement, we amplified VDJ fragments 
in DNA from fraction C cells by using VH-J558 and JH4e primer pair. The recombination of 
the V, D and J gene segments can produce non-productive or productive rearrangements. If 
there are no stop codons in the rearranged VDJ sequence and the constant region is in frame, a 
heavy chain protein can be produced. Alternatively, if there is either a stop codon or the 
constant region falls out of frame, no heavy chain protein can be produced corresponding to a 
non-productive rearrangement. The VDJ amplification showed comparable usage of JH1, JH2, 
JH3 and JH4 (Fig 14D). The frequency of productive VDJ rearrangement in WT and H19-/- 
population were 33% and 31% (Fig 14D and Table 1), respectively, indicating once the cells 
initiate the VDJ rearrangement process similar frequency of productive rearrangements were 
obtained.  
Altogether, the data above indicates that although there is aberrant Ig heavy chain VDJ 
rearrangement mainly caused by failure in the initiation of D-J, and/or V-DJ rearrangement, 
fraction C and C’ cells in H19 mutant FL are highly increased, leading to a higher B cell 
production.  
Table 1 The list of VDJ sequencing 
	
J	 D	 V	
		 CAT	AGC	ATA	GTA		 		 TCT	TGC	ACA	GTA	ATA	
WT1	 CAT	AGC		 AT	ACC	GTC	GTA	ATC	ATA	GTA	GAT	 TCT	TGC	ACA	GTA	ATA	
WT2	 CAT	AGC	ATA		 GT	AGT	TAC	CAT	ACT	 TCT	TGC	ACA	GTA	ATA	
WT3	 CAT	AGC	ATA	GTA		 A	TCG	TAA	CCA	 TGC	ACA	GAA	ATA	
WT4	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT5	 CAT	AGC	ATA	GTA		 ATC	ATA	GTA	 TGC	ACA	GTA	ATA	
WT6	 CAT	AGC	ATA		 GTA	GCT	ACT	ACC	GTA	GTA	AAA	 TCT	TGC	ACA	GTA	ATA	
WT7	 CAT	AGC	ATA		 GT	CGT	AAC	CAT	 ACA	GTA	ATA	
WT8	 CAT	AGC	ATA		 GT	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT9	 CAT	AGC		 AT	ACC	GTC	GTA	ATC	ATA	GTA	GAT	 TCT	TGC	ACA	GTA	ATA	
WT10	 CAT	AGC	ATA		 GT	GTA	GCT	ACT	ACC	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT11	 CAT	AGC	ATA		 GT	GTA	GCT	ACT	ACC	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT12	 AT	AGC	ATA	GTA	 ATC	ATA	 TCT	TGC	ACA	GTA	ATA	
WT13	 CAT	AGC	ATA	CGT		 A	ATC	ATA	GTA	 TGC	ACA	GTA	ATA	
WT14	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT15	 CAT	AGC	ATA		 GTA	GTC	GTA	ACC	ATA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT16	 CAT	AGC	 G	TCG	TAA	CCA	 TCT	TGC	ACA	GTA	ATA	
WT17	 CAT	AGC	 G	TCG	TAA	CCA	 TCT	TGC	ACA	GTA	ATA	
WT18	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT19	 CAG	 C	TAC	TAC	CGT	AGT	AAT	 TCC	ACA	ATA	ATA	
WT20	 CAT	AGC		 AT	ACC	GTC	GTA	ATC	ATA	GTA	GAT	 TCT	TGC	ACA	GTA	ATA	
WT21	 CAT	AGC		 A	TAC	GTA	ATC	ATA	GTA	 TGC	ACA	GTA	ATA	
WT22	 CAT	AGC		 A	TAC	GTA	ATC	ATA	GTA	 TGC	ACA	GTA	ATA	
WT23	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT24	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT25	 CAT	AGC	ATA		 GT	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT26	 CAT	AGC	 G	TCG	TAA	CCA	 TCT	TGC	ACA	GTA	ATA	
WT27	 CAT	AGC	ATA	 CGT	AATC	ATA	GTA	 TGC	ACA	GTA	ATA	
WT28	 CAG	 C	TAC	TAC	CGT	AGT	AAT	 TCC	ACA	ATA	ATA	
WT29	 CAT	AGC	ATA	GTA		 GTC	GTA	ACC	ATA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT30	 CAT	AGC	ATA	GTA		 GCT	ACT	ACC	GTA	GTA	AAA	 TCT	TGC	ACA	GTA	ATA	
WT31	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT32	 CAT	AGC	ATA	 GT	CGT	AAC	CAT	 ACA	GTA	ATA	
WT33	 CAT	AGC		 G	TCG	TAA	CCA	 TCT	TGC	ACA	GTA	ATA	
WT34	 CATAGC	ATA		 GT	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
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WT35	 CAT	AGC	ATA		 GT	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT36	 CAT	AGC	ATA	GTA		 ATA	GTA	ACC	ATC	ATA	GTG	 TCT	TGC	ACA	GTA	ATA	
WT37	 CAT	AGC	ATA	 CC	GTC	GTA	ATC	ATA	GTA	GAT	 TCT	TGC	ACA	GTA	ATA	
WT38	 CAT	AGC	 G	TCG	TAA	CCA	 TCT	TGC	ACA	GTA	ATA	
WT39	 CAT	AGC	ATA		 GT	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT40	 CAT	AGC	ATA	 CC	GTC	GTA	ATC	ATA	GTA	GAT	 TCT	TGC	ACA	GTA	ATA	
WT41	 CAT	AGC	ATA		 GT	GTA	GCT	ACT	ACC	GTA	GTA	 TCT	TGC	ACA	GTA	ATA	
WT42	 CAG	 C	TAC	TAC	CGT	AGT	AAT	 TCC	ACA	ATA	ATA	
KO1	 CAT	AGC	ATA	 G	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO2	 CAG	 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO3	 CAT	AGC	 G	TCG	TAA	TCA	 TCT	CTC	ACA	ATA	ATA	
KO4	 CAT	AGC	 G	TAG	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO5	 CAT	AGC	ATA	GTA		 ACG	TAG	TCA	CCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO6	 CAT	AGC	ATA	 G	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO7	 CAT	AGC	ATA	GTA	 ACG	TAG	TCA	CCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO8	 CAT	AGC	ATA	 G	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO9	 CAT	AGC	ATA	GTA		 ACG	TAG	TCA	CCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO10	 CAT	AGC	ATA	 CG	TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO11	 CAG		 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO12	 CAT	AGC	ATA	GTA		 ACG	TAG	TCA	CCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO13	 CAT	AGC	ATA		 GT	CGT	ACC	TAT	AGA	 TCT	TGC	ACA	GTA	ATA	
KO14	 CAT	AGC	ATA	GTA	 ACG	TAG	TCA	CCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO15	 CAT	AGC	 G	TAG	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO16	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO17	 CAG		 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO18	 CAT	 A	GCG	TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO19	 CAT	AGC	ATA	 G	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO20	 CAT	AGC	 G	TAG	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO21	 CAG		 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO22	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO23	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO24	 CAT	 A	TCG	TCC	CAA	TCG	TGT	TCC	 TGC	ATA	ATA	ATC	
KO25	 CAG		 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO26	 CAT	AGC	GTA		 G	TAA	CCA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO27	 CAT	AGC	ATA	GTA	 AG	TAG	TTA	CCA	 TCT	TGC	ACA	GTA	ATA	
KO28	 CAT	AGC	ATA	 CG	TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO29	 CCAT	AGC	 G	TAG	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO30	 CAT	AGC	ATA	GTA	 AC	GTA	GTC	ACC	ATA	 TCT	TGC	ACA	GTA	ATA	
KO31	 CAG		 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO32	 CAT	AGC	ATA		 GTC	GTAC	CTA	 TCT	TGC	ACA	GTA	ATA	
KO33	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO34	 CAT	AGC	ATA	 G	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO35	 CAT	AGC	 G	TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO36	 CAT	AGC	ATA	GTA		 ATA	GTC	ACC	ATA	GTA	GCT	 TGC	ACA	GTA	ATA	
KO37	 CAT	AGC	ATA	GTA	 AC	GTA	GTC	ACC	ATA	 TCT	TGC	ACA	GTA	ATA	
KO38	 CAT	AGC	 G	TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO39	 CAT	AGC	ATA	GTA		 A	TCG	TAC	CTA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO40	 CAT	AGC	 G	TAG	TAA	CCA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO41	 CAT	AGC	ATA	GTA	 AC	GTA	GTC	ACC	ATA	 TCT	TGC	ACA	GTA	ATA	
KO42	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO43	 CAT	AGC	ATA	GTA	 ACG	TAG	TCA	CCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO44	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO45	 CAT	AGC	ATA	GTA	 AC	GTA	GTC	ACCA	TAG	 TCT	TGC	ACA	GTA	ATA	
KO46	 CAT	AGC	ATA	 G	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
KO47	 CAT	 A	TCG	TAC	CTA	TAG	TGA	 TCT	TGC	ACA	GTA	ATA	
KO48	 CAG		 TCG	TAA	TCA	 TCT	TGC	ACA	GTA	ATA	
KO49	 CAT	 A	GCG	TAG	CTA	CTA	CCG	TAG	TAA	 TCT	TGC	ACA	GTA	ATA	
              productive VDJ rearrangement are labeled in red 
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Increased peripheral B cell compartment and altered B cell 
surface phenotype in the adult of H19-/- 
H19 is expressed during embryonic development but no longer in adult tissues except for the 
satellite cell compartment in the skeletal muscle and cardiomyocytes (Liu et al., 2016). 
Although H19 is the highest differentially expressed gene between embryonic and adult pro-B 
cells, the effects on B cell development although detectable appeared relatively mild. 
Moreover, H19 has been reported to impact the epigenetic landscape of target loci in addition 
to the regulation of other genes within the imprinting network (Gabory et al., 2009). 
Therefore, we decided to investigate whether adult H19 non-expressing adult lymphocytes 
differ between wild type and mutant mice. Interestingly, we had observed (see below) that 
adult B cells expressed high levels of the phosphatase CD45 isoform B220 compared to wild 
type B cells indicating that the absence of H19 during embryonic development could also 
impact cells that no longer express this transcript (Fig 17A and B). To this end, we analyzed 
different peripheral organs, including spleen, lymph node, peritoneal cavity of different aged 
adult mice. 
 
We observed, at all ages studied, that H19-/- mice showed an enlarged spleen size and 
increased spleen weight. Further investigation of cells in the spleen showed a specific 
increased B cell compartment, while erythrocytes and myeloid cells were not affected and T 
cells were modestly increased.  When we subdivided B cells into different B cell subsets, such 
as MZ, FO, immature B cells and B1 cells, we found the increased B cells in the H19-/- was 
mainly caused by enlarged FO B cell subset (Fig 17C), while immature B cells showed no 
difference, and MZ and B1 cells showed a modest increase. Similar increased B cells was also 
observed in the peritoneal cavity (Fig 17D), where B1 cells mainly reside. The peritoneal 
cavity B cell compartment was further subdivided into three subsets according to the 
expression of the cell surface markers B220, CD19, IgM, CD5, and CD23 that discriminate 
the three main B cell populations B1a (B220-/loCD19+IgM+CD5+CD23-), B1b 
(B220+CD19+IgM+CD5-CD23-) and B2 cells (B220+CD19+IgM+CD5-CD23+). All these 
three subsets in the peritoneal cavity were increased in the H19 mutant mice. In conclusion, 
loss of H19 resulted in a specifically net increase of B cells in the adult periphery.  
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Of note, all B cells in both spleen and peritoneal cavity showed an upregulated B220 
expression on the cell surface regardless of their respective cell subset (Fig 17A). H19-/- B 
cells showed an almost 2-fold increase in the mean fluorescence intensity of B220 expression 
on the cell surface (Fig 17B). In particular, B1a cells, which normally express very low levels 
of B220, exhibited a larger amount of B220 expressed on the H19-/- B1a cells. Similar 
upregulation of B220 expression on the surface of B cells was also observed in the H19 
maternal mutant H19mat-/+, but not paternal mutant H19+/pat- (data not shown). B220 is one of 
the isotypes of CD45, a member of protein tyrosine phosphatase (PTP) family, which has 
been shown to regulate BCR signaling (Huntington and Tarlinton, 2004c; Zikherman et al., 
2012), as well as GC reaction persistence (Huntington et al., 2006). Therefore, we further 
investigated the BCR signaling and GC formation in adult H19 deficient mice.  
Because H19 is not expressed in the adult mature B cells we concluded that the higher levels 
of B220 expression on the surface of peripheral B cell of H19-/- mice was controlled by 
epigenetic modifications induced by H19 expression during embryonic development. 
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Loss of H19 results in increasing newly generated B cells in BM 
and accelerated B cell egression to the periphery 
In order to understand the mechanisms leading to increased B cell compartment, we 
performed EdU incorporation in vivo to assess the rate of B cell production in the BM.  
We observed a higher frequency of proB, preB cells and newly generated B cells (defined as 
CD19+IgM+) labeled (45±3.7%, 59±4.7% and 13.2±0.5%) by the EdU in H19-/-, in 
comparison to that of wt (33.8±1.5%, 44.8±1.6%, 7.3±0,3%) in the BM (Fig 18A and C) 
whereas non-B cells were identically labeled. This observation raises two possibilities, either 
BM of H19 mutant was more efficient in producing B cell or more newly generated B cells 
were retained in the BM. To address this question, we analyzed the EdU labeling in the spleen 
of the same mice. H19 mutant spleen showed increasing EdU labeled B cells (Fig 18B and C), 
suggesting a higher production of pro-B cells in the BM and a consequent higher frequency of 
EdU labeled splenic B cells.  
In conclusion, loss of H19 during embryonic development leads to increasing B cell 
production in the BM, contributing to larger peripheral B cell compartment in H19-/- mice.  
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the lymph nodes. Data is representative of 3 independent experiments. *p<0.05; **p<0.01; ***p< 0.001, ****p< 
0.0001 unpaired t test. 
To quantify the immune response in the spleen we analyzed the GC reaction where the 
immune response takes place. We used the following antibody panel comprising anti-CD19, 
anti-IgD, anti-CD38, anti-CD95, anti-CD86 and anti-CXCR4 that allows identifying dark and 
LZ cells within the GC. GC cells are defined as CD19+IgD+CD38-CD95+ and CD86 and 
CXCR4 expression further distinguish LZ (CD86+ CXCR4-) and DZ cells (CD86- CXCR4+). 
After immunization, spleens from H19-/- mice exhibited approximately 2-fold decrease in the 
numbers of CD19+ B cells. Although both wt and H19 deficient mice showed increasing GC 
reaction compared to non-immunized control mice, spleens from H19-/- exhibited a lower 
magnitude of GC response in both frequency (Fig 20A and B) and absolute numbers (Fig 20C) 
at all time points analyzed after immunization. The frequencies of GC in the spleen of wt and 
H19-/- were 15.4±1.0% vs 11.6±1.7% on D7, 27±1.9% vs 19.4±1.5% on D14, 36.5±1.6% vs 
25.5±1.8% on D28, respectively (Fig 20B). The absolute number of GC in H19-/- spleen 
showed a 2.1, 2.8 and 2.0 -fold decrease at D7, D14 and D28 after immunization (Fig 20C), 
respectively. The higher number of splenic B cells in the non-immunized mice of H19-/- (Fig 
20C) were reversed such that after immunization the total B and GC cell numbers were now 
lower than those in wild type mice indicating an impaired B cell response in H19-/- mice. 
Similar reduced GC response pattern in H19-/- mice was also observed after OVA (in alum) 
immunization and spleens of H19-/- mice exhibited 6.1-fold decrease of GC cells at D15 after 
immunization (data not shown).   
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Impaired antibody specific IgM and IgG response in H19-/- 
An impaired GC reaction could result in a number of possible defects in the immune response. 
One is the amount of immunoglobulin produced, another includes the extent of class switch 
recombination and somatic hyper-mutation or selection of high affinity antibodies.  
We therefore sought first to determine whether the antibody response was affected. To 
address this question, we analyzed total IgG and IgM titer before and after immunization, and 
antigen specific antibody, after immunization. Total serum IgG and IgM was measured by 
ELISA, showing both wt and H19-/- mice had comparable total IgM antibody titers in the 
serum before immunization (Fig 23B first panel from the top). The total IgG (all classes) 
however showed a two-fold decrease in mutant mice. To evaluate the titer of antigen specific 
antibody after immunization with SRBC we adopted the method reported by Ellen J et al. 
(McAllister et al., 2017)(Fig 23A). Briefly, serial dilutions of the serum were incubated with 
fixed number of SRBCs that were in a second step incubated with fluorescence labelled 
secondary anti-mouse IgG or IgM or other Ig isotypes (Fig 23A). The mean fluorescence 
intensity (MFI) of the complex was measured by flow cytometry and a titration curved was 
obtained by plotting MFI against serum dilution factor. The results showed that antigen 
specific IgG and IgM response were similar in WT and mutant mice at D7 after immunization, 
indicating the initiation of antigen specific IgG and IgM response in the H19-/- mice was 
normal (Fig 23B second panel from the top). However, at D14, antigen specific IgM response 
in H19-/- showed a 4-fold decrease (Fig 23B third panel from the top), while antigen specific 
IgG response was also decreased although to a lower extent than that observed in IgM. We 
investigated the antigen specific response of the different Ig isotypes, such as IgG1, IgG2a, 
IgG2b, as well as IgE. Only IgG1 that accounts for more than 80% of the IgG immune 
response showed a 1.5-fold decrease in H19-/- compared to WT mice (data not shown). The 
most striking difference lied in the antigen specific IgM response after the second 
immunization because H19-/- mice showed a virtually undetectable antigen specific IgM in the 
serum corresponding to close to 100-fold decrease compared to wt mice that exhibited a 
continuous increase of IgM response (Fig 23B first panel from the bottom). Further 
investigation of the affinity of OVA-specific IgM by ammonium thiocyanate elution method 
(Ferreira and Katzin, 1995) and of NP-specific IgM in NP-CGG immunization by the ELISA 
(Barinov et al., 2017) showed both the affinity of OVA and NP-specific IgM were lower in 
the H19-/- mice, compared with wt (Fig. 23C), while NP-specific IgM affinity in NP-Ficoll 

Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																				
 
	
 
81	
2 independent experiments with at least three biological replicates per experiment. *p<0.05; **p<0.01; ***p< 
0.001, ****p< 0.0001 unpaired t test. 
The impaired antigen specific IgM response led us to investigate the Ig class switch 
recombination, plasma cell generation, as well as apoptosis of the GC cells after 
immunization. 
To assess Ig class switch recombination process we analyzed splenic GC 14 days after the 
immunization with SRBC from both WT and H19-/- by flow cytometry. The GC cells 
(CD19+IgD+CD38-CD95+) were sub-divided by using anti-IgG1 and anti-IgM. We observed 
that GC cells from H19 mutant mice showed a ~2-fold increased frequency of IgG1+ cells, 
which accounted for 56.3 ± 0.5% of total GC cells, while the WT was 26 ± 11,3%. On the 
contrary, the frequency of IgM+ cells showed a mild decrease, 19.0 ± 1.1% in H19-/- versus 
27.4 ±0,1% in WT (Fig 24A and B). Although the frequency of IgG1+ cells increased and that 
of IgM decreased the profound reduction in the numbers of GC cells in mutant mice results in 
a close to 10-fold decreased number of IgM+ GC cells whereas the numbers of IgG1+ GC 
cells were comparable between WT and H19 mutant mice.  These results showed that after 
entering GC, the initial IgM+ B cells switched to a similar number IgG1+ cells in WT and 
mutant mice although the IgG1 antibody titers were slightly decreased, whereas left a far 
lower number of IgM+ GC cells in H19-/-, indicating a virtual normal class switch 
recombination but a decreased IgM+ pool. As previously described, the Ig class switch is 
mediated by the activation induced cytidine deaminase (AID, encoded by Aicda). We next 
sorted the GC cells 7 days after the immunization and studied the expression of Aicda by 
qPCR, H19-/- GC cells showed a mild increase Aicda expression (see below in Fig 29C), 
reflecting the higher frequency of IgG1+ cells (Fig 24A and B). This result is therefore 
consistent with the previous observation that GC in H19 mutant mice showed a higher DZ/LZ 
ratio (Fig 22A and C), because AID is mainly expressed and exert its function of Ig class 
switch in highly proliferative DZ cells.  
To investigate the plasma cells generated after immunization, we performed the enzyme-
linked immunospot (ELISPOT) to quantify total Ig and IgM secreting cells in both BM and 
spleen of SRBC immunized mice. Interestingly, the number of total IgM secreting cells in 
both spleen and BM showed a 2-fold decrease in H19-/- mice while total antibody secreting 
cells revealed by an anti-kappa light chain antibody was comparable in both spleen and BM 
of SRBC immunized wt and H19-/- mice (Fig 24C), indicating the specific reduction of IgM 
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Reduced expression of B cell activation markers on the surface of 
H19-/- B cells after immunization 
Because H19 mutant B cells showed a defective response to anti-CD40, we investigated the 
expression of the accessory molecules displayed cell surface responsible for B cell activation. 
Splenic B cells from SRBC immunized mice from both genotypes upregulated the B cell 
activation markers, MHCII, CD40 and CD86. However, H19-/- B cells showed a lower 
expression of MHCII, and more strikingly, of CD40 and of CD86 (Fig 26). As described 
previously, MHCII presents the antigenic peptides to the TCR and get the feedback signal 
from TFH cells for B cell activation and selection (Yang Zhang, 2018). While CD40 and 
CD86 paired with CD40L and CD28 expressed on TFH cells to provide co-stimulatory signal 
for the B cell activation and selection. The lower expression of CD40, CD86 and MHCII 
indicates that H19-/- B cells received weaker signals from cognate TFH cells such that 
activation of H19-/- B cells was less efficient. In particular, blocked CD40-CD40L 
costimulatory signaling after SRBC immunization has been reported to reduce the plasma cell 
differentiation (Foy et al., 1996) (Yang Zhang et al. 2018). This is in line with our observation 
that H19-/- B cells give rise to a reduced number of plasma cells in response to both in vivo 
(Fig 24C) and in vitro (Fig 25) stimulation. This conclusion was further reinforced by in vitro 
culture, which showed that H19-/- B cells failed to upregulate MHCII and CD86 to levels 
comparable to those in WT B cells after stimulation with anti-CD40 and/or anti-IgM in vitro 
for 24h (Fig 26B).  Collectively, these results demonstrate that T-B cell interaction, caused by 
the lower costimulatory signaling (such as CD40-CD40L, CD86-CD28), is less efficient in 
H19 mutants compared to WT mice, resulting in defective B cell response and plasma cell 
differentiation, reflected by an impaired GC reaction and antigen specific IgM response. 
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profile (data not shown), indicating that the altered GC response in H19-/- was not caused by 
increased apoptosis.  
H19 functions in a B cell autonomous manner to regulate B cell 
response 
The results above indicated that H19 expression during embryonic development affects the 
adult immune response. Although most effects were observed at the level of B lymphocytes 
and plasma cells, we considered the possibility that H19 expression impacted other cells 
involved in the immune response and that the defective immunoglobulin secretion and GC 
reaction after immunization were an indirect consequence of the H19 mutation. To determine 
whether the defective B cell response in H19-/- mice is or not a B cell autonomous 
phenomenon we performed reconstitution chimeras. We used E15 FL cells from WT and H19 
mutant embryos at a 1:1 ration to reconstitute Rag-/-gc-/- CD45.1 recipient mice which have no 
B, T and NK cells. 8 weeks later a fraction of chimeric mice were immunized with SRBC and 
analyzed 10 days later (Fig 27A). Splenic B, T, and granulocytes from donor origin (CD45.2) 
were purified and submitted to quantitative genomic H19 PCR to distinguish WT cells from 
H19-/- cells. Compared with the non-immunized control, the spleen in the immunized group 
showed a decrease in both spleen size and weight (Fig 27B), exhibiting a similar phenotype as 
that observed in the immunized H19-/- mice. We generated a standard curve by doing genomic 
PCR for H19 in DNA obtained from freshly isolated B cells from WT and mutant mice mixed 
at different ratios. The PCR results of B, T, and granulocytes from both non-immunized and 
immunized recipients were fitted to the standard curve and frequency and number of the WT 
and H19-/- cells were calculated. Granulocytes and T cells from mutant mice were present at a 
similar frequency in both immunized and non-immunized chimeras. By contrast, mutant B 
cells that were present at a frequency of 54.6±4,3% before immunization decreased to 
24.1±6,8% after immunization (Fig 27C and D) 
When we calculated the absolute cell numbers, WT cells showed a mild increase in the 
immunized group, and in contrast, the H19-/- B cells exhibited a more than 4-fold decrease 
(Fig 27D). This result indicates that the B cell defective response in H19-/- mice is a B cell 
intrinsic phenomenon. 
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6.25% WT B cells plus 93.75% H19-/- B cells, and titration curve is generated by plotting the normalized Ct 
value of H19 against the percentage of WT B cells. (D, right panel) the absolute number of WT and H19-/- B 
cells calculated separately in both group.  Data is representative of 1 independent experiments with 3 replicates 
in the control group and 5 in the immunized group. *p<0.05; **p<0.01; ***p< 0.001, ****p< 0.0001 unpaired t 
test. 
 
B Cell Receptor-Mediated Calcium Signaling Is Impaired in H19-/-
B Lymphocytes  
As discussed before, the main signal for B cell activation is done through the BCR complex, 
and B220 can regulate BCR signaling through different mechanisms (Byth et al., 1996). 
Previous results indicated that the defect of H19-/- B cell response is cell autonomous 
phenomenon therefore we next determined whether the differential B220 expression impacts 
on BCR signaling by analyzing the calcium influx. In response to polyclonal IgM stimulation, 
splenic H19-/- B cells had dampened both basal and anti-IgM inducible calcium influx levels 
(Fig 28A), indicating increased threshold of BCR ligation triggered signaling, while a lower 
basal calcium flux levels, reminiscent of a less anergic B cells phenotype characterized in 
various model BCR transgenic systems (Cooke et al., 1994; Yarkoni et al., 2010). 
Furthermore, the similar dampened calcium flux profile was observed in the H19-/- splenic B 
cells after in vivo immunization (Fig 28B). We analyzed the B cell compartment according to 
the levels of B220 expression on the B cell surface, namely B220hi, B220int and B220lo, 
respectively. Calcium flux was inversely correlated to the expression of B220 in both WT and 
H19-/- splenic B cells, suggesting the upregulated B220 expression on H19-/- B cells results in 
elevated threshold of BCR signaling or reduced responsiveness on BCR stimulation. Loss of 
H19 tunes functional BCR responsiveness through regulating B220 expression, in an 
unknown manner. 
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active in cell cycle. This is consistent with the higher DZ/LZ ratio observed in the GC of 
immunized H19-/- mice, since the DZ cells are highly proliferative in compare to LZ cells, and 
larger frequency of the DZ might be responsible for the upregulated genes associated to cell 
division.  Transcripts such as Aicda, Sh2b2, smarcc1 and Usp12 show the largest fold-change 
genes within the upregulated gene set in GC cells of H19-/- (Fig 29 A and C), whereas among 
those downregulated genes in the mutant GC cells, some are related to BCR signaling and B 
cell activation, in particular, CD40, CD69, CD2, CD48, Ptk2, Akt3 and Rel, were 
downregulated in mutant GC cells. The latter downregulated transcripts are associated with 
the reduced B cell response in the GC. Except the transcripts involved in BCR signaling, a 
number of other genes were significantly downregulated in H19-/- GC cells, such as Xkr6, 
Bcl9, Bcl2, Uba7, Stag3, Elolv6, etc (Fig 29A and C). 
 
Figure 29 Reduced BCR signaling related genes in H19-/- B cells are reflected in GC 
transcriptional profile 
(A) Heat map of a selected set of genes with different expression in H19-/- versus WT GC cells. RNAseq was 
done in the GC cells from 7 days post SRBC immunization. (B) Heat map of histone genes and genes related to 
the cell cycling; Validation of the top differentially expressed genes (downregulated genes -(C) and upregulated 
genes(D) in GC of H19-/-) from RNA sequencing by quantitative RT-PCR. Results are presented in arbitrary 
units (AU) normalized to expression of housekeeping gene Hprt. Data is representative of 1 independent 
experiments with 3 biologic replicates. *p<0.05; **p<0.01; ***p< 0.001, ****p< 0.0001 unpaired t test. 
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We validated a number of the differentially expressed genes by qPCR, among 22 top 
differentially expressed genes were tested and we found SH2B2 is most upregulated genes in 
GC cells from H19-/-. SH2B2, also named APS, encodes a protein that belongs to SH2B 
adaptor family and contains pleckstrin homology (PH) and src homology 2 (SH2) domains, 
which was tyrosine phosphorylated in response to B cell receptor stimulation, as well as by 
kinase-2 (JAK2)-STAT5 (Wakioka et al., 1999). Iseki M et al. reported that APS co-localized 
with BCR complexes in activated APS-Tg B cells and appeared to negative regulate BCR 
signaling (Iseki et al., 2005).  
In addition, the Aicda, encoding AID, a crucial enzyme that mediates Ig class switch and 
somatic hyper-mutation in GC, showed also a modest increase in GC cells from H19-/- 
according to the qPCR (Fig 29C). This is consistent with previous observed accumulated 
IgG1 class switch and reduced IgM+ GC cells in H19-/-.  
We also validated that Bcl9, stag3 and Xkr6 were the most downregulated genes in H19-/- GC 
cells. Bcl9 have been extensively studied to have a regulatory role for the transcription of Wnt 
target genes (Mosimann et al., 2009), associated with B-cell malignancies through inhibition 
of apoptosis and might contribute to the maintenance of the GC reaction and expansion in the 
immunized WT mice. Although we did not find differences in caspase 3/7 expression between 
WT and mutant GC cells it could be that differences in apoptotic cells that went undetected by 
antibody staining were revealed by transcriptional analysis.  
The transcriptional landscape of GC cells revealed the links between the molecular events and 
the immune-phenotype of H19-/- impaired in mutant B cells. First, reduced BCR 
responsiveness reversely correlated to the expression of B220 is also reflected by the 
upregulated Sh2b2 that has a role in negative regulation of BCR signaling. Second, lower 
expression of costimulatory molecule CD40, CD2 and CD69 also results in reduced B cell 
activation signal from T helper cells. Dampened BCR signaling and T cell help in GC cells of 
H19-/-mice leads to decreased expression of Rel, one of the NF-kB subunits, which 
consequently slows down the GC reaction. Third, upregulated Aicda expression in GC cells of 
H19-/- reflects the accumulation of Ig class switch to IgG1.  Fourth, upregulated histone genes 
is also consistent with the increased DZ/LZ ratio, suggesting higher frequency of DZ cells 
undergoing Ig class switch and somatic hyper mutation.  
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Taken all the observations above we concluded that loss of H19 linked to the altered B cell 
development in the FL, resulting in a larger peripheral B cell compartment, which showed a 
reduced GC reaction and defected antigen specific IgM response after TD antigen stimulation. 
In this TD antigen response process, competitive reconstitution showed that H19 functioned 
in a B cell autonomous manner, also reflected by the dampened BCR signaling and impaired 
costimulatory signal from T helper cells in GC of H19-/-mice. Additional molecular evidence 
was added by lower expression of BCR signaling associated genes, genes related to B cell 
activation in response to TD antigens and higher expression of Aicda and cell cycle related 
genes, as well as Sh2b2, a negative regulator of BCR signaling. 
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Discussion 
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Long non-coding RNA H19 is highly expressed in the fetal life and decreases its expression 
after birth. In particularly, in the FL, highly expressed H19 has been linked to hepatocyte 
proliferation and differentiation, liver maturation (Pope et al., 2017) through the regulation 
metabolic propertied of developing hepatocytes. In the adult, expression of H19 has been 
reported in the skeleton muscle satellite cell (Dey et al., 2014b) and, although at very low 
levels, on hematopoietic stem cell in the BM (Venkatraman et al., 2013) where loss of H19 
leads to premature exit from quiescence and drives stem cells to enter differentiation through 
enhanced Igf2-Igf1r signaling. Our observations that H19 is the most differentially expressed 
transcript in both B and T cell progenitors between embryonic and adult lymphoid cells 
suggested a role of these cells in the development of the immune system. 
 
We first characterized early B cell development by analyzing different developmental stages, 
in both FL and adult BM.  Then we assessed the B cell migration from the BM to the 
peripheral secondary lymphoid organs, such as spleen and lymph nodes, where B cell 
maturation takes place. Finally, we assessed the functional property of WT and H19-/- B cells 
through a characterization of the immune reaction and we assessed the molecular mechanisms 
underlying the differences found in the immune reaction.  
 
Altered B cell development in FL of H19-/- 
Following the developmental scheme described by Hardy based on B cell surface markers we 
observed that H19-/- FL generated far more BP1+ proB cells, a compartment that is composed 
of fraction C (cells undergoing immunoglobulin heavy chain rearrangement) and C’ (cells 
with a productive rearrangement). Although the Hardy scheme of B cell development was 
initially designed to analyze BM B lineage cells we found that the same applies to FL 
development and three fractions in the proB compartment could clearly be distinguished after 
E17.5. However, in contrast to BM cells, a discrete fraction of intracellular Igµ+ lymphocytes 
could be found in fraction B in both wt and H19-/-(Fig 15B).  
As the B cells developed to the fraction C’ stage, the frequency of intracellular Igµ+ cells 
reached to 80% in both wt and H19-/-. This result shows increased numbers of cells that 
completed a productive heavy chain rearrangement in mutant FL cells although the 
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frequencies of cells that initiate and completed rearrangement is lower in mutant than WT 
cells.  
Transcriptional analysis of fraction C indicates elevated Igf2 expression but also of Igf1r that 
binds Igf2. Igf2 promotes cell growth and proliferation in hematopoietic cells (Martinet et al., 
2016; Venkatraman et al., 2013) and upregulated Igf2 expression by loss of imprinting is a 
common feature in tumors seen in Beckwith-Wiedemann syndrome (Cohen, 1994) and Wilms’ 
tumor (Frevel et al., 1999). However, cell cycle analysis showed that mutant cells are less 
cycling than their WT counterparts. Because the size of fraction B is identical in both strains 
the increased B cell production can only be explained by a faster B into C transition in mutant 
B lineage cells. Therefore, we found no evidence that Igf2 increase has a role in the increased 
B cell compartment of H19-/- FL. 
 
B cells egression from BM to the periphery 
The increased peripheral adult B cell compartment suggested increased B cell production also 
in the BM. After two pulses of EDU within 14 hours a marked increase in IgM+ cells labelled 
cells was observed in mutant compared to WT cells. This result indicates that in adult BM B 
cell production is increased which could reflect higher cell division rate or a faster transit 
through development. Similar frequencies of cells in G1, S/G2/M stage indicated that the 
increased B cell production in mutant cells only be explained by a faster transition of 
progenitors through the successive developmental stages. Consistent with this interpretation, 
molecules involved in the adhesion of progenitors to different BM microenvironments that 
regulate the expansion of progenitors at different developmental stages were expressed at 
similar frequencies in WT and mutant cells.   
The adhesion of the immature B cells to stromal cells is mediated by integrin α4β1, VCAM-1 
and fibronectin (Beck et al., 2014). Integrin α4β1 expression is tightly regulated by the 
chemokine receptor CXCR4 signaling (Glodek et al., 2003). The strength of integrin α4β1 
bind to VCAM-1 is enhanced by CXCL12-CXCR4 signaling. Extensive studies showed that 
focal adhesion kinase (FAK) also played a role in this process (Glodek et al., 2003). FAK is a 
cytoplasmic protein tyrosine kinase that enriched within the cell at the adhesion sites. Integrin 
signaling can lead to the phosphorylation and activation of FAK, which can be positively 
regulated by the CXCR4 signaling (Schaller, 2001). FAK deficiency (Park et al., 2013) and 
integrin β1 deficient mice (Pereira et al., 2009) lead to a mild reduction of developing B cells 
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in the BM. In the immature B cell stage, fraction E in Hardy’s scheme, the newly generated 
IgM+ B cells downregulate CXCR4 expression and egress from BM (Beck et al., 2014).  
We measured mean fluorescence intensity (MFI) of both CXCR4 and CD49d (Integrin α4) on 
the B cell surface and the Btk2 gene (encoding FAK) expression of both wt and H19-/- in the 
BM B cell development. However, no differences were observed (data not shown), indicating 
the CXCR4-FAK-Integrin α4 dependent cell egression from the BM to the periphery is not 
affected by deletion of H19. All the evidence indicates it is the B cell production, rather than 
B cell egression, that is responsible for the increased B cells in the periphery of H19-/-.  
 
B cell response –the role of CD45 in the immunological synapse 
The B cell-T cell interaction leads to formation of a dynamic structure called the 
“immunological synapse” (van der Merwe, 2000), which was initially proposed by Paul and 
Seder (Paul and Seder, 1994) to describe the interface between T cells and B cells. 
 
During B cell activation and response, the synapse between T and B cells forms through TCR 
and peptide-MHCII complex, while binding of T cell costimulatory receptors (e.g. CD40L, 
CD28) to their ligands (CD40, B7) expressed on the B cell surface, contribute to the stability 
and maturation of the immunological synapse (Victora and Nussenzweig, 2012a). The 
immunological synapse comprises a “bull’s eye” structure with an outer ring and a central 
synapse (van Der Merwe and Davis, 2002). The outer ring contains adhesion molecules (such 
as the integrin LFA-1 and its ligand), and the central synapse, where the T cell and B cell 
membranes are close to each other, is composed of peptide-MHCII complex-TCR and paired 
costimulatory molecule (CD40-CD40L, B7-CD28, etc.). In this process, CD45 has been 
reported to have a pivotal role. Upon antigen engagement, CD45, protein tyrosine 
phosphatase receptor type C (PTPRC), co-localizes with integrin thereby inhibiting synapse 
formation (Johnson et al., 2000; Depoil et al., 2008).  
In H19 mutant B cells B220, one of the CD45 isoforms, is highly expressed compared to that 
of wt. B220 has a heavier glycosylation than other CD45 isoforms in its extracellular domain 
and consequently it is more difficult to be excluded from the central synapse, so the higher 
density B220 expression on the surface of H19-/- B cells may impede the formation of a tight 
and stable synapse. We reasoned that insufficient exclusion of B220 from the central synapse 
might reduce the efficiency and/or the duration of B-T helper cell engagement. This is based 
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on the observation that after immunization, H19 mutant B cells exhibited lower activation 
status which is reflected by decreased expression of costimulatory molecule MHCII, CD86 
and CD40 compared to that of wt B cells, and all these molecules are the core players of B-T 
cell synapse. 
 
Epigenetic mechanisms modulate gene expression by lncRNA H19 
ProB cells from H19 mutant isolated from FL but also from BM showed upregulated B220 
and downregulated CD43 expressions. Extensive studies showed that H19 plays a role in 
affecting transcription through chromatin remodeling. In embryonic development, H19 
recruits epigenetic modifiers, acting as a guide to activate or repress gene expression. It has 
been shown that H19 regulates the imprinting gene network by affecting at least nine 
imprinted genes: Igf2, Igf1r, Dlk1, Meg3, Slc38a4, Peg1, Dcn, Cdkn1c and Gnas (Monnier et 
al., 2013). Some of these genes are regulated by H19 through recruitment of methyl-CpG-
binding domain protein 1 (MBD1), which can bind methylated DNA and recruit histone 
lysine methyltransferases (KMTs) to permanently suppress expression by chromatin 
compaction (Monnier et al., 2013). In some cases of bladder cancer, H19 recruits histone 
methyltransferase EZH2 at the E-cadherin promoter, leading to an increase in H3K27me3 
repressive marks and to silence the expression of E-cadherin gene (Luo et al., 2013). In our 
work on B cell development in FL, fraction C cells from H19-/- showed increased expression 
of Igf2, Igf1r, and Cdkn1c. This can be achieved by the reduced recruitment of repressive 
epigenetic modifiers to the regulatory element of these genes in H19-/- fraction C cells and 
similar differential expression is also found in BM. The upregulated B220 expression in the 
FL B cell development of H19-/- and H19mat-/+, might also be one of the consequences of loss 
of maternally expressed H19 mediated epigenetic repression, thus establishing an epigenetic 
memory on the locus of CD45.  
H19 can also promote gene expression through epigenetic modification. Binding of H19 to 
histone acetyltransferase hnRNP U results in the upregulation of genes within the miR-200 
family through histone H3 acetylation, which highlight the active role of H19 in gene 
expression by epigenetic mechanisms (Zhang et al., 2013). Since H19-/- B cells showed 
defects in the immune response to TD antigens and lower expression of B cell activation 
markers, such as CD40, CD86 and MHCII, we hypothesize that loss of H19 might also mark 
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epigenetic memories on these loci. Another possibility would be that H19 regulates the 
expression of key molecules that regulates all of the above. 
 
Affinity maturation in H19-/- GC cells 
Ig heavy chain class switch recombination (CSR) occurs rapidly after activation of mature 
naïve B cells. CSR is an AID-induced process taking place in the DZ of GC and the main 
function of this process is to switch the Ig isotype from expressing IgM to another Ig isotype 
such as IgG, IgE, or IgA. CSR only exchanges the Ig heavy chain constant region from the 
initial Cµ to an alternative set of downstream constant region exons, such as Cγ, Cε, or Cα 
whereas the antigen specificity determined by the variable region is not affected (Honjo et al., 
2002; Stavnezer et al., 2008).  
H19-/- mice, after SRBC immunization, generate a smaller GC compartment, and the 
increased DZ/LZ ratio compared to that of wt. Since the AID expression and the AID 
mediated CSR mainly takes place in the DZ of GC, the increased frequency of DZ cells in 
immunized H19-/- mice indicates larger proportion of GC cells have the chance to undergo 
CSR, resulting in a comparable number of IgG1 switched cells as in the immunized wt mice. 
This indicates the class switch in the H19-/- is normal. This is also confirmed by the EdU 
incorporation in GC cells, which showed an increased frequency EdU labeled IgG1+ GC cell, 
but the number remains at a similar level as that of wt. In addition, in vitro stimulation for 
CSR with LPS and IL4 also showed no differences of wt and H19-/- B cells in generating 
IgG1+ cells in absolute cell numbers (data not shown), indicating the TLR4 and IL4 signaling 
pathways are intact in H19-/- B cells. This added more evidence of the normal CSR in 
activated H19-/- B cells. 
However, the dramatically decrease in IgM positive GC cells rises several possibilities: fewer 
naïve cells are activated and enter the GC, or there is a decreased proliferation or increased 
apoptosis of IgM+ GC cells, or an accelerated differentiation into IgM secreting plasma cells 
or memory cells. We excluded the possibility of an accelerated differentiation by finding 
decreased plasma cells, as well the impaired primary and recall IgM antibody response, which 
indicates a defected PC and MBC generation. Secondly, cell cycle analysis and caspase3/7 
staining showed no major difference between the GC cells of H19-/- and wt, H19-/- GC cells 
even showed an increased expression of histone genes, indicating a higher proliferation and 
normal apoptosis phenotype. Altogether, the most possible cause of decreased IgM+ GC cells 
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is the fewer naïve B cells activated in the T-B border of spleen, leading to a shortage source 
of activated B cells entering the GC. This is also demonstrated in our in vitro stimulation, 
where H19-/- B cells generated less activated B cells, as well fewer plasma cells under the 
simulation of anti-CD40 and IL4. This result is consistent with the in vivo observation of 
impaired GC formation and the shortage outcome of the plasma cells. 
Further investigation found that Aicda (encoding AID) expression in GC cells from H19-/- 
mice was increased compared to that of wt GC cells. The possible explanation is that GC cells 
of H19-/- mice exhibit a larger frequency cells of DZ cells where AID highly expressed, 
leading to higher percentage GC cells undergoing CSR from the initial IgM to a switched 
IgG1 isotype. This is also reflected by the reduced antigen specific IgM response.  
SHM is a process that introduces random point mutations in the variable-region gene 
segments of the BCR, which can result in unchanged, increased or decreased BCR affinity 
and to self-reactive BCR. This process is mainly taking place in the DZ of GC.  Some of the 
B cells from DZ can exit cell cycle and relocated to the LZ, where affinity selection takes 
place. Signals from FDCs and TFH cells, as well as cytokine signaling plays important role in 
affinity maturation.  B cells can sense the antigens captured by FDCs to allow for antigen-
driven selection of high affinity BCR. Defective BCR responsiveness of H19-/- B cells 
reflected by decreased Ca2+ influx after anti-IgM stimulation can partially contribute to the 
inefficiency of BCR affinity selection, leading to the reduced IgM affinity. In addition, TFH 
cells in the LZ is essential for affinity maturation in a TD response. BCR binding to antigen 
presented by FDCs triggers the internalization of the BCR-antigen, then antigenic peptides are 
processed and displayed on major histocompatibility complex II (MHCII), which can in pair 
with TCR on the surface on TFH cells to form the immunological synapses described 
above(Reinherz et al., 1999; Lanzavecchia, 1985). The intensity of MHCII, as well the 
costimulatory molecules CD40 and CD86 on the LZ B cell surface determines the strength of 
the signals received from TFH cells and the efficiency of affinity selection. H19-/- GC B cells 
display lower expression of these three molecules compared to that of wt in TD antigen 
response, suggesting weakened signals received from TFH cells. This also contributes to the 
impaired affinity selection in the LZ, leading to reduced antigen specific IgM affinity in TD 
antigen immunized mutant. B cells bear low affinity or self-reactive BCR are not selected  
and undergo apoptosis or phagocytosis by macrophages (Smith et al., 1998). This is a possible 
explanation for the higher DZ/LZ ratio in the GC of H19-/- mice. 
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Conclusions and perspectives 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																				
 
	
 
101	
In this work, we investigated the B cell development and function in absence of H19. We 
have shown that H19 expression in B lineage cells decreases after E15 and that by P15 it is 
undetectable. However, our observations show that in the absence of H19 B cell development 
is affected in FL but also in adult BM and that more importantly the thymus-dependent B cell 
response is impaired in the adult lymphoid organs.  
B cell development in the FL of H19 (starting at E17.5) mutant FL generate far more 
BP1+proB cells. Although these pro-B cells show impaired Ig heavy chain VDJ 
rearrangement mainly caused by failure in the initiation of D-J, and/or V-DJ rearrangement, 
H19 mutant show a net increase in absolute cell number of intracellular IgM+ B lineage 
lymphocytes and consequently of B cell production. The larger peripheral B cell compartment 
in H19-/- mice is due to enhanced B cell production not only in the embryo but also throughout 
life. Venkatraman and colleagues (Venkatraman et al., 2013) also observed increased B cell 
compartment in adult mutant mouse of the maternal H19 DMR.  
Because H19 is no longer expressed in adult lymphocytes the results above can only be 
explained by an epigenetic alteration induced during H19 expression. Consistent with this, 
loss of H19 leads to a permanent alteration of the B cell surface phenotype, with a more than 
two-fold increase in B220 expression on the surface of all B cell subsets. These observations 
led us to analyze B cell responses in adult mice. We show that splenic B cell from H19-/- 
exhibited reduced GC reaction and antigen specific IgM response, leading to an impaired 
affinity maturation. Therefore, in the absence of H19 there is a suboptimal humoral immune 
response. This impaired B cell response in H19-/- cells is B cell autonomous phenomenon as 
demonstrated by the decrease in mutant but not WT B cells in competitive BM chimeras.  
Defective B cell responsiveness can be partially explained by decreased Ca2+ influx after anti-
IgM stimulation but also by the partial failure to upregulate costimulatory molecules CD40, 
MHCII and CD86 after anti-IgM treatment of B cells in vitro or after in vivo immunization 
with SRBC.   
RNA sequencing data from WT and mutant GC cells reinforced these conclusions. First, 
reduced BCR responsiveness, inversely correlated with the expression of B220, is reflected by 
the upregulation of Sh2b2 a negative regulator of BCR signaling in mutant GC cells. Second, 
lower expression of CD2, CD69 and CD40 can also result in reduced B cell activation signals 
from T helper cells. Dampened BCR signaling and T cell help in GC cells of H19-/- mice, also 
reflected by the decreased expression of Rel, one of the NF-kB subunits, which consequently 
slow down the GC reaction. Third, upregulated Aicda expression indicates a decrease in the 
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frequency of IgM+ in GC cells of H19-/-, leading to the defected antigen specific IgM response. 
This result is also consistent with the increased dark zone/like zone ration in mutant GC 
reaction with higher frequency of Ig class switch but lower affinity selection.    
We concluded that loss of H19 linked to the altered B cell development in the FL and BM 
results in a larger adult peripheral B cell compartment, which showed a reduced GC reaction 
and defected antigen specific IgM response after TD antigen stimulation. TD antigen response 
defect is B cell autonomous and is accompanied by a dampened BCR signaling and impaired 
costimulatory signal from T helper cells in GC of H19-/-mice.  
Further studies on loci accessibility in H19 mutant and WT B cells are needed to understand 
the contribution for epigenetic regulation of this long-non-coding RNA to the function of the 
immune system.  
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Material and method 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																				
 
	
 
104	
Mice 
C57BL/6 and 129SV mice were purchased from Janvier Labs, H19-/-mice (provided by Luisa 
Dondolo) (Ripoche et al., 1997; Gabory et al., 2009), Rag-/-gc-/-mice and were bred in the 
Pasteur Institute mouse facility under specific pathogen-free conditions. The H19-/- strain is 
maintained on the 129SV/Pas background. H19maternal-/paternal+ and H19 maternal+/ paternal- were 
obtained after two round crossing, the first round is crossing 129SV WT male with H19-/- 
female, and the F1 female cross back to 129SV male to get H19maternal-/paternal+, while the F1 
male cross with 129SV female to get H19maternal+/paternal-. All the breeding and crossing were 
done in the animal house at Pasteur Institute.  To obtain the FL of different embryonic date, 
mattings were done overnight; on the following day, mice showing a vaginal plug were 
isolated and were considered to be at embryonic day 0 (E0). All experiments were done in 
accordance to Pasteur Institute ethic guideline, approved by French Agriculture ministry and 
the EU guidelines.  
The genotype of both 129Sv WT and H19-/- was performed by PCR using the Fire Animal 
Tissue Direct PCR Kit (Thermo Scientific) with the following primers: 
H19 F: 5′-ccgctcaaccacctaattgt-3′; and H19 R: 5′-cagacatgagctgggtagca-3′ for H19 detection. 
While H19 promoter F: 5′-cggggctatatgttctcgac-3′; and Neo F(R): 5′-tgaatgaactgcaggacgag-3′ 
for neomycin (introduced to the H19-/- genome when the mouse model was constructed) 
detection. The PCR program is the following:  
cycle: 94C 5min 
           94C 30sec   58C 30sec    72C 1min   35 cycles 
           72C 7min 
Cell suspension. 
E13 to E19 embryos were dissected under microscope to harvest FLs. Fetal organs were 
recovered in DPBS (Gibco) supplemented with 1% fetal calf serum (FCS) and passed through 
the needle of a 1-ml syringe to obtain single cell suspensions. Before staining, cell 
suspensions were filtered with a nylon mesh. 
To recover BM cells, first dissect and harvest the femur, or tibia of the hind legs. Then 
perfuse the bone cavity with DPBS (Gibco) supplemented with 1% FCS by using a syringe, 
after collecting the BM fluid, cell suspensions were filtered with a nylon mesh. 
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Spleen and lymph nodes cell suspensions were obtained by smashing the spleen or lymph 
node inside a nylon mesh to release the cells to 3ml DPBS (Gibco) supplemented with 1% 
FCS. 
 
Flow cytometry and cell sorting 
Cells suspensions were stained with antibodies listed in Annex table1. Stained cells were 
analyzed on a FACSC LSR II and were sorted with a FACSAria III (BD Biosciences). Data 
were analyzed with FlowJo software. 
Cell culture 
First 96-well plates were coated with monolayer OP9 or OP9DL4 stromal cells (2000 cells 
per well), and cultured at 37 °C and 5% CO2 and in complete medium (OptiMEM 
supplemented with 10% FCS, penicillin (50 units/ml), streptomycin (50 µg/ml) and β-
mercaptoethanol (50 µM) from Gibco Life Technologies). Then single cells are sorted into 
96-well plates with stromal cells, together with different cytokine combination. When comes 
to bulk cell culture, cells were sorted to DPBS plus 1%FCS, then the cells were submitted to 
centrifugation, and resuspended with complete medium, then distributed 100 cells to each 
well. 
Frequency assay. 
Single cells were sorted into 96-well plates containing pre-coated OP9 stromal cells (for B -
NK – myeloid cell potential) and OP9DL4 stromal cells (for T-NK cell potential) in complete 
medium supplemented with saturating amounts of IL-7, Flt3L, KitL, IL2, GM-csf, M-csf. 
Cultures were supplemented with fresh cytokines every 7 d. After 10–12 d of culture, wells 
showing colonies were stained for CD19, NK1.1, CD3ɛ, CD11b and Gr1c and were analyzed 
with a LSR Fortessa (from BD Biosciences). Frequency scores were assigned based on the 
frequency of wells positive for B cells (CD19+), NK cells (NK1.1+), T cells (CD3ɛ+) or 
myeloid(CD11b+Gr1+) relative to the total number of plated cells. 
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Quantitative RT-PCR. 
mRNA of sorted cells was extracted using the RNeasy Micro Kit (Qiagen), and cDNA was 
obtained using the PrimeScript RT Kit (Takara). Briefly, cells were sorted to 350ul lysis 
buffer (buffer RLT), add 1 volume of 70% ethanol to the homogenized lysate, and mixed well 
by pipetting, followed by applying the sample to the RNeasy Spin column with 2ml collection 
tube, centrifuge for 15s at 10 000rpm discard the flow through and wash the column with 
350ul buffer RW1 and centrifuge 15s at 10 000rpm, then wash again with 500ul RPE buffer, 
centrifuge 15s at 10 000rpm. The next step is washing with 500ul 80% ethanol, centrifuge 
2min at 10 000rpm, transfer the spin column to a new 2ml tube, and centrifuge 5min at 10 
000rpm. Finally, elute the column with 12ul RNase free water, centrifuge 1min at 10 000rpm. 
cDNAs are prepared by using PrimeScript RT Kit (Takara) following the standard protocol 
and qPCR was performed using TaqMan primers and TaqMan Universal Master Mix 
(Applied Biosystems) for the following genes: Rag1, Rag2, IL7Ra, FOXO1, Bcl2, Bcl6, H19, 
Igf2, Igf1r, Cdkn1c, Lin28b, c-Myc, Aicda. While genes involved in the imprinting gene 
network, such as Dlk1, snurf, Igf2, Cdkn1c, MSTl1, H13, CD81, Ndn, Mstl, expression were 
assessed using SYBR Green Master Mix (Applied Biosystems).  qPCR reactions were 
performed on a ABI 7300 thermocycler (Applied Biosystems), gene expression was 
normalized to that of Hprt and relative expression was calculated using the 2−ΔCt method. 
Chimeras reconstitution and Quantitative genome PCR. 
FL cells(5x105) form both 129SV and H19-/- embryos, in a 1:1 ratio, were injected to Ly5.1 
Rag-/-rc-/- mice by i.v.  After 8 weeks reconstitution, B cells, T cells and granulocytes (5x105 
cells per cell type) from the spleen of the chimeras were sorted. Genome DNA of sorted cells 
was extracted using the DNeasy blood & tissue Kit (Qiagen). DNAs were submitted to 
quantitative PCR using H19 and IL2 primer and SYBR Green Master Mix, qPCR reactions 
were performed on a ABI 7300 thermocycler (Applied Biosystems), genome H19 was 
normalized to that of IL2 using the 2−ΔCt method. Relative percentage of H19+ cells were 
calculated using the titration curve drew by serial percentages of 129SV WT B cells. The 
setting of the titration curve is the following: 1.100% WT B cell; 2. 50% WT B cells plus 50% 
H19-/- B cells; 3. 25% WT B cells plus 75% H19-/- B cells; 4. 12.5% WT B cells plus 87.5% 
H19-/- B cells; 5. 6.25% WT B cells plus 93.75% H19-/- B cells; 
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Immunization and GC analysis in the spleen  
6-8 weeks old mice of both 129SV and H19-/- were immunized with sheep red blood cells, 
LPS, Ovalbumin, NP(31)CGG or alum only. At different time point after immunization, the 
spleens were harvest and GC cells were analysed using immunostaining and flow cytometry. 
Briefly, spleen cell suspensions were stained with antibody purchased from BD Biosciences, 
Biolegend, eBiosciences, and Mitlenyi Biotec.  Cells were incubated with biotinylated anti-
CXCR4 for 15-30min at 4 degrees in the dark, then after washing and centrifugation, cells 
were stained by a secondary antibody mixture, including CD19-APCCy7, IgD-BV421, CD38-
AF700, CD95-PECy7, CD86-PE and APC-coupled streptavidin.  After washing, the dead 
cells were excluded by propidium iodide.  Stained cells were acquired and recorded with a 
LSR Fortessa and analysed by using FlowJo software. 
Intracellular staining 
Using flow cytometry to analyse the expression of transcriptional factor, intracellular protein, 
such as Ig heavy chain and cytokine, or the EdU incorporated to the genome DNA, 
phosphorylated proteins, or even cell cycle analysis. Cells suspensions were first followed the 
normal staining, then washed once in PBS without serum.  Cells were fixed by using the 
fixation buffer, for example fixation buffer from eBioscience intracellular staining kit for 
transcriptional factor staining.  Cells were incubated for 30 min at 4°C in the dark. Cells were 
washed once in PBS and twice in permeabilization buffer, then incubate 30min with another 
fluorescent labelled antibody against different transcriptional factors or other intracellular 
protein. Cells were washed twice in permeabilization buffer and resuspended in FACS 
medium without propidium iodide. LSRII from BD Biosciences were used for flow cytometry 
analysis. Data were analyzed with FlowJo10.2 software from Tree Star. 
Cell cycle analysis 
Cells suspensions were first followed the normal staining, then washed once in PBS without 
serum followed by fixation and permeabilization described in “Intracellular staining” part. 
Then incubate with anti-Ki67-FITC antibody for 45min. Cells were washed twice in 
permeabilization buffer and incubate with DAPI for another 10min in dark in room 
temperature, add FACS medium without propidium iodide. When the samples are acquired 
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and recorded, set pacific blue channel in linear scale. Data were analyzed with FlowJo10.2 
software. 
EdU incorporation and staining 
Mice from both 129SV WT and H19-/- were immunized three or five times in a 12h interval 
with 100 µg of EdU dissolved in DMSO by intraperitoneal injection(i.p.). 2 hours after the 
last injection, the mice were sacrificed and the bone marrow, spleen were collected, cell 
suspensions were prepared and submitted to the normal cell surface marker staining for 15-
30min (avoid using PE or PE tandem fluorescence). Samples were submitted to the EdU 
staining by using “Click-iT EdU pacific blue flow cytometry assay kit”. Briefly, Samples 
washed 3 times with DPBS+1%FCS, then added 100ul of Click-iT fixative buffer and 
incubate for 15min at room temperature, protected from light, followed by washing 3 times 
with DPBS+1%FCS before permeabilization. Then incubate the samples with 100ul 1X 
Click-iT saponin-based permeabilization and washing reagent for 15min.  then the Click-iT 
reaction cocktail was prepared according to the instruction.  Add 200ul of the Click-iT 
reaction cocktail to each sample and incubate the cells for 30min at room temperature, 
protected from light. Wash cells once with 1X permeabilization buffer. Add 500ul 1X 
permeabilization buffer and analyse on flow cytometer. 
Affinity Maturation, Serum Antibody Analysis, and Enzyme-Linked ImmunoSpot 
Assay. 
C57BL/6,129SV WT, H19-/- were immunized with 100 µg of NP(31)CGG (Biosearch 
Technologies) in alum at day 0 and boosted with soluble 10 µg  NP(31)CGG per mouse; at 
day 28 and day 42. Peripheral blood serum was collected at days 0, 7, 15, 21, 28, 42, and 49. 
High-affinity (anti-NP7) and low affinity (anti-NP23) IgM and IgG antibody titers were 
determined by ELISA using standard procedures. Briefly, plates were coated with NP7-BSA 
and NP23-BSA (Biosearch Technologies) at 4 °C overnight and were blocked with PBS 
containing 2% BSA. Diluted serum samples were incubated at 37 °C for 1 h, followed by 1-h 
incubation with HRP linked anti-mouse IgM and IgG antibody. Then 3,3′,5,5′-
tetramethylbenzidine (TMB) was used as liquid substrate, and absorbance was read at 450 nm. 
Hyperimmune serum was used as standard. For the enzyme-linked immunospot (ELISPOT) 
assay, serial dilutions of BM and SP cells were added to a 96-well PVDF membrane plate 
(MSIPN4W; Millipore) coated with 10 µg/mL purified rat anti-mouse Ig kappa light chain 
Junjie	Yang	–	Thèse	de	doctorat	-	2018	
																																																																																																																				
 
	
 
109	
and rat anti mouse IgM antibody and incubated for at least 20 h at 37 °C and 5% CO2. 
Antibody-secreting cells were detected with biotinylated Ig kappa antibody and streptavidin 
conjugated to AP (Roche) and were visualized with 5-bromo-4-chloro-3'-indolyphosphate p-
toluidine salt (BCIP)/nitro-blue tetrazolium chloride (NBT) substrate (Sigma-Aldrich). 
Images of membranes were captured using an Olympus SZ61 dissection microscope equipped 
with a USB camera and OPTIKA Vision lite software (OPTIKA SRL). Spots were counted 
manually. 
Calcium influx by FACS 
Spleen cell suspensions were prepared as described above, then washed once in PBS without 
serum, cells were resuspended at 107 cells/mL in PBS with the calcium dye (Indol-1 AM, 
Invitrogen, final concentration 1mM), incubate 40min at 37°C.  After washing once in 
complete medium, resuspended the cells at 2x106 cells/mL in complete medium. Keep the 
cells in 50mL falcon tube in the water bath at 37°C near the flow cytometry during the 
experiment. Transfer the cells in FACS tube just before the acquisition.  
Keep the cells in 50mL falcon tube in the water bath at 37°C during the experiment. Transfer 
the cells in Facs tube just before the acquisition, adjust the acquisition speed at 800-1000 
events/sec, and set all the parameters as Linear. Create a ratio, set Indo-1 violet (BUV496) in 
Numerator and Indo-1 blue (BUV 737) in Denominator. Samples were acquired 60s to obtain 
the baseline, then added polyclonal anti-mouse IgM antibody to a final 10, 5, 205, 1,25ug/ml 
concentration, continue acquire the same sample for another 300s. For the negative and 
positive control, EDTA (final concentration)10ug/ml and 1ug/ml(final concentration) 
Ionomycin were added instead of anti-IgM antibody, respectively. Data were analyzed with 
FlowJo10.2 software.  
Apoptosis analysis 
Annexin V method: Spleen, lymph nodes, BM cell suspensions were prepared as described 
above, cells were stained for their surface marker, then washed once in cold PBS without 
serum, resuspend the cells were incubated with 100ul Annexin binding buffer (10mM Hepes, 
pH7,4; 0.14M NaCl; 2.5mM CaCl2) 15min in room temperature. Add more 400ul binding 
buffer with PI. LSRII from BD Biosciences were used for flow cytometry analysis. Data were 
analyzed with FlowJo10.2 software. 
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Caspase 3/7 method: after the cell surface marker staining, Adjust the cell concentration of 
the sample(s) between 1x105 cells/ml and 1x107 cells/ml using the complete medium. Add 1 
µL of CellEvent™ Caspase-3/7 Green Detection Reagent to 1 mL of sample and mix gently. 
Incubate the samples for 30 minutes at 37°C or 45–60 minutes at room temperature, protected 
from light. The final concentration of the reagent is 500 nM. During the final 5 minutes of 
staining, add 1 µL of the 1 mM SYTOX™ AADvanced™ dead cell stain solution in DMSO 
to the appropriate samples and mix gently. The final labeling concentration of stain is 1 µM. 
Analyze the samples without washing or fixing, using 488nm excitation and collecting 
fluorescence emission using a 530/30 bandpass filter or equivalent for CellEvent™ Caspase-
3/7 Green Detection Reagent and a 690/50 BP filter or equivalent for SYTOX™ 
AADvanced™ dead cell stain. 
VDJ PCR and sequencing  
Genome DNA was extracted from sorted BP1+ proB cells from both 129SV and H19-/- FL 
using blood and tissue Dneasy kit (Qiagen). PCR reactions were set up for each sample. 
Briefly, A 50 µL PCR reaction containing 10X PCR buffer, 2 mM MgCl2, 250 µM dNTPs 
(AB gene, Epsom, UK), 1.5 U of Taq Polymerase (AB gene), forward primers VHJ558, 
VHQ52, and reverse primer JH4e (for VDJ rearrangement amplification); while and reverse 
primer DQ52, DSP27 together with the same reverse primer JH4e were used for the DJ 
rearrangement. As well as genomic DNA. PCR reactions were performed using a Geneamp 
9700 thermal cycler (Applied Biosystems, USA). The PCR conditions included preactivation 
of the enzyme for 10 min at 94 followed by 35 cycles at 94 for 60 sec, 60 for 30 sec 
and 72 for 1.5 min and a final extension of 10 min at 72. The amplified products were 
visualized by electrophoresing on a 2% agarose gel. The sequences of PCR primers were 
described previously (Possot et al., 2011). 
 For PCR amplification of VDJ, VDJH4 band was cut and recovered by using Qiaquick gel 
extraction kit (Qiagen), the purified VDJH4 fragment was connected to pCR4-TOPO vector 
using the TOPO TA cloning kit for sequencing (Invitrogen). Briefly, first perform the TOPO 
cloning reaction using the reagent in table 1. Add the TOPO cloning reaction into a vial of 
One Shot chemically component E. coli and mix gently and incubate on ice for 30min. Heat-
shock the cells for 40 seconds at 42 without shaking and immediately transfer the tube to 
ice. S.O.C. medium was added to the tube, and shake the tube horizontally (200 rpm) at 37 
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for 1 hour. Then spread the transformation mixture on a pre-warmed kanamycin selective LB 
plate and incubated at 37 overnight. The clones were picked out to the tube and LB 
medium was add for the expansion of the clone in a horizontal shaker at 37 overnight. The 
bacteria were collected and plasmid was extracted by using Qiaprep Spin Miniprep kit 
(Qiagen), and the plasmids from different clones were sequenced by using T3 primer. VDJ 
sequences were analyzed by using DNADynamo software and productive VDJ 
rearrangements rate was calculated. 
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Table 1. Antibody list 
 
Mouse antibody Clone Supplier Staining panel 
anti-B220 RA3-6B2 BD Bioscience B cell detection 
anti-BP1 6B3/BP1 BD Bioscience proB cell staining  
anti-CCR6 29-2L17 Biolegend Memory B cell detection 
anti-CD117 2B8 Biolegend Progenitors and proB cells staining 
anti-CD11b M1/70 Biolegend Lineage cocktail and myeloid cell detection 
anti-CD11c N418 Biolegend Lineage cocktail and DCs detection 
anti-CD127 A7R34 Biolegend Progenitors staining 
anti-CD135 A2F10 Biolegend Progenitors staining 
anti-CD150 TC15-12F12,2 Sony HSC staining 
anti-CD16/32 2.4G2 BD Bioscience Fc block and CMP detection 
anti-CD19 6D5 Biolegend Lineage cocktail and B cell detection 
anti-CD21 7G6 BD Bioscience Splenic marginal zone B cell staining  
anti-CD23 B3B4 BD Bioscience Splenic follicular B cell staining 
anti-CD24 M1-69 Biolegend proB staining 
anti-CD25 3C7 Biolegend preB staining 
anti-CD27 LG.7F9 BD Bioscience Memory B cell staining 
anti-CD3ε 145-2C11 Biolegend Lineage cocktail and T cell detection 
anti-CD34 RAM34 eBioscience HSC staining 
anti-CD38 90 eBioscience Germinal centre B cell staining 
anti-CD4 A161A1 Biolegend Lineage cocktail and T cell detection 
anti-CD40  BD Pharmingen B cell activation 
anti-CD43 S7 BD Bioscience proB cell staining 
anti-CD44 IM7 Biolegend B cell activation and DN1,DN2 subsets staining 
anti-CD45 30-F11 BD Bioscience Pan hematopoietic marker 
anti-CD45.1 A20 Biolegend Chimeras analysis 
anti-CD45.2 104 BD Bioscience Chimeras analysis 
anti-CD48 HM48-1 eBioscience HSC staining 
anti-CD49d R1-2 BD Bioscience Cell adhesion 
anti-CD5 53-7.3 BD Bioscience B1a cell staining 
anti-CD62L MEL-14 BD Bioscience B cell activation 
anti-CD69 - A becton dickinson B cell activation 
anti-CD8 53-6.7 Biolegend Lineage cocktail and T cell detection 
anti-CD80 B7-1 A becton dickinson B cell activation 
anti-CD86 GL1 BD Bioscience B cell activation 
anti-CD93 AA4.1 eBioscience  B cell progenitors  
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anti-CD95 J02 BD Bioscience Germinal center staining 
anti-CXCR4 2B11/CXCR4 BD Bioscience DZ and LZ staining 
anti-Gr1 
RB6-8C5 Biolegend Lineage cocktail and Myeloid cells 
detection 
anti-H2AX N1-431 BD Bioscience DNA double strands staining 
anti-IFNg - BD Pharmingen Cytokine detection 
anti-IgD 11-26C.2A BD Pharmingen  
anti-IgE R35-118 BD Pharmingen Ig class switch detection 
anti-IgG1 - BD Pharmingen Ig class switch detection 
anti-IgG2a - Southern biotech Ig class switch detection 
anti-IgG2b - Southern biotech Ig class switch detection 
anti-IgI R26-46 BD Pharmingen Ig light chain detection 
anti-Igk 187.1 BD Pharmingen Ig light chain detection  
anti-IgM RMM-1 Biolegend B cell development 
anti-IL10 - BD Pharmingen Cytokine detection 
anti-IL13 - BD Pharmingen Cytokine detection 
anti-IL17 - BD Pharmingen Cytokine detection 
anti-IL2 - BD Pharmingen Cytokine detection 
anti-IL21 - BD Pharmingen Cytokine detection 
anti-IL4 - BD Pharmingen Cytokine detection 
anti-IL6 - BD Pharmingen Cytokine detection 
anti-Ki67 - BD Pharmingen Cell cycle analysis 
anti-MHCII M5/114.15.2 Biolegend B cell response  
anti-NK1.1 PK136 Biolegend Lineage cocktail and NK cell detection 
anti-Ter119 TER-119 Biolegend Lineage cocktail 
anti-Sca1 D7 Biolegend Progenitors staining 
DAPI - Sigma Cell cycle analysis 
Propidium 
iodide 
- Sigma Viability dye 
Annexin V - Biolegend Apoptosis staining 
Caspase 3/7 - invitrogen Apoptosis staining 
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Table 2. primer list 
Primer sequence 
VH J558 ARGCCTGGGRCTTCAGTGAAG 
VH Q52 CTCACAGAGCCTGTCCATCAC 
DQ52 CATCCACCCTTCTGATGCTTGCATT 
JH4e AGGCTCTGAGATCCCTAGACA 
DSP2,7 TCACTGGTCCATGTGGAGAGCTGAG 
Stag3 F TCCTCAGGCAGTGAGTCTTCC 
Stag3 R GTTCCCTGTGAGTCTCTGTCAT 
Elovl6 F GAAAAGCAGTTCAACGAGAACG 
Elovl6 R AGATGCCGACCACCAAAGATA 
Bcl9 F AGCAGCACCTAATGGGCAAAG 
Bcl9 R GGATAAGTCGAACTCAGGAATGC 
Man1a2 F TCTGGTCGTAGGATACCACCT 
Man1a2 R GAAGGCACTAAGGATGAGGAGA 
Uba7 F CTACGAGCGACTCCATATACCT 
Uba7 R TACACACAGGGTAGGGAGCAT 
Lmo7 F TTGAAACAACGGATTTTCGAGC 
Lmo7 R GACGCCAGGTTTGAGCTTATT 
Daglb F AGCGACGACTTGGTGTTCC 
Daglb R GCTGAGCAAGACTCCACCG 
Aldh2 F GACGCCGTCAGCAGGAAAA 
Aldh2 R CGCCAATCGGTACAACAGC 
Wls F ATGGCTGGGGCAATTATAGAAAA 
Wls R GGGTGCTGGAGCGATCAAG 
Usp46 F ATGACTGTCCGAAACATCGCC 
Usp46 R TTGACCAATCCGAAGTAGTGTTC 
Sh2b2 F GTGGACTTCGCACACAAGTTC 
Sh2b2 R GGGTTCCATAGTGTCGGCT 
Cux1 F TGACCTGAGCGGTCCTTACA 
Cux1 R TGGGGCCATGCCATTTACATC 
Spata13 F GTTAGGCTTCGAGTCAATCAGG 
Spata13 R ATGACGTTGGTCCGCATCTG 
Parp3 F ATGGCTCCAAAACGAAAGGC 
Parp3 R TCCTCCTCTGTCCCTTGTCG 
Usp12 F ACAGTCTCCAAATTCGCCTCC 
Usp12 R ACTGAGTTGCAGTAGCAGGTATT 
Smarcc1 F AGCTAGATTCGGTGCGAGTCT 
Smarcc1 R CCACCAGTCCAGCTAGTGTTTT 
Gpr89 F TTTTTGGATTCGGATGGCTTTTC 
Gpr89 R TGCTGTTCAGAACTCCCAAGA 
Lnx2 F CAGCACTGGGCGAGAGAAAA 
Lnx2 R CTTGTGGCAGAACGTGTGTC 
Xkr6 F TCACCATCTCATCCCGAGTTAT 
Xkr6 R GATCCCTACCACCATGTTGAAG 
B3glct F CGCTTTCGAGTACCCAGACT 
B3glct R CTTTGCCATCCTCCCAGATA 
Slc24a2 F TGGGCCAACTTTACCGTCG 
Slc24a2 R GGCGATCTTGTGGAGAATTGAAG 
Nrros F ACTGCAGCTTCCCAAGGA 
Nrros R TGGGTACCGAAGCAAGGT 
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Introduction 
 
 
Multitude external and endogenous processes can cause DNA damage during life of all living 
organisms	(Sancar	et	al.,	2004). DNA double strands breaks (DSBs) represents one of the most 
severe forms of DNA damage. Under physiological condition, DNA DSBs can be induced by 
the Rag1/2 protein in developing lymphocytes, where the somatic rearrangement of 
immunoglobulin (Ig) and TCR genes takes place in B and T lymphocytes, respectively. This 
endogenous physiological process leads to the diversification of the immune system through 
V(D)J recombination of variable (V), diversity (D), and joining (J) gene segments via a cut-
and-paste mechanisms	(Bassing	et	al.,	2002). After cleavage, the RAG proteins associate with 
the broken DNA ends to form a post-cleavage complex (PCC), which is thought to stabilize the 
broken DNA ends and facilitate end joining activities (Deriano	and	Roth,	2013;	Schatz	and	
Swanson,	2011). Subsequently, the DNA repair is conducted for the end joining to complete 
V(D)J rearrangement.  
In mammalian cells, two main sets of DNA repair mechanisms are used: homologous 
recombination (HR) and classical non-homologous end joining (C-NHEJ). The former requires 
a homologous template for precise restoration of DNA sequences and normally exert its repair 
function in S/G2 cell cycle phase	(Orthwein	et	al.,	2015), while the latter (C-NHEJ) directly 
ligates DSBs without homologies, but with a loss and gain of nucleotides at the joins. NHEJ 
functions in DNA repair can occur during all phases of the cell cycle	(Lieber,	2010;	Lieber	et	
al.,	2010).  
The core factors required for NHEJ include Ku70, Ku80, DNA Ligase IV, DNA-PKcs (DNA-
dependent protein kinase catalytic subunit) and XRCC4 (Ciccia	and	Elledge,	2010). In addition, 
several other factors were found to participate in NHEJ, such as Artemis, XLF	(Kumar	et	al.,	
2014) and PAXX (Paralog of XRCC4 and XLF) (Xing	et	al.,	2015;	Ochi	et	al.,	2015;	Craxton	
et	al.,	2015). In NHEJ of V(D)J rearrangement, Rag1/2 cleavage induces broken DNA ends 
and activate the ataxia telangiectasia mutated (ATM)-kinase-dependent DNA damage response 
(DDR) (Helmink	and	Sleckman,	2012), then the DSBs are recognized and protected by the 
Ku70/Ku80/DNA-PKcs complex. Artemis participates in processing the DNA ends and finally 
the XRCC4/ DNA-Ligase IV/Xlf complex together with PAXX ultimately ligate the ends and 
reseals the DNA breaks.  
Deficiency of these core NHEJ factors results in immunodeficiency in patients and animal 
models due to the impaired repair of DNA breaks, which leads to blocked lymphocyte 
development at the early progenitor stage (Blunt	et	al.,	1995;	Deriano	and	Roth,	2013;	Revy	et	
al.,	2005). In addition, in peripheral lymphoid organs, class switch recombination (CSR) in 
antigen activated B cells in GC also requires NHEJ core factors to repair the broken DNA ends 
induced by AID. Thus, loss of any core NHEJ factor, leads to increased NDA DSBs and reduces 
CSR efficiency (Franco	et	al.,	2006;	Boboila	et	al.,	2010). 
Furthermore, NHEJ plays important role in post-mitotic neurons survival in the central nervous 
system (CNS). Loss of core NHEJ factors results in neuronal apoptosis which can lead to 
embryonic lethality in Lig4 or XRCC4 -deficient mice	(Frank	et	al.,	2000;	Gao	et	al.,	1998;	Buck	
et	al.,	2006). 
 
In contrast, although Xlf is an important NHEJ factor, Xlf deficiency mice showed a mild 
phenotype in growth, immune system and CNS	 (Li	 et	 al.,	 2008;	 Ahnesorg	 et	 al.,	 2006). In 
lymphocyte development, the V(D)J recombination of Xlf-/- B lymphocytes is normal, 
suggesting that there might be other mechanisms to compensate the loss of XLF.  
Recently, another NHEJ factor, Paxx (also known as XLS), has been identified independently 
by three laboratories (Xing	et	al.,	2015;	Ochi	et	al.,	2015;	Craxton	et	al.,	2015). Paxx belongs to 
the XRCC4 superfamily and shows structural similarities with both XRCC4 and XLF factor. 
However, PAXX does not directly interact with either XLF or XRCC4	(Xing	et	al.,	2015;	Ochi	
et	 al.,	 2015), instead, PAXX is recruited to DNA DSBs and interact with Ku/DNA-PKcs 
complex through binding to Ku70	(Craxton	et	al.,	2015). However, similar to Xlf-/- mice, Paxx-
/- mice are viable, grow normally, are fertile, and do not show severely impaired lymphocyte 
development (Kumar	 et	 al.,	 2014;	 Lescale	 et	 al.,	 2016). This suggests a possible functional 
complementation of PAXX deficiency in certain conditions. 
However, Paxx/Xlf double-knockout mice display embryonic lethality associated with genomic 
instability, neuron apoptosis in the CNS, and an almost complete block in lymphopoiesis	
(Balmus	et	al.,	2016;	Kumar	et	al.,	2014;	Lescale	et	al.,	2016). Thus, combined loss of Paxx and 
Xlf plays crucial role in NHEJ and Paxx provides core NHEJ factor functions in the absence of 
Xlf and vice versa. 
In this work, we analyzed the role of Paxx during mouse development and investigate the 
impact of Paxx and Xlf double deficiency on the CNS and lymphopoiesis. The results showed 
that mice with Xlf or Paxx loss of function are viable and present with very mild immune 
phenotypes, although their lymphoid cells are more sensitive to ionizing radiation compared to 
the wt cells, showing these two factors have a role in NHEJ. In contrast, mice defective for both 
Xlf and Paxx are embryonically lethal owing to a massive apoptosis of post-mitotic neurons, a 
phenotype similar to XRCC4 or DNA Ligase IV KO mice. The lymphopoiesis in E18.5 
embryos of Paxx-/-Xlf-/- is severely blocked at the stage of IgH and TCRβ gene rearrangements 
in B and T lymphocyte, respectively. This phenotype highlights the functional links between 
Xlf and Paxx, which is critical for the completion of NHEJ-dependent mechanisms during 
mouse development. 
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PAXX and Xlf interplay revealed by impaired CNS
development and immunodeficiency of double KOmice
Vincent Abramowski1,7, Olivier Etienne2,7, Ramy Elsaid3,4,5,7, Junjie Yang3,4,5,7, Aurélie Berland1, Laetitia Kermasson1, Benoit Roch1,
Stefania Musilli1, Jean-Paul Moussu6, Karelia Lipson-Ruffert6, Patrick Revy1, Ana Cumano3,4,5, François D Boussin2 and
Jean-Pierre de Villartay*,1
The repair of DNA double-stranded breaks (DNAdsb) through non-homologous end joining (NHEJ) is a prerequisite for the proper
development of the central nervous system and the adaptive immune system. Yet, mice with Xlf or PAXX loss of function are viable
and present with very mild immune phenotypes, although their lymphoid cells are sensitive to ionizing radiation attesting for the
role of these factors in NHEJ. In contrast, we show here that mice defective for both Xlf and PAXX are embryonically lethal owing to
a massive apoptosis of post-mitotic neurons, a situation reminiscent to XRCC4 or DNA Ligase IV KO conditions. The development
of the adaptive immune system in Xlf− /−PAXX−/− E18.5 embryos is severely affected with the block of B- and T-cell maturation at
the stage of IgH and TCRβ gene rearrangements, respectively. This damaging phenotype highlights the functional nexus between
Xlf and PAXX, which is critical for the completion of NHEJ-dependent mechanisms during mouse development.
Cell Death and Differentiation (2018) 25, 444–452; doi:10.1038/cdd.2017.184; published online 27 October 2017
All living organisms are subjected to multitude sources of DNA
damage during their lifespan, either as a result of external
assault or endogenous physiological processes.1 Among
endogenous sources of physiological DNAdsb is the somatic
rearrangement of immunoglobulin (Ig) and TCR genes in B
and T lymphocytes, respectively, during the diversification of
the adaptive immune system through V(D)J recombination.2
DNA double-stranded breaks (DNAdsb) are considered the
most toxic lesions. DNAdsbs are repaired by two main
mechanisms: the homologous recombination (HR) in cycling
cells, when a sister chromatid is available as DNA repair
template, and the non-homologous end joining (NHEJ) during
all phases of the cell cycle.
NHEJ proceeds via the simple religation of DNA ends
without the need for a repair template.3 Briefly, the NHEJ is
composed of seven core factors comprising the Ku70/80/
DNA-PKcs (DNA-dependent protein kinase catalytic subunit)
complex, which recognizes and protects the broken DNA
ends, the Artemis endo/exonuclease, which participates,
when needed, in processing the DNA ends and the XRCC4/
DNA-Ligase IV/Xlf complex, which ultimately reseals the DNA
break. The critical function of the NHEJ apparatus in various
aspects of higher eukaryote development has been exten-
sively perceived in several animal and human pathological
conditions. As emblematic examples, loss of function of either
XRCC4 or DNA ligase IV results in embryonic lethality in
mice4,5 andmutations in Artemis or DNA-PKcs result in severe
combined immunodeficiency conditions in bothmen andmice,
owing to aborted V(D)J recombination.6 In addition, defects in
NHEJ results in genetic instability and the propensity to
develop various types of cancers, notably leukemia and
lymphomas.7
Recently, a new DNA repair factor, PAXX (PAralog of
XRCC4 and Xlf, also known as C9orf142 or XLS), has been
identified independently by three laboratories based on
bioinformatics and biochemistry approaches.8–10 PAXX
belongs to the XRCC4 superfamily and shows structural
similarities with both XRCC4 and Xlf. PAXX is recruited to
DNAdsb and is a physical interactor of the Ku/DNAPK
complex, notably through its interaction with Ku70.11 Surpris-
ingly, for a NHEJ factor, the deficiency of PAXX does not
systematically result in an increased sensitivity to ionizing
radiation (IR) and the results of the various DNA repair assays
are highly controversial, depending on the experimental
settings.8–10,12–15 This suggested a possible functional
complementation of PAXX deficiency in certain conditions.
To analyze the role of PAXX during mouse development
in vivo and identify a possible redundant function with another
DNA repair factor, we created CRISPR/Cas9 PAXX mutant
mouse lines. Although the sole inactivation of PAXX did not
result in an overwhelming phenotype, the concomitant
deletion of PAXX and Xlf had severe consequences resulting
in embryonic lethality and arrest of V(D)J recombination in
embryos. Altogether, these results are consistent with PAXX
being a bona fide NHEJ factor and highlight the critical
functional interplay between PAXX and Xlf during mouse
development.
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Results and discussion
Generation of PAXX KO mice. PAXX KO mice were
generated using CRISPR/Cas9. Two guide RNA target
sequences were selected in exon 1 (PAXX1) and exon 2
(PAXX2) of the murine PAXX gene (Figure 1a and
Supplementary Figure S1A). The efficacy of the two gRNA
was scored through the disappearance of restriction sites
BsrBI and SacI upon transfection of MEFs with the pX330
vector expressing the gRNAs and Cas9 (Supplementary
Figure S1B). To generate mutant mouse lines, zygotes were
microinjected with pX330 according to the protocol of
Mashiko et al.16 Thirteen and five F0 mice were obtained
for PAXX1 and PAXX2, respectively. Tail DNA was analyzed
by PCR and restriction digest (PCR-RE) to identify four
PAXX1 and two PAXX2 F0 mutant mice showing clear
retention of undigested DNA above background
(Supplementary Figure S1C). F0 mice were crossed onto
C57Bl/6 to segregate the various CRISPR/Cas9-generated
mutant alleles. Two F0-derived F1 mice, #2 for PAXX1 and
#14 were selected upon direct DNA sequencing of the mutant
alleles. CRISPR/Cas9 mutagenesis resulted in an 8-bp
deletion and subsequent frameshift in both cases
(Figure 1a). Each line was backcrossed up to six times on
C57Bl/6 to segregate away any off-target event outside of
chromosome 2. Homozygous mutant mice were obtained by
intercross of either PAXX1+/− or PAXX2+/− heterozygous
founders. Homozygous mice were viable and were produced
at Mendelian frequencies ruling out a major effect of PAXX
deficiency during embryogenesis. The loss of function of the
CRISPR/Cas9-generated PAXX mutant allele were ascer-
tained by western blotting using protein extracts from thymus,
spleen, and MEFs from PAXX2 mouse line. As shown in
Figure 1b, PAXX protein expression was undetectable in
PAXX2−/− mice, in contrast to wild-type littermates. We
conclude that CRISPR/Cas9 mutagenesis resulted in com-
plete PAXX loss of function.
Normal development of the immune system in PAXX KO
mice. Proficiency of the DNA Damage Response (DDR)
machinery, in particular the NHEJ pathway, is critical for the
appropriate development of B and T lymphocytes, owing to
the generation of DNAdsb during the somatic DNA rearran-
gement of both Ig and TCR genes.6 Nevertheless, Xlf
deficiency does not have a severe impact on the V(D)J
recombination process and Xlf-deficient mice present with a
very mild defect in their immune system, characterized mainly
by a slight reduction in lymphocyte numbers and an
Figure 1 Design and immunophenotyping of PAXX KO mice. (a) Design of gRNA used to create CRISPR/Cas9 mutations in the PAXX gene. The BsrBI and SacI restriction
enzyme sites used to screen for mutagenesis are underlined. The two lines PAXX1 and PAXX2 harbor an 8-bp deletion resulting in frameshift. (b) Western blot analysis confirming
the PAXX loss of function in PAXX2 mutant mice, with the absent protein in the thymus, spleen, and MEFs. (c) Immunophenotyping of wt. (N= 11), PAXX1 (N= 4), PAXX2
(N= 12), and Xlf (N= 7) mice. FACS representation of thymocytes and splenocytes and representation of absolute count numbers. (d) Illustrative Circos-plot representations of
TCRα repertoire in thymocytes from C57Bl/6, Xlf, and PAXX2 mice. Each chord line represents the association between one TRAV and one TRAJ segment as determined by
TCRα transcript sequencing. Quantification of TCRα TRAV gene usage in C57Bl/6, Xlf, and PAXX2 mice. TCRα repertoire determination was repeated two times using an overall
six PAXX2 KO, five C57Bl/6, and six Xlf KO mice. Statistical analyses were performed using Mann–Whitney non-parametric t-test using Prism v6 (***Po 0.001)
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increased in thymocyte apoptosis.17,18 Qualitatively, this
translates into a skewing in the TCRα repertoire with the
under-representation of distal TRAV and TRAJ gene
segments.17 Analysis of the immune system in both PAXX1
and PAXX2 KO mice revealed an overall normal development
of T cells in the thymus, despite a statistically significant
reduction in thymocyte numbers in the range of what
observed in Xlf mice (Figure 1c). Mature B- and T-cell
numbers in the spleen were comparable between PAXX mice
and WT littermates. This is in general agreement with
previously described PAXX mutant mice.12,15 Analysis of
the TCRα repertoire through 5’ RACE RT-PCR and next-
generation sequencing revealed a well-diversified TCRα
repertoire in PAXX mice, comparable to WT and Xlf animals
(Figure 1d). However, in contrast to the important decrease in
distal VαJα usage in Xlf thymocytes as previously
described,17 thymocytes from PAXX mice did not show any
skewing in the representation of these TCRα gene segments.
From these observations, we conclude that PAXX loss of
function does not have any detrimental impact on the V(D)J
recombination process and/or the overall viability of
thymocytes.
DNAdsb repair defect in PAXX KO mice. Given its
homology with both XRCC4 and Xlf, PAXX is thought to
intervene during DNA repair through NHEJ.8–10 T lympho-
cytes isolated from blood or spleen are mainly non-cycling
resting cells which, as a result, utilize NHEJ to cope with
DNAdsb when HR is operational only in cycling cells. We set
up to analyze the role of PAXX during NHEJ through the
survey of splenic T-cell sensitivity to IRs (Figure 2a). Ex vivo
isolated resting splenic mature T cells were subjected to
various doses of IR (0–4 Gy). After 4 h of recovery to allow for
repair of IR-induced DNAdsb, cells were incubated with anti-
CD3/anti-CD28-coated beads during 4 days, which activates
and induces a strong proliferative response of T lymphocytes
Figure 2 DNA repair defect in PAXX KO mice. (a) Radiosensitivity assay performed on mature splenic T lymphocytes. For FACS analysis, doubling populations were scored
in gates defined by the dilution of the CellTrace signal and the proliferative index calculated according to Roederer.26 The relative proliferative indexes were plotted for each sample
according to the proliferation in the absence of IR and used to define the radiosensitivity level. The experiment was repeated twice with two mice per genotype each time. (b)
Phleomycin and IR sensitivity on SV40-transformed MEFs. MEFs from XRCC4, DNA-Ligase IV, and Xlf KOmice were used as radiosensitive controls. The relative growth indexes
were calculated by comparing the confluence of treated cells and non-treated cells during culture with real-time Incucyte monitoring (see Materials and Methods). This experiment
was repeated three times
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that can be readily quantified through the dilution of the
CellTrace dye upon cell divisions. We used this readout as a
mean to score the relative index of proliferation, and hence
the cell survival, following IR. Using this protocol, T cells from
Xlf mice showed an extreme sensitivity to IR as compared
with WT (Figure 2a) with a fall in cell survival already at the
first dose of 1 Gy, as expected for Xlf deficiency. PAXX-
deficient T lymphocytes were also strikingly radiosensitive,
although to a lesser extent than Xlf-defective T cells. In
contrast, murine embryonic fibroblasts (MEFs) derived from
PAXX mutants were resistant to either IR or the DNAdsb
inducer Phleomycin with cell survival comparable to that of
WT MEFs (Figure 2b), whereas MEFs defective for XRCC4,
DNA-Ligase IV, or Xlf were highly sensitive as expected. This
is in accord with the previously noted mild sensitivity of
PAXX−/− MEFs to IR15 but contrasts with the results from
Balmus et al.12 Ever since the identification of PAXX by three
different groups, its implication in the DDR as judged by the
sensitivity to genotoxic drugs or IR has been highly
controversial, depending on the cell line analyzed in vitro,
the experimental conditions, and the drugs used to inflict
DNA damage.8–10 Interestingly, asynchronous PAXX-
defective CH12 B-cell lines or v-Abl-transformed Pro-B-cell
lines do not demonstrate any IR sensitivity above that of their
wt counterparts, as we found in MEFs, and the concomitant
PAXX and Xlf deficiency does not worsen the sensitivity
caused by Xlf mutation alone in these cycling cells.13 In
contrast, the synchronization of PAXX−/−/Xlf− /− v-Abl pro-B
cells into the G1 phase of the cell cycle with either STI-571 (v-
Abl kinase inhibitor) or PD033991 (CDK4/6 inhibitor) results
in an extreme sensitivity to IR, well beyond that of Xlf− /−
single mutants in the same conditions arguing for a unique
role of PAXX in classical NHEJ when DNA damage occurs in
G1, hence in the absence of functional HR. Our observation
of an IR sensitivity of small resting, ex vivo purified T
lymphocytes from PAXX− /− mice concords with this conclu-
sion of a specific role of PAXX during C-NHEJ.
PAXX-Xlf interplay during neuronal development. We
next set up to evaluate the possible functional relationship
between PAXX and Xlf during the DNA damage response
(DDR) by generating doubly deficient mice through inter-
crossing either PAXX− /−Xlf+/− or PAXX+/−Xlf− /− animals. In
no instance did we obtain PAXX− /−/Xlf− /− mice on a total of
176 newborns (44 PAXX1 and 132 PAXX2) obtained from
crosses of various genotype combinations for which about 31
(11 PAXX1 and 20 PAXX2) were expected to harbor the
PAXX− /−/Xlf− /− DKO genotype, arguing for an embryonic
lethality of the concomitant inactivation of both factors
(Figure 3a) as previously noted in two different studies.12,15
The embryonic lethality was observed with both PAXX1 and
PAXX2 mutant lines, excluding an off-target effect as
responsible for this phenotype. Lived DKO embryos could
be readily obtained in E18.5 mice downward (Figure 3b)
arguing for a late embryonic lethality of DKO animals, similar
to the previously described late embryonic lethality of XRCC4
and DNA Ligase IV KO mice.4,5 Nevertheless, embryos at
E18.5 usually appeared smaller than their heterozygous
littermates (Figure 3b), confirming their overall abnormal
development. The lethality of PAXX/Xlf DKO embryos was to
us the first evidence of a functional interplay between PAXX
and Xlf, the co-inactivation of which results in a major viability
phenotype, when both single mutants do not present
evidence for developmental defect (this study and Vera
et al.
17). In XRCC4 and DNA-Ligase IV KO mice, the
embryonic lethality is caused by the massive apoptosis of
post-mitotic neurons.4,5 Likewise, the presence of numerous
pyknotic nuclei and the cleaved-caspase 3 (CC3)
immunostaining19 revealed a severe neuronal apoptosis in
the brain of Xlf− /−PAXX− /− embryos (Figures 3c–e,
Supplementary Figure S3) as previously reported.12,15 This
contrasted with the scarce apoptotic cells in the brains of
Xlf− /− embryos and their absence in that of PAXX− /−
embryos (Figures 3c–e, and Supplementary Figure
S3A). The observation of a massive neuronal apoptosis in
PAXX− /−Xlf− /− DKO whatever the type of PAXX1 or PAXX2
mutants used in intercrosses again ruled out a CRISPR/Cas9
off-target effect as responsible for this phenotype. Although
apoptosis was detected in the regions where neural
progenitors proliferate (that is, the ventricular (VZ) and
subventricular zones (SVZ), surrounding the lateral hemi-
spheres), it was most prominent in the regions that contain
post-mitotic neurons. Indeed, consistent with the kinetics of
neuronal production in the different brain structures, apopto-
sis was predominantly found in the ventral telencephalon at
E12.5 (Figure 3a) and in the dorsal telencephalon at E15.5
(Figures 3b and c and Supplementary Figure S3B).
PAXX-Xlf interplay during lymphoid development. The
profound impact of the concomitant deletion of PAXX and Xlf
on the development of the central nervous system, resulting
in late embryonic lethality, is highly reminiscent of both
XRCC4 and DNA Ligase IV-deficient conditions, in which
NHEJ is severely affected.4,5 As a major defect in the
development of the immune system is also one typical feature
of these NHEJ-deficient murine models, we aimed at
analyzing this question qualitatively and quantitatively in
Xlf− /−PAXX− /− DKO embryos. TCR gene rearrangements
begin around E13 and thymuses are easily recovered at
E18.5, the gestation day we choose for this analysis. At
E18.5, thymuses from wt mice contained 1.71× 106 thymo-
cytes on average (Figures 4a and b), a number that was not
affected by the deletion of PAXX alone (1.84× 106) but was
significantly reduced around twofold in the context of Xlf KO
(0.9× 106, Po0.0001) as previously found in thymuses from
6- to 8-week-old mutant mice.17,18 Strikingly, Xlf− /−PAXX− /−
embryos exhibited a 10-fold decrease in thymocyte number
(1.7× 105, Po0.0001). This reduction in the total numbers of
thymocytes was mainly accounted for by the loss of CD4+
CD8+ double-positive (DP) thymocytes in Xlf− /−PAXX− /−
mice when compared with wt mice (7.40× 103 versus
7.75× 105, Po0.0001), arguing for an abnormal maturation
process. CD4−CD8− double-negative (DN) thymocytes,
which precede the maturation to DP, can be further divided
into various populations according to their differential
expression of the CD44, CD25, and CD28 surface
markers.20 In particular, the CD44−CD25+CD28+ (DN3b)
fraction represents thymocytes that have undergone β-
selection upon successful rearrangement of their TCR-β
locus. They will subsequently progress to DN3c, DN4a, and
PAXX and XLF interplay
V Abramowski et al
447
Cell Death and Differentiation
DN4b, and ultimately to DP as depicted in Figure 4a.
Analyses of these archetypical thymocyte populations in
Xlf− /−PAXX− /− DKO E18.5 embryos revealed a major block
at the transition DN3a to DN3b (Figures 4a and b), resulting
in a significant decrease in the number of thymocytes from
DN3b stage onward when compared with wt mice (1.3× 104
versus 8.3×104, Po0.0001). This developmental arrest at
the critical step of β-selection strongly suggested a possible
impairment of V(D)J recombination at the TCR-β locus in
thymocytes from Xlf− /−PAXX− /− embryos. TCR-β rearrange-
ments involving Vβ10 and the Dβ2-Jβ2 cluster were analyzed
by PCR in thymocytes from mice with various genotypes as
depicted in Figure 4c. Rearrangements of Dβ2 or Vβ10Dβ2
segments to Jβ2 elements resulted in a ladder of PCR
products identified by an intronic 3’Jβ2 probe the length of
which depends on the Jβ2 element utilized during the
recombination process. No detectable PCR product corre-
sponding to either Dβ2Jβ or Vβ10Dβ2Jβ rearrangements could
be detected in DNA from Xlf− /−PAXX− /− thymocytes
(Figure 4c, lanes 8, 9,16, and 20), although they were readily
identified in PAXX and Xlf single KO mice, attesting for the
severely impaired V(D)J recombination process in the
concomitant absence of PAXX and Xlf.
B-cell maturation in fetus takes place in the fetal liver (FL)
with rearrangement and expression of the Ig heavy chain locus
occurring around E17.5 at which time μH chain becomes
detectable intracellularly.21CD19+B220+ B-lineage cells were
present in the FL of WT, Xlf− /− and PAXX− /−Xlf− /− E18.5
embryos, attesting for the normal B-cell lineage commitment in
all conditions (Figure 5a). However, whereas ~ 20% of CD43
+B220+ pro-B cells expressed the intracytoplasmic μH chain
(iIgM) in FL of littermates PAXX+/−Xlf+/− embryos, this
population represented only 5% of the CD43+B220+ popula-
tion in the PAXX− /−Xlf− /− DKO embryos (Figures 5a and b),
attesting for a major defect in either rearrangement or
expression of the IgH locus in these embryos. Interestingly,
a gradient of severity of this phenotype followed the severity of
the genotype involved with a statistically significant contribu-
tion of Xlf KO on its own (Figure 5b). This could also be noticed
in the fetal thymuswith the partial block of Xlf− /− thymocytes at
the DN3a stage when compared with wt embryos (Figure 4a).
As for TCRβ rearragement in the thymus, we used a PCR
approach to analyze the recombination of the IgH locus in
Figure 3 Embryonic lethality and massive neuronal apoptosis in PAXX−/−Xlf−/− embryos. (a) Impaired development of PAXX−/−Xlf−/− DKO mice. No DKO mice were born
from various combinations of PAXX1 or PAXX2 and Xlf crosses (44 and 132 pups, respectively). Statistical significance of the differences between the observed (Obs.) and
expected (Exp.) genotype distributions was assessed by χ2-test. (b) Survival of PAXX−/−Xlf−/− embryos up to E18.5. Photograph showing the reduced size of PAXX−/−Xlf−/−
E18.5 embryos. (c and d) Coronal sections of cerebral hemispheres of wt., PAXX−/−, Xlf−/−, and PAXX−/−Xlf−/− embryos collected at E12.5 (c) and E15.5 (d) and stained with 4’-
6-Diamidino-2-phenylindole (DAPI; gray) and CC3 (red). Blood vessels are colored in orange. Scale bars: 200 μm. (c) At E12.5, apoptosis in PAXX−/−Xlf−/− embryos is
massively detected in the intermediate zones (IZs) of the ganglionic eminences (1, 2) containing newly generated neurons for the striatum and the globus pallidus. (d) At E15.5,
apoptosis in PAXX−/−Xlf−/− embryos is predominant in the IZ and the cortical plates (CPs) of the dorsal telencephalon containing newly generated post-mitotic neurons of the
neocortex (3) and the hippocampus (4). (e) The bar graph shows the mean numbers per cortical slice of cleaved-caspase-3-positive cells±S.D. detected in the ventricular zone
(VZ), subventricular zone (SVZ), IZ, and CP of the neocortex of wt., PAXX−/−, Xlf−/−, and PAXX−/−Xlf−/− embryos at E12.5 and E15.5. Data have been obtained from at least
three embryos per group. Stars indicate the statistical significance in comparison to the wt controls. **P≤ 0.01, ***P≤ 0.001; Mann–Whitney test
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B-commited cell within the FL. This analysis clearly demon-
strated an almost complete absence of detectable VH–DJH
rearrangement in FL from PAXX− /−Xlf− /− embryos (Figure 5c,
lanes 9, 10, and 11) in contrast to wt animals. Interestingly, all
embryos carrying the Xlf− /− genotype already demonstrated a
decrease in V(D)J recombination efficiency, as judged by the
decreased signal intensity of the PCR products, in line with the
fall in IgM-expressing pro-B cells in these animals.
Our observations of an impaired V(D)J recombination
in vivo in both B- and T-cell lineages in PAXX− /−Xlf− /− E18.5
embryos are in agreement with the reports of a
similar malfunction in v-Abl-transformed pro-B-cell lines
in vitro using chromosome-integrated V(D)J recombination
substrates.13–15,22 Altogether, these experiments demon-
strate that, although Xlf and PAXX are largely dispensable
for V(D)J recombination, their concomitant defect sharply
impairs the rearrangement of the TCRβ and IgH loci in T- and
B-cell lineages, respectively, resulting in the block of their
maturation in the thymus and the FL. This is consistent with the
single ever born PAXX− /−Xlf− /− mouse that had no thymus
and had a microspleen.12 We anticipate that the conditional
ablation of these two genes in the hematopoietic system to
bypass the embryonic lethality should result in live animals
with a severe combined immunodeficiency phenotype char-
acterized by the absence of mature B and T lymphocytes.
We identified here a robust functional interplay in vivo
between the two DNA repair factor paralogs Xlf and PAXX, as
evidenced by the synthetic lethality of their concomitant defect
owing to a massive apoptosis of post-mitotic neurons and the
negative impact on V(D)J recombination in immature B and T
lymphocytes. In that sense, PAXX− /−Xlf− /− DKO mice share
most of the phenotypic characteristics of XRCC4 and DNA-
Ligase IV single-mutant mice. The survival of post-mitotic
neurons and the development of the adaptive immune system
both rely on efficient NHEJ as demonstrated in several animal
models and human conditions.6 The impairment of these
two functions specifically in PAXX− /−Xlf− /− animals, there-
fore, confirms the role of PAXX as a bona fide NHEJ factor.
Others and we have previously reported that Xlf, like PAXX, is
largely dispensable during V(D)J recombination.17,18We have
recently highlighted the relationship between RAG2 and Xlf as
a mean to provide a two-tier mechanism ensuring the proper
repair of DNAdsb generated during V(D)J recombination and,
hence to avoid genetic instability.14 A similar functional
interaction between PAXX and Xlf can be proposed to account
for the unaffected V(D)J recombination in PAXX− /− mice as
Figure 4 V(D)J recombination defect and impaired development of thymocytes in PAXX− /−/Xlf− /− E18.5 embryos. (a) Immunostaining of thymocytes from wt, Xlf− /−,
PAXX− /−, and PAXX− /−Xlf− /− E18.5 embryos. Upper panel (red) shows the important decrease in CD4+CD8+ DP in the thymus from PAXX− /−Xlf− /− embryos. DN
(CD4−CD8−CD3−) thymocytes were subdivided into DN1–DN4 according to the expression of CD44 and CD25 (middle panel). Lower panel (green) shows the severe block at the
transition DN3a (CD44−CD25+CD28−) to DN3b (CD44−CD25+CD28+) in PAXX− /−Xlf− /− embryos. B220+CD19+ FL cells were analyzed for the expression of CD43 that marks pro-
B cells (middle panel). In the lower panel, cells were gated on the CD43+B220+CD19+ population and analyzed for iIgM expression. (b) Quantification of thymocyte subpopulations in
the various PAXX/Xlf genotypes. Mann–Whitney test was used for statistical analysis. (c) PCR strategy to analyze TCRβ rearrangement according to Gartner et al.29 and
autoradiogram of PCR products revealed with the TCR-Jβ probe demonstrating the absence of either Dβ-Jβ or VβDβJβ rearrangements in thymocytes from PAXX− /−Xlf− /−
embryos. GAPDH-specific PCR was used as loading control
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opposed to PAXX− /−Xlf− /− embryos. This would place PAXX
on the same side as RAG2 in this safeguard mechanism.
Accordingly, RAG2 and PAXX are epistatic, as their combined
mutations do not impair V(D)J recombination in v-Abl pro-B
cells in vitro.14 Likewise, whereas V(D)J recombination is
severely compromised in ATM− /−Xlf− /−mice,23 it is efficient in
ATM− /−RAG2cc mutated v-Abl cells,14 positioning ATM on the
'same side' as RAG2 and PAXX, opposite to Xlf. Indeed,
ATM− /−PAXX− /− animals do not present defect in the
development of their adaptive immune system beyond that
of the sole ATM deficiency as expected according to this
model.12
Materials and Methods
gRNA design, cloning, and validation. Two guide RNA sequences were
selected on exons 1 and 2 of the MuPAXX gene using the CRISPOR web tool
(http://crispor.tefor.net/crispor.py).24 gRNA-overlapping restriction enzyme (RE)
diagnostic sites near the Cas9 cleavage site were selected to facilitate mutagenesis
screening and subsequent mouse genotyping (Supplementary Figures S1A and B).
Double-stranded DNA oligonucleotides corresponding to the selected guide
RNA were cloned into the pX330-U6-Chimeric_BB-CBh-hSpCas9 vector (the
generous gift of Feng Zhang, Addgene, Cambridge MA, USA, #42230) according to
Zhang lab’s recommendations.25 For mutagenesis scoring and mouse genotyping,
genomic DNA surrounding the guide RNA target sequences were PCR-amplified
(MuPAXX_F1: 5′-CAACCTTGAGTACCGCCCAT-3′, MuPAXX_R1: 5′-CAACCTTGA
GTACCGCCCAT-3′, 500 bp) and the resulting PCR products digested with either
BsrBI or SacI RE to analyze PAXX1 and PAXX2 mutagenesis, respectively
(Supplementary Figure S1C and D). Undigested PCR products represent
mutagenized DNA molecules. To validate CRISPR/Cas9 mutagenesis, the two
gRNA expressing pX330 constructs were transfected into MEFs using the NEPA21
electroporator (Nepagene, Ichikawa-City, Chiba, Japan) with the following settings:
pulse1 175v/5 ms/50 ms/2 × /10%/+ -pulse2 20v/50 ms/50 ms/5 × /40%/+-. Genomic
DNA was recovered 5 days later and was analyzed using PCR-RE (Supplementary
Figure S1C).
Generation of mutant mice. PAXX mutant mice were generated using
CRISPR/Cas9 according to the protocol developed by Masahito Ikawa’s
laboratory.16 Briefly, the pX330-derived plasmid coding for Cas9 and the guide
RNA were microinjected into mouse zygotes that were isolated from the ampullae of
superovulated mice. For superovulation, 5 IU PMS and, 48 h later, 5 IU HCG was
injected intraperitoneally into female B6/CBA F1 mice of ~ 6 weeks. Subsequently,
they were mated with male B6/CBA F1 mice (C57Bl6NCr and CBA mice: Charles
River Laboratories, Saint-Germain-Nuelles, France). The day after, embryos were
isolated and placed into M2 medium (Sigma, St. Louis, CA, USA) and the plasmid
was injected at a concentration of 5 ng/μl into the pronucleus using a microscope
(Nikon, Tokyo, Japan) with micromanipulators (Narishige, London, UK), Vacutip
holding pipettes (Eppendorf, Hamburg, Germany), and homemade injection pipettes
prepared from borosilicate capillary glass (Harvard Apparatus, Holliston, MA, USA)
as well as a Femtojet apparatus (Eppendorf). Pseudopregnant mice received ~ 20
zygotes. The procedure was approved by the local ethical committee and the
French Ministry of Education and Research (#01501.03).
PAXX1 and PAXX2 mice were genotyped by PCR-RE (MuPAXX_F1, MuPAXX_R1,
500 bp) followed by BsrBI or SacI RE digestion, respectively (Supplementary Figures
S1C and D). Xlf KO mice were genotyped as previously described.17 PAXX1 and
PAXX2 mice were backcrossed up to six times on C57Bl/6 to segregate away any
putative off-target mutation. PAXX/Xlf double KOmice were generated by intercrossing
PAXX− /−/Xlf+/− or PAXX+/− /Xlf− /− mice. All mice were sacrificed humanely.
Phleomycin and IR sensitivity assay. T lymphocytes were isolated from
6- to 10-week-old spleens and enriched for CD3+ cells using magnetic sorting
(Dynabeads Untouched mouse T cells, Invitrogen). Purified T cells were stained
with CellTrace BV421 fluorescent dye (Thermo-Fisher Scientific, Villebon sur Yvette,
France). Overall, 3 × 105 T cells were plated in 48-well plates in triplicate in DMEN-
Glutamax, FCS 10%, β-Me 0.1%, sodium pyruvate 1%, penicillin and streptomycin
1%, and NEAA 1%. Culture plates were irradiated (0–4 Gy) and let for 4 h in
incubator at 37 °C to allow for DNAdsb repair. T cells were then activated by the
Figure 5 V(D)J recombination defect and impaired B-cell development in PAXX− /−/Xlf− /− E18.5 embryos. (a) Immunostaining of FL cells from PAXX−/−Xlf−/−, Xlf−/−, and
PAXX−/−Xlf−/− E18.5 embryos. In the lower panel, B-lineage cells were gated on CD43+B220+ population and analyzed for intracytoplasmic IgM (iIgM) staining. (b) Quantification of
iIgM-positive cells among various PAXX/Xlf genotypes showing the severe deficit in PAXX−/−Xlf−/− embryos. (c) PCR strategy to analyze IgH rearrangement according to Schlissel
et al.30 and autoradiogram of PCR products revealed with the JH3 probe demonstrating the profound defect of IgH rearrangement in FL cells from PAXX−/−Xlf−/− embryos. GAPDH-
specific PCR was used as loading control
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addition of CD3/CD28-coated dynabeads (Thermo-Fisher Scientific) and 1000 u/ml
IL2. After 4 days of culture, cells were stained with anti-TCRβ− PE (Sony,
Weybridge, Surrey, UK) and analyzed by FACS (LSR-Fortessa, Becton Dickinson,
Rungis, France) to score the number of T-cell divisions through the dilution of the
CellTrace dye (Figure 2a). The index of proliferation (EI) was calculated according to
the following formula:
EI ¼
Xi
0
Ni=ð
Xi
0
Ni=2i Þ
where N represents the number of cells in each (0–i) divided cell
population.26 For each sample, the relative proliferative index after IR
was calculated relative to the proliferation without IR and dose–
response curves were drawn to compare samples.
MEFs were obtained and transformed with SV40 Large T antigen (MEF-SV) as
previously described.17 Phleomycin sensitivity assays were performed on MEF-SV
using the IncuCyte Live Cell Analysis System (Essen BioScience, Ann Harbor, MI,
USA). Briefly, MEF-SV of various genotypes were plated in triplicates at 3500 cells/
well in 48-well plates and incubated with increasing doses (0, 50, 100, and 200 ng/ml)
of Phleomycin. Real-time images of the wells were recorded (×4 lens) every 12 h over
7 days to monitor cell proliferation. A mask, which identifies visible objects in each
image, was applied to quantify the occupied area (% confluence) of every well at each
time points (Supplementary Figure S2A). The final score of cell viability/proliferation
was determined by integrating the area under the % confluence curves over time by
using rectangular approximation as depicted in Supplementary Figure S2B). Given i,
the various time points used for recording (from 1 to n), the growth index (GI),
represented by the area under the curve, is calculated by the formula:
GI ¼
Xn
i¼1
L $ H1ð Þ þ ðL $ H2Þ=2
For each experimental condition, cell viability is calculated relative to
the GI in the absence of drug (set as 100% growth) and plotted
according to Phleomycin concentrations.
Immunoblotting, histology, and immunohistochemistry. Expres-
sion of PAXX was analyzed by western blotting on thymic protein extracts using
rabbit polyclonal anti-C9orf142 antibody (ab126353, Abcam, Paris, France).
Embryonic heads were fixed overnight at 4 °C by immersion in 4% paraformalde-
hyde and embedded in paraffin with a Tissu-tek processor (VIP, Leica, Wetzlar,
Germany). Five μm coronal sections were then obtained using a microtome (Leica
RM2125RT) and mounted onto glass slides for histologic analyses. After paraffin
removal and citrate treatment, the brain sections were permeabilized with 0.5%
Triton X-100 in phosphate-buffered saline (PBS) for 15 min and incubated for 2 h
with 7.5% fetal bovine serum and 7.5% goat serum in PBS. The sections were
incubated with rabbit anti-CC3 (Cell Signaling, Leiden, The Netherlands, 9661,
1 : 200) overnight at 4 °C. After washing, the sections were incubated with goat anti-
rabbit Alexa Fluor 488 or 594 conjugated secondary antibody (Thermo-Fisher
Scientific, 1 : 400) for 1 h. After washing, nuclear staining was achieved by
incubation with 4’-6-Diamidino-2-phenylindole to quantify apoptosis induction by the
detection of pyknotic nuclei. Slides were mounted under Fluoromount (Southern
Biotechnologies Associates, Birmingham, AL, USA). Tissues were examined under
a fluorescence microscope (Pathfinder, Nikon) with a × 10 or × 20 objective in three
channels (appearing red, green, and blue in all figures) as separate files. These
images were then stacked with Photoshop software (Adobe, San Jose, CA, USA).
All statistical analyses were performed on Prism (GraphPad, La Jolla, CA, USA,
Version 7.00).
Immunophenotyping. Immunophenotyping of PAXX mice was performed as
described.17 T-cell populations from the thymus and spleen were identified with anti-
CD8 (clone 5.3–6.7), anti-CD4 (GK1.5), and anti-CD3 (145-2C11). Splenic B cells
were analyzed using anti-B220 (R6-60.2) and anti-IgM (II/41) and anti-CD19 (6D5).
All antibodies were from BD Biosciences. Flow cytometry was performed on the BD
LSR-Fortessa (Becton Dickinson, Rungis, France) and analyzed with FlowJo
(Ashland, OR, USA). For immunophenotyping of PAXX/Xlf DKO embryos, FLs and
thymuses were microdissected under a binocular magnifying lens and passed
through a 26-gauge needle of 1-ml syringe and filtered. For thymocytes, cell
suspensions were stained with fluorescent-labeled antibodies from BD Biosciences
(Becton Dickinson, Rungis, France) Anti-CD25 (clone PC61) and Anti-CD3ε (145-
2C11) and from Sony anti-CD4 (GK1.5), anti-CD8β (YTS156.7.7), anti-CD44 (IM7),
anti-CD117 (2B8), and anti-CD28 (E18). For B-lineage, cell suspensions were
stained with fluorescent-labeled antibodies from Biolegend (San Diego, CA, USA):
anti-IgM (clone RMM-1) and anti-CD43 (S11), and from the Sony: anti-CD19-
APCCy7 (6D5) and anti-B220 (RA3-6B2). For intracellular IgM staining, cell
suspensions were first labeled as above, fixed with the fixation buffer from
eBioscience (ThermiFischer Scientific, Villebon sur Yvette, France) intracellular
staining kit, and incubated 30 min with anti- IgM from Sony (clone RMM-1).
TCRα repertoire study. TCRα repertoire analyses were performed by
SMARTer 5’ RACE cDNA amplification as previously described on thymocytes.17
CDR3 sequences were identified using LymAnalyzer27 and represented by circos-
plot using VDJtools.28 Each TRAV–TRAJ association was recorded in a FlowJo-
based file to calculate frequencies of TRAV and TRAJ proximal and distal gene
usage. Statistical analyses were performed using Mann–Whitney non-parametric
t-test under Prism v6.
TCRβ and IgH V(D)J rearrangement analysis. TCRβ rearrangements
(D-Jβ2 and Vβ10-D-Jβ2) were analyzed by PCR on genomic DNA from E18.5
fetal thymuses of various genotypes according to Gartner et al.29 Briefly, 1ng
of thymic gDNA were amplified using primers TCRB-D2U-S 5′-GTA
GGCACCTGTGGGGAAGAAACT-3′, TCRB-J2D-A 5′-TGAGAGCTGTCTCCTACT
ATCGATT-3′, TCRB-V10-S 5′-GCGCTTCTCACCTCAGTCTTCAG-3′, blotted, and
hybridized using a PCR-derived TCR-Jβ2 DNA probe (Jbeta2F-5′-GAATTCTTG
GTAGCCCTTTTCTGC-3′ and Jbeta2 R-5′-GGGTGGAAGCGAGAGATGT-3′) as
depicted on Figure 3b. For IgH rearrangements (VH–DJH) studies, FL CD19+
B-lineage cells were sorted on FACSAriaIII and analyzed by PCR on 1ng genomic
DNA according to Schlissel et al.30 Input DNA was analyzed using a GAPDH PCR.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. We thank Catherine Cailleau (SEAT) for exceptional care
of our mouse lines, Sophie Berissi for help in immunohistochemistry and Olivier
Alibeu, Aurore Pouliet, and Christine Bole-Feyssot (Genomic facility, Imagine
Institute) for their assistance in NGS. This work was supported by institutional grants
from INSERM, the Institut National du Cancer (PLBIO16-280), the Agence Nationale
de la Recherche ('Investissement d’Avenir' program ANR-10-IAHU-01), and by grants
from La Ligue Nationale contre le Cancer (Equipe Labellisée LA LIGUE), Pasteur
Institute, ANR (Program REVIVE and grant Twothyme) to AC.
1. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S. Molecular mechanisms of mammalian
DNA repair and the DNA damage checkpoints. Annu Rev Biochem 2004; 73: 39–85.
2. Jung D, Giallourakis C, Mostoslavsky R, Alt FW. Mechanism and control of V(D)J
recombination at the immunoglobulin heavy chain locus. Annu Rev Immunol 2006; 24:
541–570.
3. Lieber MR. The mechanism of double-strand DNA break repair by the nonhomologous DNA
end-joining pathway. Annu Rev Biochem 2010; 79: 181–211.
4. Gao Y, Sun Y, Frank KM, Dikkes P, Fujiwara Y, Seidl KJ et al. A critical role for DNA end-
joining proteins in both lymphogenesis and neurogenesis. Cell 1998; 95: 891–902.
5. Frank KM, Sekiguchi JM, Seidl KJ, Swat W, Rathbun GA, Cheng HL et al. Late embryonic
lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998; 396:
173–177.
6. de Villartay JP, Fischer A, Durandy A. The mechanisms of immune diversification and their
disorders. Nat Rev Immunol 2003; 3: 962–972.
7. Alt FW, Zhang Y, Meng FL, Guo C, Schwer B. Mechanisms of programmed DNA lesions and
genomic instability in the immune system. Cell 2013; 152: 417–429.
8. Xing M, Yang M, Huo W, Feng F, Wei L, Jiang W et al. Interactome analysis identifies a new
paralogue of XRCC4 in non-homologous end joining DNA repair pathway. Nat Commun
2015; 6: 6233.
9. Ochi T, Blackford AN, Coates J, Jhujh S, Mehmood S, Tamura N et al. DNA repair. PAXX, a
paralog of XRCC4 and XLF, interacts with Ku to promote DNA double-strand break repair.
Science 2015; 347: 185–188.
10. Craxton A, Somers J, Munnur D, Jukes-Jones R, Cain K, Malewicz M. XLS (c9orf142) is a
new component of mammalian DNA double-stranded break repair. Cell Death Differ 2015;
22: 890–897.
11. Tadi SK, Tellier-Lebegue C, Nemoz C, Drevet P, Audebert S, Roy S et al. PAXX is an
accessory c-NHEJ factor that associates with Ku70 and has overlapping functions with XLF.
Cell Rep 2016; 17: 541–555.
12. Balmus G, Barros AC,Wijnhoven PW, Lescale C, Hasse HL, Boroviak K et al. Synthetic lethality
between PAXX and XLF in mammalian development. Genes dev 2016; 30: 2152–2157.
PAXX and XLF interplay
V Abramowski et al
451
Cell Death and Differentiation
13. Kumar V, Alt FW, Frock RL. PAXX and XLF DNA repair factors are functionally redundant in
joining DNA breaks in a G1-arrested progenitor B-cell line. Proc Natl Acad Sci USA 2016;
113: 10619–10624.
14. Lescale C, Abramowski V, Bedora-Faure M, Murigneux V, Vera G, Roth DB et al. RAG2 and
XLF/Cernunnos interplay reveals a novel role for the RAG complex in DNA repair. Nat
Commun 2016; 7: 10529.
15. Liu X, Shao Z, Jiang W, Lee BJ, Zha S. PAXX promotes KU accumulation at DNA breaks and
is essential for end-joining in XLF-deficient mice. Nat Commun 2017; 8: 13816.
16. Mashiko D, Fujihara Y, Satouh Y, Miyata H, Isotani A, Ikawa M. Generation of mutant mice by
pronuclear injection of circular plasmid expressing Cas9 and single guided RNA. Sci Rep
2013; 3: 3355.
17. Vera G, Rivera-Munoz P, Abramowski V, Malivert L, Lim A, Bole-Feysot C et al. Cernunnos
deficiency reduces thymocyte life span and alters the T cell repertoire in mice and humans.
Mol Cell Biol 2013; 33: 701–711.
18. Li G, Alt FW, Cheng HL, Brush JW, Goff PH, Murphy MM et al. Lymphocyte-specific
compensation for XLF/cernunnos end-joining functions in V(D)J recombination. Mol Cell
2008; 31: 631–640.
19. Roque T, Haton C, Etienne O, Chicheportiche A, Rousseau L, Martin L et al. Lack of a
p21waf1/cip -dependent G1/S checkpoint in neural stem and progenitor cells after DNA
damage in vivo. Stem cells 2012; 30: 537–547.
20. Teague TK, Tan C, Marino JH, Davis BK, Taylor AA, Huey RW et al. CD2 expression
redefines thymocyte development during the pre-T to DP transition. Int Immunol 2010; 22:
387–397.
21. Kajikhina K, Tsuneto M, Melchers F. B-lymphopoiesis in fetal liver, guided by chemokines.
Adv Immunol 2016; 132: 71–89.
22. Hung PJ, Chen BR, George R, Liberman C, Morales AJ, Colon-Ortiz P et al. Deficiency of
XLF and PAXX prevents DNA double-strand break repair by non-homologous end joining in
lymphocytes. Cell Cycle 2017; 16: 286–295.
23. Zha S, Guo C, Boboila C, Oksenych V, Cheng HL, Zhang Y et al. ATM damage response and
XLF repair factor are functionally redundant in joining DNA breaks. Nature 2011; 469:
250–254.
24. Haeussler M, Schonig K, Eckert H, Eschstruth A, Mianne J, Renaud JB et al. Evaluation of
off-target and on-target scoring algorithms and integration into the guide RNA selection tool
CRISPOR. Genome Biol 2016; 17: 148.
25. Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N et al.Multiplex genome engineering using
CRISPR/Cas systems. Science 2013; 339: 819–823.
26. Roederer M. Interpretation of cellular proliferation data: avoid the panglossian. Cytometry A
2011; 79: 95–101.
27. Yu Y, Ceredig R, Seoighe C. LymAnalyzer: a tool for comprehensive analysis of next
generation sequencing data of T cell receptors and immunoglobulins. Nucleic Acids Res
2016; 44: e31.
28. Shugay M, Bagaev DV, Turchaninova MA, Bolotin DA, Britanova OV, Putintseva EV et al.
VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires. PLoS Comput Biol 2015;
11: e1004503.
29. Gartner F, Alt FW, Monroe R, Chu M, Sleckman BP, Davidson L et al. Immature thymocytes
employ distinct signaling pathways for allelic exclusion versus differentiation and expansion.
Immunity 1999; 10: 537–546.
30. Schlissel MS, Corcoran LM, Baltimore D. Virus-transformed pre-B cells show ordered
activation but not inactivation of immunoglobulin gene rearrangement and transcription.
J Exp Med 1991; 173: 711–720.
Supplementary Information accompanies this paper on Cell Death and Differentiation website (http://www.nature.com/cdd)
PAXX and XLF interplay
V Abramowski et al
452
Cell Death and Differentiation
Supplementary	information	
	
Figure	S1:	Strategy	for	CRISPR/Cas9	mutagenesis.	A)	Design	of	gRNA	target	sequences	on	the	
murine	 PAXX	 gene.	 The	 PAXX1	 (Exon	 1)	 and	 PAXX2	 (Exon	 2)	 gRNA	 encompass	 restriction	
enzyme	 sites	 to	 facilitate	 the	 subsequent	 analysis	 of	mutagenesis	 through	 the	 loss	of	 PCR	
product	 restriction	 digest	 (PCR-RE)	 using	 BsrB1	 and	 SacI	 respectively.	 B)	 Validation	 of	
CRISPR/Cas9	mutagenesis	 upon	 transfection	 of	MEFs	 with	 the	 two	 gRNA	 cloned	 into	 the	
pX330	vector.	BsrBI	and	SacI	undigested	PCR	products	are	diagnostic	of	mutagenesis	using	
PAXX1	 and	 PAXX2	 gRNA	 respectively.	C)	 Screening	 of	 F0	mice	 by	 PCR-RE	 showing	 specific	
retention	of	undigested	PCR	products	for	PAXX1	and	PAXX2	in	4	and	2	animals	respectively.		
	
	Figure	S2:	Schematic	representation	of	Phleomycin	sensitivity	assay	using	the	IncuCyte®	Live	
Cell	Analysis	System.	A)	Sample	images	of	the	IncuCyte®	Live	Cell	Analysis	System	showing	
various	 degrees	 of	 cell	 confluence	 and	 the	 mask	 (orange)	 applied	 to	 calculate	 the	 %	 of	
confluence.	B)	Calculation	of	the	Growth	Index	by	integrating	the	area	under	the	confluence	
curve	using	rectangular	approximation.	Given	i	the	various	time	points	ranging	from	1	to	n,	
the	sum	of	the	area	of	the	rectangle	L*H1	plus	half	the	area	of	the	rectangle	L*H2	gives	the	
area	under	the	curve	between	the	time-points	 i	and	(i+1).	Summing	all	 these	 intermediate	
values	gives	the	total	area	under	the	confluence	curve,	which	 is	considered	as	the	Growth	
index	 (GI).	 C)	 Schematic	 representation	 of	 the	 survival/confluence	 curves	 obtained	 with	
various	MEFs	incubated	with	increasing	doses	of	Phleomycin	(0-200	ng/ml)	over	time.	X4	and	
L4	represent	XRCC4-/-	and	DNA-LigaseIV-/-	MEFs	respectively.	The	IncuCyte®	software	delivers	
Excel	files	with	raw	data	of	confluence	for	each	time	points,	from	which	the	Growth	indexes	
are	calculated	as	described	in	B).	
	
	
	
Figure S3: No difference in the level of spontaneous apoptosis in the brain of PAXX1-/- 
and PAXX2-/- embryos. On the left: Coronal sections of cerebral hemispheres of PAXX1-/- 
and PAXX2-/- embryos at E12.5. A) and of PAXX1-/-Xlf-/- and PAXX2-/-Xlf-/- embryos at E15.5 
B) stained with DAPI (gray) and CC3 (red). Blood vessels are colored in orange. On the Right: 
quantification of the numbers of CC3+ cells in the Neocortex A) and the ganglionic eminences 
at E12.5 B). Data have been obtained from 3 embryos per group. 	
	
